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Summary 
 
Bacteria have evolved chemical-mediated cell-to-cell communication systems (quorum sensing) to 
coordinate gene expression and group activities within communities. Quorum sensing systems exist 
in a wide range of different bacterial species and play major roles in determining virulence factor 
production, adaption and biofilm formation. 
 
Biofilms are complex microbial communities consisting of microcolonies embedded in self-
produced extracellular polymer substances. It has been estimated that 65% of microbial infections 
in the developed countries are associated with biofilms. Biofilm bacteria show much greater 
resistance to antimicrobial agents than their free-living counterparts, and therefore give rise to 
persistent infections.  
 
Biofilm development is a dynamic and complicated process which involves many different 
components and group activities such as cell surface structures (e.g. type IV pili), motility, 
chemotaxis, subpopulation differentiation, and iron siderophore synthesis. Understanding the 
regulation mechanisms of bacterial biofilm development can provide knowledge for better control 
of biofilm related problems.  
 
Pseudomonas aeruginosa is an important opportunistic pathogen, and a model organism for biofilm 
studies. The P. aeruginosa biofilm matrix contains primarily polysaccharides, proteins and 
extracellular DNA (eDNA). This Ph.D. project aimed at understanding roles of quorum sensing in P. 
aeruginosa biofilm structure development, and in addition an identification of potential 
antipathogenic drugs targeting P. aeruginosa quorum sensing was carried out. The Pseudomonas 
quinolone signal (PQS)-mediated quorum sensing system was identified to be necessary for release 
of eDNA which was shown to play a key role in P. aeruginosa biofilm structure development and 
maintenance. The spatiotemporal pattern of PQS synthesis gene expression in P. aeruginosa 
biofilms was monitored and found to be in accordance with the pattern of eDNA release. A high 
iron concentration was found to reduce P. aeruginosa PQS synthesis, eDNA release and biofilm 
formation. A transposon insertion mutant library was constructed and mutants deficient in eDNA 
release were identified. The majority of the eDNA release deficient mutants had the transposon 
inserted in genes directly involved in the PQS synthesis pathway. A tatA mutant, which is defective 
in the twin-arginine translocation (Tat) system, was DNA release deficient, and was found to 
synthesize the same amount of PQS as its parent strain, but failed to release PQS to the extracellular 
environment. These studies indicated that PQS synthesis and its release process are involved in 
eDNA release. In addition, the two different group activities, PQS mediated eDNA release, and 
pyoverdine mediated iron up take, were studied and found to mediate subpopulation interactions in 
P. aeruginosa biofilms. Finally, a high-throughput virtual screening of P. aeruginosa quorum 
sensing inhibitors was performed via computer based molecular docking methods. Several 
recognized drugs were identified and verified as quorum sensing inhibitors, which could 
significantly reduce virulence and biofilm formation by P. aeruginosa. 
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中文简介 
 
     细菌生物膜（biofilm）是指由细菌黏附于固体或有机腔道表面后，并分泌多糖蛋白聚
合物（Extracellular Polymeric Substances）将自身包裹其中而形成的膜状物。细菌生物
膜广泛存在于自然界，在医疗、食品、工业、军事等诸多领域给人类社会带来了严重的危
害，造成巨大的经济损失。细菌生物膜的成分比较复杂，其主要生物大分子有蛋白质、多
糖、DNA、肽聚糖、脂和磷脂等物质。这些物质对细菌的初期黏附和维持生物膜的结构都有
重要的作用。这些大分子的合成和释放机制还不是非常的清楚。生物膜的形成是一个非常复
杂的动态过程。细菌的表面附属结构（如鞭毛和纤毛），分泌系统 （secretion），移动能
力 （motility），密度感应系统（quorum sensing），化学趋化（chemotaxis）系统等都
在生物膜的形成中发挥作用。 
   目前，由于铜绿假单胞菌(Pseudomonas aeruginosa)形成生物膜而引发的感染已成为
医院亟待解决的问题之一。铜绿假单胞菌是一种非发酵革兰阴性杆菌。对人类而言，铜绿假
单胞菌属于条件致病菌。长期应用激素、免疫抑制剂，进行肿瘤化疗、放射治疗、大面积烧
伤等导致病人免疫功能低下，以及手术后或某些治疗操作后 (如气管切开、保留导尿管等)
的病人易导致本菌感染，故认为该菌为医院内感染的重要病原菌之一。铜绿假单胞菌感染是
高加索人群最常见遗传病囊肿性纤维化（Cystic Fibrosis，CF）患者的主要致死原因。 
 
本研究以铜绿假单胞菌作为模式菌株，通过转座文库的构建，荧光标记，基因芯片，蛋白质
组学等手段，以激光共聚焦显微镜为工具来研究生物膜形成的分子机制、生理生化特点及其
调控机理。同时，本研究还通过分子对接及虚拟筛选来寻找抑制细菌密度感应系统及生物膜
形成的新药物。本研究的主要结果如下: 
 
（1）铜绿假单胞菌生物膜的组成。 
     通过建立转座文库，本研究发现了调控铜绿假单胞菌生物膜膜基质多糖蛋白聚合物中
主要成分胞外核算（extracellular DNA）相关的一系列基因。研究显示 DNA 主要来自一部
分细胞的死亡，而这种细胞死亡又是受环境中的营养因素（比如铁离子浓度）及密度感应系
统调控的。同时该文库还表明表面附属结构，分泌系统，移动能力及信号传导系统相关的基
因都能调控细胞死亡，由此推断细胞死亡是在生物膜形成的动态过程中发生的。 
 
（2）铜绿假单胞菌生物膜的形成及其对耐药性的影响。 
     通过荧光标记和激光共聚焦显微镜研究，揭示了铜绿假单胞菌生物膜动态发展过程
（粘附，菌落的形成、发展和成熟）中细胞死亡的发生及其对生物膜结构和生理生化的影
响。并进一步阐明了其与抗生素耐药性与生物膜中不同亚群的分化有关。生物膜中不同的亚
群有着不同的生长速率和对抗生素的耐药性。 
 
（3）计算机辅助药物设计在铜绿假单胞菌感染中的应用。 
     通过分子对接（Molecular Docking）其对大量化合物数据库进行虚拟筛选 （Virtual 
Screen），从已知的药物库中筛选出了 3 中能够抑制铜绿假单胞菌的密度感应系统，毒素释
放及生物膜形成的药物，这些药物将在小鼠肺部感染模型中进行测试。 
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1 Introduction 
 
This initial chapter aims at introducing bacterial cell-to-cell communication (quorum sensing), the 
biofilm mode of growth, and the problems caused by biofilms. 
 
1.1 Quorum sensing - small molecules play a big role 
 
Bacteria have evolved chemical-mediated cell-to-cell communication systems to coordinate gene 
expression and group activities within communities, which was defined as ‘quorum sensing’ by Dr. 
Peter Greenberg in 1994 (Fuqua et al., 1994). Quorum sensing is widely spread in the bacterial 
kingdom, with many different species ‘speaking’ systems (Gray & Garey, 2001). Within a 
community, individual bacterial cells produce and respond to their specific secreted small 
molecules (often referred to as autoinducers). Despite the fact that there are a variety of different 
quorum sensing autoinducers, the principles of quorum sensing are conserved in a wild range of 
bacteria (Gray & Garey, 2001). As a bacterial population is growing, the level of the released 
autoinducer increases with the increasing cell number. When the autoinducer level reaches a crucial 
threshold level, the quorum sensing system will be activated and cause a population-wide alteration 
of gene expression. Autoinducers thus coordinate the gene expression of individual cells within 
communities to perform group activities and this phenomenon only happens when bacterial cells 
live together in communities.  
 
There are generally three major classes of bacterial quorum sensing systems based on the type of 
autoinducer signals and the receptors used for its detection. First, gram negative bacteria typically 
use LuxI/R quorum-sensing systems (Fuqua et al., 1994) (Figure 1, left column). LuxI is an enzyme 
that synthesizes an acylated homoserine lactone (AHL) based autoinducer which interacts with the 
transcriptional regulator LuxR and then controls transcription of quorum-sensing target genes. 
LuxI/R systems are found existing in more than 70 species of gram negative bacteria (Henke & 
Bassler, 2004; Miller & Bassler, 2001). The second class of quorum sensing systems exists in gram 
positive bacteria, where modified oligopeptides are used as autoinducers (Figure 1, center column). 
The extracellular peptide autoinducer is recognized by a two-component signal transduction protein 
called sensor histidine kinase (Hakenbeck & Stock, 1996). The sensor histidine kinase then 
transmits sensory information via phosphorylation of a two-component response regulator protein 
and modifies its DNA binding activity and thus enables it to control transcription of quorum-
sensing target genes (Hakenbeck & Stock, 1996). The third class of quorum sensing systems is a 
combination of the gram negative and gram positive systems (Figure 1, right column). Small 
molecule autoinducer (e.g. AHL) is synthesized and released into the environment like the first 
quorum sensing systems among gram negative bacteria. However, the sensing of the autoinducer 
and control of transcription of quorum-sensing target genes is through a two-component signal 
transduction system like the second class of quorum sensing system among gram positive bacteria 
(Bassler et al., 1993; Bassler et al., 1994; Chen et al., 2002). Besides the above three quorum 
sensing systems, there are many minor quorum sensing systems which only exist in certain 
organisms.  
 
One thing that needs to be taken into consideration is that some autoinducer signals can be used for 
interspecies interactions. For example, P. aeruginosa, which does not possess the luxS gene and 
does not produce autoinducer II was shown be able to respond to autoinducer II produced by 
indigenous (nonpathogenic) populations in cystic fibrosis (CF) sputum samples from host 
microflora (Duan et al., 2003). In mixed biofilms formed by P. aeruginosa and Burkholderia 
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cepacia, B. cepacia was capable of sensing the AHL signals produced by P. aeruginosa (Riedel et 
al., 2001).  
 
Quorum sensing systems are used to regulate important behaviors that are most effective when 
coordinated within a large population, including production of virulence factors, motilities, 
production of iron chelators, exoenzymes, antibiotics, biofilm formation and so on (Williams et al., 
2000). Many of these quorum sensing regulated behaviors share another important feature – energy 
costing. Thus quorum sensing provides a way where bacteria can coordinate cooperative group 
activities. Quorum sensing determined virulence factors play an important role in infection diseases 
caused by pathogenic bacteria and quorum sensing systems are potential drug targets for infection 
diseases treatments (Hentzer et al., 2003). 
 
 
 
Fig. 1. The three general classes of quorum-sensing systems in bacteria (Henke & Bassler, 2004).  
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In P. aeruginosa, there are three interconnected quorum sensing systems las, rhl and pqs and 
together they control expression of a wide range of virulence factors (Latifi et al., 1995; Passador et 
al., 1993; Pesci et al., 1999).  The major signal molecules involved are 3-oxo-C12-homoserine 
lactone (3-oxo-C12-HSL) in the case of the las system, C4-HSL in the case of the rhl system, and 
2-heptyl-3-hydroxy-4-quinolone, designated the Pseudomonas quinolone signal (PQS), in the case 
of the pqs system (Latifi et al., 1996; Pesci et al., 1999). Fig. 2 summarized the synthesis and 
interactions of the three different quorum sensing systems in P. aeruginosa (Dubern & Diggle, 
2008). In P. aeruginosa, the las system is required for full expression of pqsH, and pqsR is 
positively regulated by LasR/3-oxo-C12-HSL. In contrast, both pqsA and pqsR are repressed by the 
rhl system. PQS can induce the expression of pqsA in a PqsR dependant manner (Dubern & Diggle, 
2008). 
 
 
 Fig. 2. P. aeruginosa quorum sensing systems.      represents positive regulation;      represents negative regulation. 
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1.2 Biofilms - together we stand 
 
1.2.1 Biofilm definition and problems 
 
In the past centuries, it was well known by human beings that bacteria live as unicellular lives. The 
traditional way of culturing bacteria in liquid medium has been adopted in studying of microbial 
pathogenesis and revealed some of the essential facets of microbial physiology. However, pure 
culture planktonic cells are rarely how bacteria exist in nature. Recent development in microscopy 
and molecular technologies has enabled us to observe the complex microbial communities in situ in 
great detail.  Direct observation of a wide range of natural microorganisms has revealed the fact that 
the majority of microbes persist as surface attached communities surrounded by self-produced 
matrix materials, also called biofilms (Costerton et al., 1995). Fig. 3 shows a staphylococcal biofilm 
on the inner surface of an indwelling medical device, where bacterial cells are entrapped by an 
extensive amount of slime matrix material.  
 
Fig. 3. Scanning electron micrograph of a staphylococcal biofilm on the inner surface of an indwelling medical device. 
Photograph by Janice Carr, CDC (http://www.medscape.com).  
 
What drive bacteria to produce biofilms? It was proposed by Jefferson in his review that there could 
be at least four explanations: (1) protection from harmful conditions in the host (defense), (2) 
sequestration to a nutrient-rich area (colonization), (3) utilization of cooperative benefits 
(community), (4) bacteria normally grow as biofilms and planktonic cultures are an in vitro artifact 
(biofilms as the default mode of growth) (Jefferson, 2004). There will be more details about the 
biofilm formation mechanisms discussed in the next chapter.  
 
Biofilm formation has brought huge amounts of problems to our everyday life (Fig. 4 and Fig. 5). 
Microbial biofilms cost billions of dollars every year world wide in equipment damage, product 
contamination, energy losses and medical infections. Conventional methods for eradicating bacteria 
such as antibiotics, and disinfection are often ineffective to biofilm populations due to their special 
physiology and physical matrix barrier (Stewart, 2002). So novel strategies based on a better 
understanding of the biofilm formation mechanisms are urgently needed by many industries as well 
as hospitals.  
 5
 
Fig.4. Problems duo to bacterial biofilms (http://www.erc.montana.edu/) 
 
 
Fig. 5. Human infections diseases caused by bacterial biofilms (del Pozo & Patel, 2007). (1) Chronic sinusitis. (2) 
Central nervous system shunt infection. (3) Contact lens-associated keratitis. (4) Chronic otitis media. (5) Cochlear 
implant infection. (6) Burn-related infection. (7) Intravascular catheter infection. (8) Prosthetic valve endocarditis. (9) 
Pacemaker infection. (10) Electrophysiological wire endocarditis. (11) Biliary stent infection. (12) Peritoneal dialysis 
catheter infection. (13) Prosthetic joint infection. (14) Urinary stent infection. (15) Intravascular stent infection. (16) 
Pulmonary infection in cystic fibrosis patient. (17) Ventilator associated pneumonia. (18) Breast implant infection. 
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The formation of biofilms is a complicated process which involves many physiological activities 
and is highly dependent on the environmental factors (e.g. oxygen level, shear force, nutrition). 
Scientists often term this process ‘biofilm development’. Biofilm development is a dynamic process 
which can be shown as Fig. 6. In a recent review by Monds and O’Toole, a criteria for microbial 
biofilm development was proposed as following (Monds & O'Toole, 2009): 
 
“ 
• Changes in form and function that are part of the normal life cycle of the cell. 
• Genetic pathways regulate stage-specific transitions in form and function in response to environmental cues. 
• Genetic pathways directly couple changes in form with changes in function. 
• Genetic pathways are hierarchically ordered, with hierarchical divisions serving as checkpoints enforcing 
coordination and directionality of development. 
• Developmental pathways have evolved as dedicated systems for regulation of biofilm formation. 
• The developmental model describes biofilm formation in terms of a multicellular process, wherein genetic 
pathways are presumed to have evolved to facilitate cooperation among members of the biofilm. 
                                                                                                                                                             ” 
 
 
Fig. 6 An example showing the development of a biofilm as a five-stage process under continuous-flow conditions. 
Stage 1: initial attachment of cells to the surface. Stage 2: production of EPS resulting in more firmly adhered cells. 
Stage 3: early development of biofilm architecture. Stage 4: maturation of biofilm architecture. Stage 5: dispersion of 
single cells from the biofilm. The bottom panels (1-5) show each of the five stages of development represented by a 
photomicrograph of P. aeruginosa when grown under continuous-flow conditions on a glass substratum (Stoodley et al., 
2002). 
 
No matter which models are used to describe biofilm development, the two things microbiologists 
interested in are always the biofilm cells and extracellular polymeric substances (EPS). The cell 
physiology has been extensively studied by using reporter genes, mutation analysis, transcriptomics 
and proteomics (Stewart & Franklin, 2008). These studies showed that cells with diverse genotypes, 
phenotypes, distinct metabolic pathways, stress responses and other specific biological activities 
coexist in biofilms (Stewart & Franklin, 2008). At the same time, the biofilm EPS matrix is also 
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well characterized with the help of chemical methods such as HPLC and specific staining. The EPS 
varies a lot in different biofilms and consists of a wide variety of proteins, glycoproteins, 
glycolipids, as well as extracellular DNA (e-DNA) (Flemming et al., 2007). The mechanisms that 
contribute to the heterogeneity both in cells and EPS include microscale chemical gradients, 
interspecies interactions, stochastic gene expression and the genotypic variation that occurs through 
mutation and selection (Parsek & Tolker-Nielsen, 2008; Stewart & Franklin, 2008).  
 
Matrix components may serve as a “wall” to hinder penetration of bactericidal agents into biofilms. 
The heterogeneity in biofilms can greatly facilitate the adaptation of bacterial cells under harmful 
conditions, which brings many problems (such as persister cells and antibiotic tolerant 
subpopulation development) for treatment of biofilm related infections diseases (see Fig. 7a & 7b).   
 
a                                                                                       b 
   
 
Fig. 7. Biofilm drug resistance. Figure 7a shows a model of biofilm resistance to killing based on persister survival. 
Initial treatment with antibiotic kills normal cells (coloured green) in both planktonic and biofilm populations. The 
immune system kills planktonic persisters (coloured pink), but the biofilm persister cells (coloured pink) are protected 
from the host defences by the exopolymer matrix. After the antibiotic concentration is reduced, persisters resuscitate 
and repopulate the biofilm and the infection relapses (Lewis, 2007). Figure 7b shows distribution of live (green) and 
dead (red) cells in EDTA (upper) and ciprofloxacin (down) treated P. aeruginosa biofilms (Liang Yang, unpublished).  
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1.2.2 Social activities in bacterial biofilms 
 
It is well know now that bacteria and other microorganisms exhibit a wide range of social behaviors 
involving complex systems of cooperation, competition, adaptation, communication and 
synchronization just as mammals, birds and insects (Crespi, 2001). Microorganisms are ideal for 
social behavior studies since they have short generation times and are easy for genetic 
manipulations. The social lives of microbes have a significant impact on our everyday lives: 
cooperative behaviors play key roles in the microbial infections to humans, animals and agriculture 
plants (Kolter & Greenberg, 2006; Williams et al., 2000). Biofilm formation involve many different 
group activities such as quorum sensing, iron siderophore production and rhamonolipid production 
(Banin et al., 2005; Davey et al., 2003; Davies et al., 1998). These activities can determine the 
structure and antibiotic resistance of biofilms.   
 
One of the most common forms of social behaviors in microbes is the production of public goods. 
Public goods are products manufactured by an individual cell that can be utilized by itself or its 
neighbors (West et al., 2006). However, the production of public goods will usually lead to the 
problem of cheating due to the fact that it is metabolically costly for the individuals who produce 
public goods. Cheaters who do not produce but could use public goods will evolve. According to 
the different consequences of both the actor and the recipient caused by the public goods, the social 
behaviors could be classified into four categories (Table 1). 
 
 
 
Table 1. Social behaviors can be classified according to the fitness consequences they encounter for the actor and 
recipient. A behavior increasing the direct fitness of the actor is mutually beneficial if the recipient also benefits, while 
selfish if the recipient suffers a loss. A behavior reducing the fitness of the actor is altruistic if the recipient benefits, 
while spiteful if the recipient suffers a loss (West et al., 2006). 
 
Bacteria produce numerous extracellular public goods that are released into the environment (Table 
2) (West et al., 2007). The following figure has illustrated the problem of cooperation (Fig. 8). 
There are many unknown mechanisms regarding bacterial cooperative activities. For example, how 
a single bacterial cell can sense its relatedness with the neighbor cells around it? How the genes in 
different bacterial cells are coordinated to express at the same time to perform the cooperative 
activities?  
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Table 2. Potential public goods (West et al., 2007). 
 
 
 
Fig. 8. The problem of cooperation (West et al., 2007). 
 
 10
1.2.3 Biofilm investigation approaches 
 
Microtiter plates are used very often to quantify biofilm formation by crystal violate assay (O'Toole 
& Kolter, 1998). Colony morphology in agar plates containing Congo red dye is also used as a 
indication of production of biofilm EPS materials (Friedman & Kolter, 2004a). To visualize the 
dynamic biofilm development, scientists often use flow-cell technology in combination with 
confocal laser scanning microscopy (CLSM) as a gold standard. With the help of fluorescent 
reporter proteins and staining, researchers can observe the biofilm development such as spatial 
organization, gene expression and antibiotics resistance in real time under different conditions. A 
standard flow-chamber biofilm cultivation system is illustrated in Fig. 9. A detail protocol of flow-
chamber biofilm system set up was described by Sternberg & Toker-Nielsen (Sternberg & Tolker-
Nielsen, 2006).  
 
 
Fig. 9. Schematic representation of the flow-chamber biofilm cultivation system. A peristaltic pump is used to maintain 
a continuous flow of media through the flow-chambers and bubble traps are interconnected to catch air bubbles arising 
during cultivation (Barken & Haagensen, unpublished). 
Other biofilm investigation technology includes scanning electron microscopy (SEM) and atomic 
force microscopy (AFM). These two technologies can observe biofilm structure and topography in 
really high resolution. However, the biofilm samples will usually be destroyed after observation of 
SEM or AFM.  
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2 P. aeruginosa biofilm development 
 
A large part of the mechanisms of subpopulation differentiation and interactions during microbial 
biofilm development still remains unknown. Understanding these mechanisms can further help us to 
build novel strategies to eradicate bacterial biofilms. P. aeruginosa is used as a model organism to 
study biofilm development in this PhD thesis. 
 
 
2.1 Extracellular polymeric substances (EPS) in P. aeruginosa biofilms 
 
P. aeruginosa is a gram negative bacterium which exists in a varity of environmental conditions.  P. 
aeruginosa is an important opportunistic pathogen which can cause a wide range of human 
infections such as pulmonary infections, medical-device-related infections, urinary tract infections, 
wound infections and bacteremia (Bodey et al., 1983). P. aeruginosa is notorious for its tolerance to 
antimicrobial agents and this is to a large extent due to its ability to form biofilms (Costerton et al., 
1995; Costerton et al., 1999). 
 
The EPS materials of P. aeruginosa biofilms vary a lot in composition. Extracellular DNA, 
exopolysaccharide and proteinaceous compounds can all function as matrix components in P. 
aeruginosa biofilms, and that their relative importance as structural component may depend on the 
environmental conditions, the age of the biofilm and the particular P. aeruginosa strain forming the 
biofilm (Flemming et al., 2007).  
 
There are three well studied exopolysaccharides, Pel, Psl and alginate that contribute to biofilm 
formation in P. aeruginosa (Friedman & Kolter, 2004b; Ryder et al., 2007; Stapper et al., 2004).   
The Pel polysaccharide is synthesis through the pel gene cluster (Friedman & Kolter, 2004a). 
Friedman & Kolter showed that P. aeruginosa PA14 pel mutant in could not form a pellicle at the 
air-liquid interface of bacterial cultures grown in static conditions. They have further showed that 
the pel mutants are unable to form robust biofilms on a solid surface of plastic or glass. By using 
Congo red staining and carbohydrate linkage analysis, Friedman & Kolter provided evidence that 
the pel genes encode a glucose-rich matrix polysaccharide polymer, which does not appear to be 
cellulose (Friedman & Kolter, 2004a; Friedman & Kolter, 2004b). In a later study, Vasseur and 
colleges showed that Pel polysaccharide play a compensate role of type IV pili in the initial phase 
adherence of bacterial cells (Vasseur et al., 2005). The Pel polysaccharide synthesis genes, pelA–G,  
are highly conserved in other P. aeruginosa strains (Ryder et al., 2007). CF clinical isolates which 
autoaggregate in liquid culture and hyperadhere to solid surfaces were shown increased their 
expression of the psl and pel loci (Kirisits et al., 2005). However, there is no immunological or 
lectin reagents available for probing pel expression or localization in developing P. aeruginosa 
biofilms until now (Ryder et al., 2007).  
  
The Psl polysaccharide is encoded from the polysaccharide synthesis locus (PA2231-2245), which 
is another crucial EPS component for bacterial adherence and biofilm development (Jackson et al., 
2004; Matsukawa & Greenberg, 2004). It was suggested that the Psl polysaccharide was mainly 
composed of mannose, galactose, rhamnose, glucose, and trace amounts of xylose (Ma et al., 2007). 
Until recently, Ma and colleagues used fluorescently labeled lectins MOA (from Marasmium 
oreades agglutinin) and HHA (from Hippeastrum hybrid) to stain and visualize Psl polysaccharide 
in P. aeruginosa biofilms (Ma et al., 2009). They have found that Psl polysaccharide forms a matrix 
to hold bacterial cells in the biofilm and on the surface at the early stage of biofilm development 
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and accumulates on the periphery of 3D-structured macrocolonies during the biofilm maturation 
(Ma et al., 2009). The Psl polysaccharide synthesis genes and there putative functional annotations 
are listed in Fig. 10 as well as the Pel polysaccharide synthesis genes. 
 
Fig. 10. Structure of pel and psl operons. Putative functions and localization of Pel and Psl polysaccharide enzymes are 
shown (M-membrane, C-cytoplasm, S-secreted) (Ryder et al., 2007). 
 
Unlike the above polysaccharides, alginate is a kind of special polysaccharide mainly found from P. 
aeruginosa clinical isolates from patients with life threating Cystic Fibrosis (CF)  (Govan & Deretic, 
1996; Hoiby, 1974). In CF patients, especially chronic pulmonary infected CF patients, P. 
aeruginosa mucoid phenotype can be isolated quite often (Fig. 11). The mucoid P. aeruginosa 
strains over produce copious quantities of alginate polysaccharide, which can help P. aeruginosa 
strains to adapt to the CF lung conditions (Govan & Deretic, 1996; Hoiby, 1974). Alginate is a high 
molecular weight, acetylated polymer composed of non-repetitive monomers of β-1,4 linked L 
guluronic and D-mannuronic acids (Govan & Deretic, 1996). Its special physical and chemical 
properties have multiple roles in protecting P. aeruginosa cells (Govan & Deretic, 1996). 
Nevertheless, alginate was shown not to be a necessary component for in vitro P. aeruginosa 
biofilm development (Wozniak et al., 2003). 
 
 
          
Fig. 11. P. aeruginosa nonmucoid strain (left) and mucoid strain (right) on plates (Darzins & Chakrabarty, 1984). 
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Recently, extracellular DNA (eDNA) was recognized as one of the major EPS matrix components 
of bacterial biofilms (Qin et al., 2007; Rice et al., 2007; Whitchurch et al., 2002). It was shown that 
DNase treatment lead to dispersal of young P. aeruginosa biofilms (Fig. 12) (Whitchurch et al., 
2002). However, DNase will not disperse P. aeruginosa mature biofilms formed in this flow 
chamber system probably due to the increasing amount of other EPS materials. 
 
 
 
Fig. 12. DNase treatment of P. aeruginosa biofilms at different development stages (Whitchurch et al., 2002).  
 
In a recent study, our group showed that eDNA was mainly localized in the out layer of the stalk 
subpopulation of the 3D mushroom like structures of P. aeruginosa biofilm, which can be 
visualized by cell non-permeable fluorescent DNA specific staining propidium iodide (PI) and 
ethidium bromide (EB)  (Fig. 13) (Allesen-Holm et al., 2006). This localization was in accordance 
with the interface between motile subpopulations and non-motile subpopulations (Haagensen et al., 
2007; Klausen et al., 2003), and which suggests us that eDNA release in P. aeruginosa biofilms 
might come from some group activities involved in subpopulation interactions. I will discuss about 
this in the next chapter.   
 
Unlike the production of Pel, Psl and alginate polysaccharides as EPS materials, it is hard for us to 
understand why bacteria will release DNA as EPS material. Polysaccharides are relatively simple 
molecules and easy to synthesize while DNA is a complicated molecule containing genetic 
information of an organism. By chemical analysis, our group as well as other groups showed that 
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eDNA in the biofilm matrix was chromosome DNA (Allesen-Holm et al., 2006; Qin et al., 2007). 
eDNA was shown by our group to serve as an interconnector between the motile and non-motile 
subpopulations and it could significant reduce the dispersion effects of detergent sodium dodecyl 
sulfate (SDS) on P. aeruginosa biofilms (Allesen-Holm et al., 2006; Barken et al., 2008).  
 
 
Fig. 13. eDNA visualized by cell non-permeable fluorescent DNA specific staining propidium iodide (PI) (A, B, C) and 
ethidium bromide (EB) (D, E, F). 4-day-old gfp tagged PAO1 biofilms were showed by a top-down views (A, D) and 
horizontal optical sections (B, C, E, F) (Allesen-Holm et al., 2006). The bars represent 50 µM.  
 
To investigate the mechanisms of eDNA release in P. aeruginsoa biofilms, Allesen-Holm and 
colleagues screened a couple of P. aeruginosa lab strains and mutants (Allesen-Holm et al., 2006). 
They found that release of eDNA is regulated through the N-Acyl Homoserine Lactone (AHL) 
mediated quorum sensing systems and Pseudomonas quinolone signal (PQS) mediated quorum 
sensing system (Allesen-Holm et al., 2006). AHL quorum sensing system was reported to be able to 
control PQS quorum sensing system and this means that studying the PQS quorum sensing system 
could help to identify genes that directly control eDNA release of P. aeruginosa (Diggle et al., 2003; 
McGrath et al., 2004). The detail mechanism of PQS mediated cell lysis is still unclear. Membrane 
vesicles containing DNA and other virulence factors were shown to be released from the outer 
membrane of P. aeruginosa cells under PQS regulation (Mashburn & Whiteley, 2005). Membrane 
vesicles were found to be a common particulate feature of the matrix of Pseudomonas aeruginosa 
biofilms (Schooling & Beveridge, 2006). Other studies showed that PQS was an iron chelator 
(Bredenbruch et al., 2006) and it was wrapped together with iron and other molecules as inclusion 
bodies in periplasmic vacuoles (Royt et al., 2007). Recently, PQS was reported acting as a pro-
oxidant and sensitizes the bacteria towards oxidative stress and other stresses (Haussler & Becker, 
2008) and this may provide another explanation of cell lysis. To better understand P. aeruginosa 
biofilm development, more studies are needed to be carried out about PQS mediated DNA release.  
 
It is mentioned above that localization of eDNA is in accordance with the interface between motile 
subpopulation and non-motile subpopulation of P. aeruginosa biofilms (Allesen-Holm et al., 2006). 
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It seems that eDNA release might be due to interactions between motile and non-motile 
subpopulations during P. aeruginosa biofilm development.  
 
2.2 Group activities in P. aeruginosa biofilm development 
 
Several models describing P. aeruginosa biofilm development were summarized by Kirisits and 
Parsek in a recent review (Kirisits & Parsek, 2006). Many group activities are involved in biofilm 
structure development and maintenance. eDNA release described above is just an example of group 
activity in P. aeruginosa biofilm development.  
 
2.2.1 Motilities 
 
Our group has used a two strain model to study different group activities in P. aeruginosa biofilm 
development. In this model, a mixture of yellow fluorescent protein (Yfp) tagged P. aeruginosa 
wild type and cyan fluorescent protein (Cfp) tagged pilA mutant (deficient in biogenesis of type IV 
pili) was grown in minimal medium supplemented with glucose as carbon source and developed 
mushroom-like biofilm structures. As shown in Fig. 14, the pilA mutants could only form stalks 
whereas the wild-type bacteria formed all the caps, suggesting that type IV pili are necessary for 
cap formation (Klausen et al., 2003). Because cap formation was shown to occur via bacterial 
migration and require type IV pili, the process was suggested to involve type IV pili mediated 
migration (Klausen et al., 2003).  
 
 
 
Fig. 14. Mushroom-shaped multicellular biofilm structures with yellow caps and cyan or yellow stalks. CLSM images 
were acquired in a 4-day-old biofilm which was initiated with a 1:1 mixture of Yfp tagged P. aeruginosa PAO1 wild 
type and Cfp tagged pilA derivative and grew on glucose minimal medium. The bars represent 20 µM. Biofilms were 
showed by a horizontal optical section view (A) and 3D view (B) (Klausen et al., 2003). 
 
Since we also found that eDNA was mainly localized within the interface between motile 
subpopulation and non-motile subpopulation (Allesen-Holm et al., 2006), it would be interesting to 
study whether eDNA play a role in the migration of P. aeruginosa PAO1 wild type onto the pilA 
stalk. Based on this concept, a pilAlasRrhlR mutant was constructed and tagged with Cfp by Barken 
and collegues (Barken et al., 2008). This strain was defective at both type IV pili and AHL 
mediated quorum sensing as well as eDNA release. When this mutant was mixed with a Yfp tagged 
PAO1 wild type in biofilms, PAO1 wild type tend to form independent mushroom like biofilm 
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structures instead of associating with the pilAlasRrhlR mutant (Fig. 15) (Barken et al., 2008). In 
addition, feeding the pilA Cfp/PAO1 Yfp mixed biofilm medium with DNaseI after 2 days of 
cultivation could significant repress the association of the two strains and mushroom like biofilm 
structure development (Barken et al., 2008). However, quorum sensing controls production of a 
wide range of other factors such as rhamnolipid, which is also necessary for P. aeruginosa biofilm 
development (Pamp & Tolker-Nielsen, 2007). Thus the structures of pilAlasRrhlR Cfp/PAO1 Yfp 
mixed biofilms and pilA Cfp/PAO1 Yfp mixed biofilms fed with DNaseI in the medium were 
different (Barken et al., 2008). 
 
 
Fig. 15.  Confocal laser scanning micrographs of a 2-day-old (A) and 4-day-old (B) biofilms formed by a mixture of P. 
aeruginosa pilAlasRrhlR Cfp and wild-type Yfp. The central images show top-down views and the flanking images 
show vertical optical sections (Barken et al., 2008). The bars represent 20 µM. 
 
The above example shed some light on how eDNA release is involved in P. aeruginosa biofilm 
development. However, there are still many mechanisms about this phenomenon remaining 
unknown. For example, which subpopulation (pilA or wild type) in this pilA Cfp/ wild type Yfp 
mixed biofilm contributes to the eDNA release? Why wild type subpopulation will associate with 
pilA subpopulation since the competition for nutrition will be high when they stay together?  
 
2.2.2 Quorum sensing 
 
In biofilms, bacterial cells encounter much higher local cell densities than their planktonic 
counterparts. An obvious consequence of this is the elevated levels of local nutrition competition, 
metabolic by-products, secondary metabolites and other secreted or excreted microbial factors 
(Parsek & Greenberg, 2005). How these activities are coordinated and contribute together to P. 
aeruginosa biofilm development is still largely unknown. Quorum sensing was shown to play an 
important role on regulating gene expression in a density dependent manner in many organisms 
(Henke & Bassler, 2004). There is no doubt it can regulate many essential pathways and products 
for P. aeruginosa biofilm development (Kirisits & Parsek, 2006; Parsek & Greenberg, 2005). 
  
As a high level regulator, quorum sensing was shown to be able to regulate other group activities 
such as biosurfactant rhamnolipid synthesis, swarming motility, and iron siderophore pyoverdine 
synthesis (Wagner et al., 2003), which are necessary for P. aeruginosa biofilm development (Banin 
et al., 2005; Lequette & Greenberg, 2005; Pamp & Tolker-Nielsen, 2007). Rhamnolipid synthesis 
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deficient P. aeruginosa rhlA mutant could only form flat biofilms in flow chamber system (Davey 
et al., 2003). A rhlA mutant could only weakly associate with a non-motile pilA mutant and formed 
reduced mushroom like biofilm structures in mixed biofilm cocultures (Fig. 16A) (Pamp & Tolker-
Nielsen, 2007). Rhamnolipid may have several functions on the development of the mushroom like 
biofilm structures. Rhamnolipid is required for detachment of the P. aeruginosa cells from the 
substratum (Davey et al., 2003). It also mediates the flagellum mediated swarming motility, which 
was further reported to be necessary for the association of non-motile and motile subpopulations 
(Fig. 16B) (Barken et al., 2008). The P. aeruginosa flagellum deficient fliM mutant and the 
flagellum mediated chemotaxis deficient cheA mutant could not associate with a non-motile pilA 
mutant in mixed biofilm cocultures (Barken et al., 2008). These studies indicated that P. aeruginosa 
type IV pili while not pili mediated motility were necessary for biofilm structure development and 
both flagellum and flagellum mediated chemotaxis were necessary for biofilm structure 
development. It is high possible the requirement of type IV pili for P. aeruginosa biofilm 
development is through its ability to bind with eDNA since it was reported that P. aeruginosa type 
IV pili could bind with DNA at a very high efficiency (van Schaik et al., 2005). 
                 A                                                              B 
    
 
Fig. 16. Confocal laser scanning micrographs of 4-day-old biofilms formed by a mixture of P. aeruginosa pilA Cfp and 
rhlA Yfp mutant  (A) and a mixture of P. aeruginosa pilA Cfp and fliM Yfp mutant. The bar represents 40 µM for A 
and 20 µM for B (Barken et al., 2008; Pamp & Tolker-Nielsen, 2007). 
 
To investigate the role of type IV pili and eDNA interactions during P. aeruginosa biofilm 
development, we have fed eDNA in the medium of P. aeruginosa biofilms cultivated in our 
standard flow chamber system after 2 days of cultivation. The P. aeruginosa wild type PAO1 
formed giant mushroom like structures compared to non-fed control (Fig. 17A), while the pilA 
mutant did not change significantly compared its non-fed control (Fig. 17B). The eDNA fed mixed 
pilA Cfp and wild type Yfp biofilms also develop to giant mushroom like structures compared to 
their non-fed control (Fig. 17C). Considering the existence of large amounts of eDNA in many 
environmental samples as well as the lungs of CF patients (Dell'Anno & Danovaro, 2005; Kirchner 
et al., 1996), the interaction between type IV pili and eDNA might help bacteria to build stable 
biofilm structures.  
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Fig. 17. Confocal laser scanning micrographs of 4-day-old biofilms formed by wild type Gfp (A), pilA Gfp mutant (B) 
and a mixture of pilA Cfp and wild type Yfp. The bars represent 20 µM. (Liang Yang, unpublished). 
 
2.2.3 Iron siderophore production 
 
We have mentioned in the above text that another quorum sensing regulated phenomenon, iron 
siderophore pyoverdine synthesis, are  reported to be necessary for the P. aeruginosa biofilm 
development (Banin et al., 2005). Unlike rhamnolipid, the synthesis of pyoverdine was only 
partially regulated by quorum sensing system, and a quorum sensing lasI mutant produced half 
amount of the pyoverdine compared to its isogenic parent strain (Stintzi et al., 1998). Due to its key 
role in P. aeruginosa growth, the regulation of pyoverdine synthesis is very complicated (Oglesby 
et al., 2008). The synthesis and transportation of pyoverdine to its major receptor fpvA was 
summarized in a review (Poole & McKay, 2003) and is shown in Fig. 18. Recently, it was reported 
that pyoverdine has a second receptor fpvB, which played a relatively less important role compared 
to fpvA and was essential for growth under iron limited condition when fpvA was deficient 
(Ghysels et al., 2004). P. aeruginosa also synthesis another siderophore pyochelin (Heinrichs et al., 
1991) and can uses ferric citrate uptaking pathway when ferric citrate is the iron resource (Cox, 
1980). A pyoverdine deficient pvdA mutant formed a flat biofilm in iron limited medium and 
supplement of ferric citrate to this medium could restore its ability to develop mushroom like 
biofilm structures (Banin et al., 2005). What is more, iron limitation can also induce expression of 
genes involved in production of virulence factors in P. aeruginosa (Cornelis & Aendekerk, 2004).  
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Fig. 18. Illustration of synthesis of pyoverdine and its major receptor fpvA in P. aeruginosa. OM, outer membrane; PP, 
periplasm; CM, cytoplasmic membrane (Poole & McKay, 2003).  
 
Under iron replete conditions (+Fe) the Fur repressor binds to Fur box in the promoter regions and 
blocking gene expression of ECF sigma factor genes (pvdS, fpvI), which are required for 
siderophore (pvd) and receptor (fpvA) gene expression. Under iron-limiting conditions (-Fe), Fur is 
released from the promoters and permit expression of the ECF sigma factors (pvdS, fpvI). (Poole & 
McKay, 2003). Under iron replete conditions, the Fur repressor also represses the expression of two 
regulatory RNAs (sRNAs) encoded by prrF1 and prrF2, which are needed for PQS production 
(Oglesby et al., 2008). Thus, under iron-limiting conditions, Fur can activate production of a series 
of virulence factors through PQS regulation.  
 
It is clear that eDNA release, rhamnolipid synthesis, type IV pili structure, flagellum mediated 
motility and chemotaxis, and iron siderophore pyoverdine synthesis are involved in the association 
of non-motile and motile subpopulations during P. aeruginosa biofilm development. However, 
there are still many unknown gaps between these different events. For example, why there will be 
subpopulation differentiation during P. aeruginosa biofilm development? Which subpopulation 
mainly contributes to the matrix material eDNA release and siderophore synthesis, since these 
activities cost a lot of energy? Understanding these mechanisms will help us develop novel 
treatment strategies for biofilm related infections caused by P. aeruginosa and other bacteria. 
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3 P. aeruginosa virulence inhibition 
 
Biofilms and the emergence of antibiotic resistance have become a major threat for current medical 
treatment for bacterial infection diseases (Costerton et al., 1999; Neu, 1992). Due to the extensive 
using of antibiotics, clinically significant antibiotic resistance has arisen against virtually every 
antibiotic developed (Fig. 19) (Clatworthy et al., 2007). It is a big challenge for us to develop novel 
classes of antibiotics to catch up our growing need for such drugs. Recently, it was proposed by 
many scientists that rather than focusing on therapeutics that target in vitro viability, much like 
conventional antibiotics, we should try an alternative approach which target functions essential for 
infection, such as virulence factors required to cause host damage and disease (Clatworthy et al., 
2007). Also, novel strategies to inhibit bacterial biofilm formation and disrupt mature biofilms are 
obviously in need. In the following text, the concept of anti virulence strategy, anti biofilm strategy 
and computer aided drug design will be introduced.  
 
 
Fig. 19. Schedule of antibiotic deployment and the rise of antibiotic resistance. The year each antibiotic was deployed is 
depicted above the timeline, and the year resistance to each antibiotic was observed is depicted below the timeline 
(Clatworthy et al., 2007). 
 
3.1 Anti virulence strategy development 
Since the discovery of penicillin in 1928, regular antibiotics have routinely been identified based on 
their ability to kill bacteria (bacteriocidal) or inhibit growth (bacteriostatic). These regular 
antibiotics could inhibit a range of bacterial functions that are essential for in vitro growth such as 
cell wall synthesis (Beta-lactams), DNA replication (Fluoroquinolones), and protein synthesis 
(Aminoglycosides). However, the high mutation rate of bacterial genome has made it possible for 
bacteria to evolve resistant populations towards almost all classes of regular antibiotics (Maki & 
Schuna, 1978; Martinez & Baquero, 2000). Considering the current gap between our current effort 
to develop novel antibiotics and the real need for them, we must consider developing antimicrobials 
that have novel modes of action in addition to target only in vitro cell growth. 
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Pathogenic bacteria usually possess a wide range of virulence factors to enable themselves to 
successfully invade host tissues and cause disease. These virulence factors include adhesion, 
extracellular toxins, iron chelating siderophores and so on. For example, P. aeruginosa mutants 
which lack type IV pili or flagellum were seriously deficient in causing infections based on animal 
models (Feldman et al., 1998; Tang et al., 1995). Therefore, development of anti virulence therapies 
is aiming at inhibiting the invasion abilities of the pathogenic bacteria. The bacteria will then 
eventually be cleared by the host immune response with little to no impact on the normal human 
microbiota. It is proposed by some researchers that a potential (though yet unproven) advantage of 
this approach is that new anti virulence compounds may impose weaker selective pressure for the 
development of antibiotic resistance compared to the conventional antibiotics (Clatworthy et al., 
2007). 
Table 3 summarized some of the recent strategies that target various pathways related to virulence, 
including inhibiting toxin function, toxin delivery, virulence expression regulator (quorum sensing), 
and adhesin (Clatworthy et al., 2007).  
 
Table 3. Targets of anti virulence inhibitors, modes of action and effects on infection in vivo (Clatworthy et al., 2007). 
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3.2 Anti biofilm strategy development 
 
Once the biofilms developed to a mature stage, it is extremely difficult to eradicate them with 
traditional antimicrobial agents (Costerton et al., 1999). As our knowledge about the importance of 
biofilms in infections is increasing, researchers have started to develop anti biofilm strategies 
(Danese, 2002). Different anti biofilm strategies have been tried that were targeting different 
biofilm development mechanisms. These include nonbactericidal and bactericidal approaches. 
 
For example, a wide range of novel catheter surface coating materials and catheter lock solutions 
were tried to reduce the initial attachment of bacterial cells to the catheter (Chiang et al., 2009; 
Francolini et al., 2004; Liedberg & Lundeberg, 1989; Shanks et al., 2006; Stewart, 2003). In 
general, these approaches are similar to the antibiotic based approaches as far as their development 
is concerned. However, there is a lack of consistent demonstration of efficiency for the clinical 
usage of these antibacterial catheters (Danese, 2002). This is probably due to the fact that the dead 
cells of the initial attached bacteria will form a layer on the anti bacterial surface and provide a new 
surface for the attachment of the additional bacteria.    
Digestion of EPS matrix materials may be another way to reduce biofilm formation. Without these 
‘house of biofilm cells’, bacteria will only loosely attach to each other and will be sensitive towards 
the treatments of antimicrobial agents and host immune attack. Recombinant human DNase I was 
shown to be able to reduce the viscosity of the sputum of CF patients (Shak et al., 1990; Shak, 
1995). This is probably because that a large amount of DNA in the airways of CF patients can 
provide scaffolds for biofilm formation by the CF bacteria. It was reported that alginate lyase could 
enhance antibiotic killing of mucoid P. aeruginosa in biofilms (Alkawash et al., 2006). 
Azithromycin was reported to be able to block EPS material alginate formation and quorum sensing 
(Hoffmann et al., 2007) and it was further shown to improve lung function of CF patients, 
especially in the subgroup colonized with Pseudomonas (Florescu et al., 2009).  
Targeting the iron up taking pathways may also be a good choice to battle biofilm infections. Singh 
and colleagues has used an innate immunity component, lactoferrin, to prevent P. aeruginosa 
biofilm formation (Singh et al., 2002). By chelating iron, lactoferrin could stimulate the type IV pili 
mediated twitching motility of P. aeruginosa thus block it to settle down and form biofilms (Singh 
et al., 2002). Further more, Kaneko and colleagues have investigated a “Trojan horse” strategy by 
using the transition metal gallium to disrupt P. aeruginosa iron metabolism and exploit the iron 
stress of in vivo environments (Kaneko et al., 2007). Due to its chemical similarity to iron, gallium 
can substitute for iron in many biologic systems and inhibit Fe-dependent processes. They have 
found that gallium could inhibit P. aeruginosa growth and biofilm formation (Kaneko et al., 2007). 
What is more, too high concentration of iron was also found to be unfavorable for bacterial biofilm 
development (Johnson et al., 2005; Musk et al., 2005). Must and colleagues used iron salts such as 
ferric ammonium citrate to treat fully developed P. aeruginosa biofilms and found that iron salts 
could not only perturb biofilm formation but also disrupt existing biofilms by P. aeruginosa (Musk 
et al., 2005).  
Even though biofilm cells are very resistant toward conventional antimicrobial agents, there are still 
approaches to kill biofilm cells. One way is to treat biofilms with different combinations of 
antimicrobial agents. For example, several antibiotics targeting fast growing cells such as 
tobramycin, ciprofloxacin could only kill the surface cells of in vitro P. aeruginosa biofilms 
(Bjarnsholt et al., 2005; Pamp et al., 2008), while antimicrobial agents such as EDTA and colistin 
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were reported to prefer to kill slow growing cells inside the biofilm (Banin et al., 2006; Haagensen 
et al., 2007). A combination of antimicrobial agents from these above two classes could almost kill 
all the cells of in vitro P. aeruginosa biofilms (Pamp et al., 2008). 
 
Besides synergy of conventional antimicrobial agents, compounds targeting biofilm specific 
pathways can be used alone and together with conventional antimicrobial agents to eradicate 
biofilms. It was showed that garlic extract containing quorum sensing inhibitors could repress genes 
involved in oxidative stress response (Bjarnsholt et al., 2005; Passador et al., 1993) and could in 
combination with hydrogen peroxide efficiently eradicate P. aeruginosa biofilms. Barraud and 
colleagues showed that nitric oxide (NO) could cause dispersal of P. aeruginosa biofilm bacteria 
(Barraud et al., 2006). They have found that exposure to NO donor sodium nitroprusside (SNP) 
(500 nM) greatly enhanced the efficacy of antimicrobial compounds (tobramycin, hydrogen 
peroxide, and sodium dodecyl sulfate) in removal of established P. aeruginosa biofilms (Fig. 20) 
(Barraud et al., 2006).  
 
 
 
 
Fig. 20. SNP treatment disperse biofilm formed by P. aeruginosa. Cells remaining on the surface after SNP treatment 
could be easily removed by various antimicrobials (tobramycin, hydrogen peroxide, and SDS). (A) Microscopic 
pictures of the biofilms on the glass slides after the combinatorial treatments. (B) Levels of biofilm biomass after 
antimicrobial treatment when grown with or without 500 nM SNP, and error bars indicate standard errors (Barraud et 
al., 2006). 
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3.3 Computer aided drug discovery 
 
It is a trend to convert biological research from a qualitative, descriptive science to quantitative, 
predictive science. This process requires the integration of modern high-throughput experimental 
technologies with computational data-intensive analysis and high-performance modeling and 
simulation. There are numerous methods for identification of drug like or lead like compounds (Fig. 
21) (Bleicher et al., 2003). We have learned from many textbooks that the identification and 
optimization of new leads in the drug development process are mainly rely on experimental 
screening of either synthetic or natural large chemical libraries against a relevant therapeutic target 
(High-Throughput Screening, HTS). However, it has come to an age that computer aided drug 
discovery methods are playing a more and more important role in the drug discovery process 
(Hibert et al., 1988; Marshall, 1987). This strategy has been accelerated in recent years with the 
developments of novel biologically validated target identification, protein production and 
purification methods, 3D structural determination methods (e.g. X-ray and NMR), homology 
modeling methods, in silico ligand docking and structure based virtual screening (SBVS) programs 
(Barril et al., 2004; Kitchen et al., 2004).  Computer aid methods are extensively used in the lead 
identification process including target model building, pharmacophore analysis, chemical database 
management, virtual screening, (absorption, distribution, metabolism, and excretion) ADME/Tox 
prediction and so on. Bioinformatics and cheminformatics are two rapid developing disciplines with 
powerful theoretic supports for computer aided drug discovery. 
 
 
Fig. 21. Drug like or lead like compound identification strategies (Bleicher et al., 2003). 
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Chemoinformatics is the mixing of those information resources to transform data into information 
and information into knowledge for the intended purpose of making better decisions faster in the 
area of drug lead identification and optimization (Brown, 2005). While bioinformatics approaches 
mainly deal with the early stages of target selection and structure identification, cheminformatics 
mainly deal with the later stage problems such as lead identification and lead optimization. 
Combining bioinformatics and cheminformatics tools, a new method termed as structure based 
virtual screening (SBVS), that screens virtual libraries of compounds by computational means, has 
been developed (Barril et al., 2004). SBVS is conceptually and economically attractive since it 
makes possible the evaluation of an unlimited number of chemical structures in silico, and only a 
subset of which will be selected and subsequently assayed in lab screening experiments. 
 
In the present, all drugs that are on the market are estimated to target less than 500 biomolecules. 
These targets include nucleic acids to enzymes, G-protein-coupled receptors (GPCRs), ion channels 
and so on (Fig. 22) (Barril et al., 2004; Drews, 2000). Among these targets, enzymes and receptors 
represent the largest part. Thus, studying and predicting the protein-ligand interactions is obviously 
the primary methods for SBVS, which is also referred to as Docking. 
 
 
Fig. 22. Therapeutic target classes (Bleicher et al., 2003). 
 
When the 3D structures (either NMR or X-ray) of the protein are available, docking methods can be 
employed to predict the binding energies of small molecules with the target proteins (Fig. 23).  
 
Fig. 23. Small molecule docked into a protein. The 
docking process can be thought of as a problem of “lock-
and-key”, where the protein is a “lock” and the ligand is a 
“key” (http://en.wikipedia.org/wiki/Docking). Even 
though the basic principles remain the same as “lock-and-
key” mode, many new algorithms and scoring functions 
have been developed in recent years.  However, unlike the 
“key” of a “lock”, there are many structurally different 
ligands which can fit in the same protein since ligands can 
usually induce conformation changes of the proteins. 
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Fig. 24 illustrate the key steps of molecular docking based virtual screening process for lead 
compounds identification (Cavasotto & Orry, 2007). After properly preparation (e.g. 3D 
confirmation generation) of the virtual ligand libarary, the ligands will be docked to the potential 
active binding site of a target protein one by one. Then the binding energy and pose of each ligand 
to the target will be calculated and ranked by specific scoring functions of the docking programs.  
 
Fig. 24. Key steps of molecular docking based virtual screening process for lead compounds identification (Cavasotto & 
Orry, 2007).  
When the 3D structural data of the target proteins are unknown, quantitative structure-activity 
relationship (QSAR) (Fig. 25) and pharmacophore modeling (Fig. 26) methods could be applied to 
search for the potential drugs (Kubinyi, 1998). These methods are based on some previously 
reported active molecules or drugs of the targets. Firstly, the topological, physical and/or chemical 
properties (also called molecular descriptors) of known ligands will be calculated and 2D or 3D 
pharmacophore models can be generated. Then the models can be used to search virtual chemical 
libraries in order to find new structural classes, or as a tool for lead optimization. 
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Fig. 25. QSAR based virtual screening methods (http://www.chemaxon.com/). 
 
 
Fig. 26. Estrogen receptor beta (ERβ) agonist pharmacophore. Pharmacophore model of ERβ agonist consisting of two 
hydrogen bond donor (HD), one aromatic (AR) and one hydrophobic (H) descriptors, was generated by using Catalyst 
4.11 tool (http://www.accelrys.com/products/catalyst/) based on published IC50 data from Chemical Sciences Group at 
Wyeth Research (Kapetanovic, 2008). 
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When the 3D structural data of target proteins are unknown and there is also no previously reported 
active molecule or drug, one can still have the chance to perform docking based virtual screening to 
identify potential drugs. This is highly depending on the development of techniques of protein 
homologue modeling. The fast growing speed of Protein Data Bank (PDB) has enhanced our 
capabilities to building good structural models of our target proteins with the help of a wide range 
of protein modeling tools.  
Computer aided structural based virtual screening has been successfully applied to identify drug 
like compounds in microbiology fields. For example, Qin and colleagues used a SBVS method and 
identify seven potential inhibitors of YycG/YycF two component system (TCS) of Staphylococcus 
epidermidis (Qin et al., 2006). 7 out of 70 highly scored compounds were shown to be able to bind 
with YycG proteins at high specificity and not affect the stability of mammalian cells. What is more, 
these identified compounds were shown to be able to efficiently kill S. epidermidis cells living as 
biofilms (Qin et al., 2006). This study reminds us that searching antimicrobial agents targeting 
biofilm dependent pathways might provide better therapy strategies for biofilm related infections. 
 
Computer aided drug design was also applied to identify P. aeruginosa quorum sensing inhibitors 
recently. Three-dimensional quantitative structure-activity relationships (3D-QSAR) analyses using 
CoMFA and CoMSIA were applied by Woodard and colleagues to investigate structural 
requirements for improving potency and selectivity of AHL as a quorum sensing inhibitors 
(Woodard & Saleh, 2008). They have build a pharmacophore model of quorum sensing inhibitors 
and revealed that electrostatic and steric properties play a significant role in potency and selectivity 
(Woodard & Saleh, 2008). However, AHL structural similar compounds might be very toxic and 
not good for further development as drugs (Hentzer & Givskov, 2003). Further more, P. aeruginosa 
quorum sensing AHL molecule was reported to inhibit T-Cell differentiation and cytokine 
production by a mechanism involving an early step in T-Cell activation (Ritchie et al., 2005). Thus, 
molecular docking based screening might find better candidates of potential quorum sensing 
inhibitors with different structures as AHLs. 
 
Soulere and colleagues have done an initial molecular docking study basing on the crystallized 
structure of quorum sensing receptor TraR and some already know quorum sensing inhibitors such 
as carboxamides, sulfonamides and ureas (Soulere et al., 2007). They showed that AHL dependent 
quorum sensing transcriptional regulators (TraR, SdiA, LuxR and LasR) had a high structural 
homology of their active site (Soulere et al., 2007). Their molecular docking studies indicated that 
conserved residues Tyr53, Tyr61 and Asp70 were implicated in both the development of additional 
hydrogen bonds and attractive interactions with the N-sulfonyl homoserine lactones and AHLs 
derived ureas antagonists (Fig. 27) (Soulere et al., 2007). 
 
Recently, the crystallized structure of P. aeruginosa quorum sensing receptor lasR protein was 
published and available via RCSB Protein Data Bank (entry code 2UV0) (Fig. 28) (Bottomley et al., 
2007). This structure was compared with previously published TraR structure and many active AHL 
binding sites were found to be conserved (Bottomley et al., 2007). A virtual screening of lasR 
specific binding compounds will provide many potential quorum sensing inhibitors for the further 
development of anti virulence drugs. 
 
 29
 
Fig. 27. Representation of the overall folding with secondary structure of the domain receiver and of the active site for 
the AHL mediated quorum sensing receptor proteins TraR and SdiA (conserved and homologous residues are indicated 
in red and green, respectively) (Soulere et al., 2007). 
 
 
 
Fig. 28. The AHL binding site in LasR protein. A, LasR side chains make many H-bonds (dotted lines) to the 
autoinducer 3-oxo-C12-HSL. These binding networks include Tyr-56-OH with the amide 1-oxo, Ser-129-OG with the 1-
oxo, Trp-60-NE with the lactone carbonyl, Asp-73-OD2 with the amide NH, Thr-75-OG1 and then Arg-61 NE1 and 
NH1. The conformation of Asp-73 is stabilized by an H-bond with Tyr64. The 12-carbon AHL is entrapped by a large 
hydrophobic pocket formed by surrounded residues. B, part of the density-modified electron density map (2Fo - Fc) 
contoured at 1.5 sigma, showing that the density is well defined for the AHL in the ligand binding site and also for the 
water molecule (red sphere) mediating an H-bond between Arg-61 and the 3-oxo group (Bottomley et al., 2007). 
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4. Concluding remarks 
 
Group activities exist in a wide range of microbes of the microbial kingdom. Bacteria tend to form 
biofilm communities as an adaptive strategy towards stressful environmental factors. These biofilm 
complexes consist of different bacterial cells and their self produced sticky EPS matrix materials. 
The formation of mature biofilms is a dynamic process with many development stages. Many other 
group activities are also involved in the biofilm development such as iron siderophore synthesis and 
quorum sensing. Understanding how these different activities are coordinated during biofilm 
development will provide useful information for the development of anti biofilm strategies. 
 
In this thesis work, a large amount of screening based methods was used to investigate both the 
mechanisms of biofilm formation and anti biofilm methods. The opportunistic pathogen P. 
aeruginosa was used as a model organism for biofilm study since this bacterium causes many 
biofilm related infections, and some of these infections are fatal (e.g. cystic fibrosis lung infections). 
Also, the genome sequence of P. aeruginosa is available via NCBI, which enable us to construct 
mutation library for screening of different phenotypes.  
 
In this thesis work, the quorum sensing molecule Pseudomonas quinolone signal (PQS) synthesis 
pathway was found to directly regulate eDNA release in P. aeruginosa biofilms. The dynamics of 
eDNA release and PQS synthesis were found to be correlated with each other very well during flow 
chamber biofilm development. Iron was found to be able to manipulate PQS synthesis pathway, 
which provides some clues and ideas for development of iron based therapy strategies (paper I). To 
further investigate genes involved in eDNA release, a transposon insertion mutant library was 
constructed for high-throughput screening. To our surprise, the majorities of the eDNA release 
deficient mutants we found were mutated in genes that directly involved in the PQS synthesis 
pathway. A tatA mutant which was defective in the twin-arginine translocation (Tat) system was 
found to synthesize the same amount of PQS as its parent strain while fail to release PQS to the 
extracellular environment. These studies indicated that PQS synthesis and its releasing process 
caused eDNA release (paper II).  
 
To better understand biofilm development, two different group activities, PQS mediated eDNA 
release and siderophore pyoverdine mediated iron up taking were studied together to observe 
subpopulation  interactions in P. aeruginosa biofilms. Both eDNA and pyoverdine are important 
shareable sources in P. aeruginosa biofilms. Type IV pili was shown to be necessary for interaction 
of cells with eDNA while pyoverdine major receptor fpvA was shown to be necessary for cells to 
up take iron. The non-motile stalk subpopulation in P. aeruginosa biofilms was shown to be the 
major provider of both eDNA and pyoverdine sources, while the motile subpopulation can utilize 
these sources and exploit the non-motile subpopulation. These studies clearly shown how a 
diversified biofilm population was maintained and these might provide some cues for the 
mechanisms of antibiotics tolerance rendered by P. aeruginosa biofilms (paper III). 
 
Finally, as the last part of the thesis work, a computer aided structure based virtual screening (SBVS) 
was performed to identify novel class of quorum sensing inhibitors as anti biofilm drug leads. 
Chemical compounds were searched by similarity to quorum sensing signal molecule and their 
affinities to quorum sensing receptor lasR protein were predicted through molecular docking studies. 
Several recognized drugs were found to be efficient quorum sensing inhibitors and could significant 
reduce quorum sensing regulated reduce virulence factors and biofilm development in vitro (paper 
IV). 
 31
 
5 References 
 
 
Alkawash, M. A., Soothill, J. S. & Schiller, N. L. (2006). Alginate lyase enhances antibiotic 
killing of mucoid Pseudomonas aeruginosa in biofilms. Apmis 114, 131-138. 
 
Allesen-Holm, M., Barken, K. B., Yang, L., Klausen, M., Webb, J. S., Kjelleberg, S., Molin, S., 
Givskov, M. & Tolker-Nielsen, T. (2006). A characterization of DNA release in Pseudomonas 
aeruginosa cultures and biofilms. Mol Microbiol 59, 1114-1128. 
 
Banin, E., Vasil, M. L. & Greenberg, E. P. (2005). Iron and Pseudomonas aeruginosa biofilm 
formation. Proc Natl Acad Sci U S A 102, 11076-11081. 
 
Banin, E., Brady, K. M. & Greenberg, E. P. (2006). Chelator-induced dispersal and killing of 
Pseudomonas aeruginosa cells in a biofilm. Appl Environ Microbiol 72, 2064-2069. 
 
Barken, K. B., Pamp, S. J., Yang, L. & other authors (2008). Roles of type IV pili, flagellum-
mediated motility and extracellular DNA in the formation of mature multicellular structures in 
Pseudomonas aeruginosa biofilms. Environ Microbiol 10, 2331-2343. 
 
Barraud, N., Hassett, D. J., Hwang, S. H., Rice, S. A., Kjelleberg, S. & Webb, J. S. (2006). 
Involvement of nitric oxide in biofilm dispersal of Pseudomonas aeruginosa. J Bacteriol 188, 7344-
7353. 
 
Barril, X., Hubbard, R. E. & Morley, S. D. (2004). Virtual screening in structure-based drug 
discovery. Mini Rev Med Chem 4, 779-791. 
 
Bassler, B. L., Wright, M., Showalter, R. E. & Silverman, M. R. (1993). Intercellular signalling 
in Vibrio harveyi: sequence and function of genes regulating expression of luminescence. Mol 
Microbiol 9, 773-786. 
 
Bassler, B. L., Wright, M. & Silverman, M. R. (1994). Multiple signalling systems controlling 
expression of luminescence in Vibrio harveyi: sequence and function of genes encoding a second 
sensory pathway. Mol Microbiol 13, 273-286. 
 
Bjarnsholt, T., Jensen, P. O., Burmolle, M. & other authors (2005). Pseudomonas aeruginosa 
tolerance to tobramycin, hydrogen peroxide and polymorphonuclear leukocytes is quorum-sensing 
dependent. Microbiology 151, 373-383. 
 
Bleicher, K. H., Bohm, H. J., Muller, K. & Alanine, A. I. (2003). Hit and lead generation: 
beyond high-throughput screening. Nat Rev Drug Discov 2, 369-378. 
 
Bodey, G. P., Bolivar, R., Fainstein, V. & Jadeja, L. (1983). Infections caused by Pseudomonas 
aeruginosa. Rev Infect Dis 5, 279-313. 
 
 32
Bottomley, M. J., Muraglia, E., Bazzo, R. & Carfi, A. (2007). Molecular insights into quorum 
sensing in the human pathogen Pseudomonas aeruginosa from the structure of the virulence 
regulator LasR bound to its autoinducer. J Biol Chem 282, 13592-13600. 
 
Bredenbruch, F., Geffers, R., Nimtz, M., Buer, J. & Haussler, S. (2006). The Pseudomonas 
aeruginosa quinolone signal (PQS) has an iron-chelating activity. Environ Microbiol 8, 1318-1329. 
 
Brown, F. (2005). Editorial opinion: chemoinformatics - a ten year update. Curr Opin Drug Discov 
Devel 8, 298-302. 
 
Cavasotto, C. N. & Orry, A. J. (2007). Ligand docking and structure-based virtual screening in 
drug discovery. Curr Top Med Chem 7, 1006-1014. 
 
Chen, X., Schauder, S., Potier, N., Van Dorsselaer, A., Pelczer, I., Bassler, B. L. & Hughson, F. 
M. (2002). Structural identification of a bacterial quorum-sensing signal containing boron. Nature 
415, 545-549. 
 
Chiang, W. C., Schroll, C., Hilbert, L. R., Moller, P. & Tolker-Nielsen, T. (2009). Silver-
palladium surfaces inhibit biofilm formation. Appl Environ Microbiol 75, 1674-1678. 
 
Clatworthy, A. E., Pierson, E. & Hung, D. T. (2007). Targeting virulence: a new paradigm for 
antimicrobial therapy. Nat Chem Biol 3, 541-548. 
 
Cornelis, P. & Aendekerk, S. (2004). A new regulator linking quorum sensing and iron uptake in 
Pseudomonas aeruginosa. Microbiology 150, 752-756. 
 
Costerton, J. W., Lewandowski, Z., Caldwell, D. E., Korber, D. R. & Lappin-Scott, H. M. 
(1995). Microbial biofilms. Annu Rev Microbiol 49, 711-745. 
 
Costerton, J. W., Stewart, P. S. & Greenberg, E. P. (1999). Bacterial biofilms: a common cause 
of persistent infections. Science 284, 1318-1322. 
 
Cox, C. D. (1980). Iron uptake with ferripyochelin and ferric citrate by Pseudomonas aeruginosa. J 
Bacteriol 142, 581-587. 
 
Crespi, B. J. (2001). The evolution of social behavior in microorganisms. Trends Ecol Evol 16, 
178-183. 
 
Danese, P. N. (2002). Antibiofilm approaches: prevention of catheter colonization. Chem Biol 9, 
873-880. 
 
Darzins, A. & Chakrabarty, A. M. (1984). Cloning of genes controlling alginate biosynthesis 
from a mucoid cystic fibrosis isolate of Pseudomonas aeruginosa. J Bacteriol 159, 9-18. 
 
Davey, M. E., Caiazza, N. C. & O'Toole, G. A. (2003). Rhamnolipid surfactant production affects 
biofilm architecture in Pseudomonas aeruginosa PAO1. J Bacteriol 185, 1027-1036. 
 
 33
Davies, D. G., Parsek, M. R., Pearson, J. P., Iglewski, B. H., Costerton, J. W. & Greenberg, E. 
P. (1998). The involvement of cell-to-cell signals in the development of a bacterial biofilm. Science 
280, 295-298. 
 
del Pozo, J. L. & Patel, R. (2007). The challenge of treating biofilm-associated bacterial infections. 
Clin Pharmacol Ther 82, 204-209. 
 
Dell'Anno, A. & Danovaro, R. (2005). Extracellular DNA plays a key role in deep-sea ecosystem 
functioning. Science 309, 2179. 
 
Diggle, S. P., Winzer, K., Chhabra, S. R., Worrall, K. E., Camara, M. & Williams, P. (2003). 
The Pseudomonas aeruginosa quinolone signal molecule overcomes the cell density-dependency of 
the quorum sensing hierarchy, regulates rhl-dependent genes at the onset of stationary phase and 
can be produced in the absence of LasR. Mol Microbiol 50, 29-43. 
 
Drews, J. (2000). Drug discovery: a historical perspective. Science 287, 1960-1964. 
 
Duan, K., Dammel, C., Stein, J., Rabin, H. & Surette, M. G. (2003). Modulation of 
Pseudomonas aeruginosa gene expression by host microflora through interspecies communication. 
Mol Microbiol 50, 1477-1491. 
 
Dubern, J. F. & Diggle, S. P. (2008). Quorum sensing by 2-alkyl-4-quinolones in Pseudomonas 
aeruginosa and other bacterial species. Mol Biosyst 4, 882-888. 
 
Feldman, M., Bryan, R., Rajan, S., Scheffler, L., Brunnert, S., Tang, H. & Prince, A. (1998). 
Role of flagella in pathogenesis of Pseudomonas aeruginosa pulmonary infection. Infect Immun 66, 
43-51. 
 
Flemming, H. C., Neu, T. R. & Wozniak, D. J. (2007). The EPS matrix: the "house of biofilm 
cells". J Bacteriol 189, 7945-7947. 
 
Florescu, D. F., Murphy, P. J. & Kalil, A. C. (2009). Effects of prolonged use of azithromycin in 
patients with cystic fibrosis: A meta-analysis. Pulm Pharmacol Ther. 
 
Francolini, I., Norris, P., Piozzi, A., Donelli, G. & Stoodley, P. (2004). Usnic acid, a natural 
antimicrobial agent able to inhibit bacterial biofilm formation on polymer surfaces. Antimicrob 
Agents Chemother 48, 4360-4365. 
 
Friedman, L. & Kolter, R. (2004a). Genes involved in matrix formation in Pseudomonas 
aeruginosa PA14 biofilms. Mol Microbiol 51, 675-690. 
 
Friedman, L. & Kolter, R. (2004b). Two genetic loci produce distinct carbohydrate-rich structural 
components of the Pseudomonas aeruginosa biofilm matrix. J Bacteriol 186, 4457-4465. 
 
Fuqua, W. C., Winans, S. C. & Greenberg, E. P. (1994). Quorum sensing in bacteria: the LuxR-
LuxI family of cell density-responsive transcriptional regulators. J Bacteriol 176, 269-275. 
 
 34
Ghysels, B., Dieu, B. T., Beatson, S. A., Pirnay, J. P., Ochsner, U. A., Vasil, M. L. & Cornelis, 
P. (2004). FpvB, an alternative type I ferripyoverdine receptor of Pseudomonas aeruginosa. 
Microbiology 150, 1671-1680. 
 
Govan, J. R. & Deretic, V. (1996). Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas 
aeruginosa and Burkholderia cepacia. Microbiol Rev 60, 539-574. 
 
Gray, K. M. & Garey, J. R. (2001). The evolution of bacterial LuxI and LuxR quorum sensing 
regulators. Microbiology 147, 2379-2387. 
 
Haagensen, J. A., Klausen, M., Ernst, R. K., Miller, S. I., Folkesson, A., Tolker-Nielsen, T. & 
Molin, S. (2007). Differentiation and distribution of colistin- and sodium dodecyl sulfate-tolerant 
cells in Pseudomonas aeruginosa biofilms. J Bacteriol 189, 28-37. 
 
Hakenbeck, R. & Stock, J. B. (1996). Analysis of two-component signal transduction systems 
involved in transcriptional regulation. Methods Enzymol 273, 281-300. 
 
Haussler, S. & Becker, T. (2008). The pseudomonas quinolone signal (PQS) balances life and 
death in Pseudomonas aeruginosa populations. PLoS Pathog 4, e1000166. 
 
Heinrichs, D. E., Young, L. & Poole, K. (1991). Pyochelin-mediated iron transport in 
Pseudomonas aeruginosa: involvement of a high-molecular-mass outer membrane protein. Infect 
Immun 59, 3680-3684. 
 
Henke, J. M. & Bassler, B. L. (2004). Bacterial social engagements. Trends Cell Biol 14, 648-656. 
 
Hentzer, M., Eberl, L., Nielsen, J. & Givskov, M. (2003). Quorum sensing : a novel target for the 
treatment of biofilm infections. BioDrugs 17, 241-250. 
 
Hentzer, M. & Givskov, M. (2003). Pharmacological inhibition of quorum sensing for the 
treatment of chronic bacterial infections. J Clin Invest 112, 1300-1307. 
 
Hibert, M. F., Gittos, M. W., Middlemiss, D. N., Mir, A. K. & Fozard, J. R. (1988). Graphics 
computer-aided receptor mapping as a predictive tool for drug design: development of potent, 
selective, and stereospecific ligands for the 5-HT1A receptor. J Med Chem 31, 1087-1093. 
 
Hoffmann, N., Lee, B., Hentzer, M., Rasmussen, T. B., Song, Z., Johansen, H. K., Givskov, M. 
& Hoiby, N. (2007). Azithromycin blocks quorum sensing and alginate polymer formation and 
increases the sensitivity to serum and stationary-growth-phase killing of Pseudomonas aeruginosa 
and attenuates chronic P. aeruginosa lung infection in Cftr(-/-) mice. Antimicrob Agents Chemother 
51, 3677-3687. 
 
Hoiby, N. (1974). Pseudomonas aeruginosa infection in cystic fibrosis. Relationship between 
mucoid strains of Pseudomonas aeruginosa and the humoral immune response. Acta Pathol 
Microbiol Scand [B] Microbiol Immunol 82, 551-558. 
 
 35
Jackson, K. D., Starkey, M., Kremer, S., Parsek, M. R. & Wozniak, D. J. (2004). Identification 
of psl, a locus encoding a potential exopolysaccharide that is essential for Pseudomonas aeruginosa 
PAO1 biofilm formation. J Bacteriol 186, 4466-4475. 
 
Jefferson, K. K. (2004). What drives bacteria to produce a biofilm? FEMS Microbiol Lett 236, 
163-173. 
 
Johnson, M., Cockayne, A., Williams, P. H. & Morrissey, J. A. (2005). Iron-responsive 
regulation of biofilm formation in staphylococcus aureus involves fur-dependent and fur-
independent mechanisms. J Bacteriol 187, 8211-8215. 
 
Kaneko, Y., Thoendel, M., Olakanmi, O., Britigan, B. E. & Singh, P. K. (2007). The transition 
metal gallium disrupts Pseudomonas aeruginosa iron metabolism and has antimicrobial and 
antibiofilm activity. J Clin Invest 117, 877-888. 
 
Kapetanovic, I. M. (2008). Computer-aided drug discovery and development (CADDD): in silico-
chemico-biological approach. Chem Biol Interact 171, 165-176. 
 
Kirchner, K. K., Wagener, J. S., Khan, T. Z., Copenhaver, S. C. & Accurso, F. J. (1996). 
Increased DNA levels in bronchoalveolar lavage fluid obtained from infants with cystic fibrosis. Am 
J Respir Crit Care Med 154, 1426-1429. 
 
Kirisits, M. J., Prost, L., Starkey, M. & Parsek, M. R. (2005). Characterization of colony 
morphology variants isolated from Pseudomonas aeruginosa biofilms. Appl Environ Microbiol 71, 
4809-4821. 
 
Kirisits, M. J. & Parsek, M. R. (2006). Does Pseudomonas aeruginosa use intercellular signalling 
to build biofilm communities? Cell Microbiol 8, 1841-1849. 
 
Kitchen, D. B., Stahura, F. L. & Bajorath, J. (2004). Computational techniques for diversity 
analysis and compound classification. Mini Rev Med Chem 4, 1029-1039. 
 
Klausen, M., Aaes-Jorgensen, A., Molin, S. & Tolker-Nielsen, T. (2003). Involvement of 
bacterial migration in the development of complex multicellular structures in Pseudomonas 
aeruginosa biofilms. Mol Microbiol 50, 61-68. 
 
Kolter, R. & Greenberg, E. P. (2006). Microbial sciences: the superficial life of microbes. Nature 
441, 300-302. 
 
Kubinyi, H. (1998). Quantitative Structure-Activity Relationships - 12th European Symposium 
Molecular modeling and prediction of bioactivity. IDrugs 1, 781-786. 
 
Latifi, A., Winson, M. K., Foglino, M., Bycroft, B. W., Stewart, G. S., Lazdunski, A. & 
Williams, P. (1995). Multiple homologues of LuxR and LuxI control expression of virulence 
determinants and secondary metabolites through quorum sensing in Pseudomonas aeruginosa PAO1. 
Mol Microbiol 17, 333-343. 
 
 36
Latifi, A., Foglino, M., Tanaka, K., Williams, P. & Lazdunski, A. (1996). A hierarchical 
quorum-sensing cascade in Pseudomonas aeruginosa links the transcriptional activators LasR and 
RhIR (VsmR) to expression of the stationary-phase sigma factor RpoS. Mol Microbiol 21, 1137-
1146. 
 
Lequette, Y. & Greenberg, E. P. (2005). Timing and localization of rhamnolipid synthesis gene 
expression in Pseudomonas aeruginosa biofilms. J Bacteriol 187, 37-44. 
 
Lewis, K. (2007). Persister cells, dormancy and infectious disease. Nat Rev Microbiol 5, 48-56. 
 
Liedberg, H. & Lundeberg, T. (1989). Silver coating of urinary catheters prevents adherence and 
growth of Pseudomonas aeruginosa. Urol Res 17, 357-358. 
 
Ma, L., Lu, H., Sprinkle, A., Parsek, M. R. & Wozniak, D. J. (2007). Pseudomonas aeruginosa 
Psl is a galactose- and mannose-rich exopolysaccharide. J Bacteriol 189, 8353-8356. 
 
Ma, L., Conover, M., Lu, H., Parsek, M. R., Bayles, K. & Wozniak, D. J. (2009). Assembly and 
development of the Pseudomonas aeruginosa biofilm matrix. PLoS Pathog 5, e1000354. 
 
Maki, D. G. & Schuna, A. A. (1978). A study of antimicrobial misuse in a university hospital. Am 
J Med Sci 275, 271-282. 
 
Marshall, G. R. (1987). Computer-aided drug design. Annu Rev Pharmacol Toxicol 27, 193-213. 
 
Martinez, J. L. & Baquero, F. (2000). Mutation frequencies and antibiotic resistance. Antimicrob 
Agents Chemother 44, 1771-1777. 
 
Mashburn, L. M. & Whiteley, M. (2005). Membrane vesicles traffic signals and facilitate group 
activities in a prokaryote. Nature 437, 422-425. 
 
Matsukawa, M. & Greenberg, E. P. (2004). Putative exopolysaccharide synthesis genes influence 
Pseudomonas aeruginosa biofilm development. J Bacteriol 186, 4449-4456. 
 
McGrath, S., Wade, D. S. & Pesci, E. C. (2004). Dueling quorum sensing systems in 
Pseudomonas aeruginosa control the production of the Pseudomonas quinolone signal (PQS). 
FEMS Microbiol Lett 230, 27-34. 
 
Miller, M. B. & Bassler, B. L. (2001). Quorum sensing in bacteria. Annu Rev Microbiol 55, 165-
199. 
 
Monds, R. D. & O'Toole, G. A. (2009). The developmental model of microbial biofilms: ten years 
of a paradigm up for review. Trends Microbiol 17, 73-87. 
 
Musk, D. J., Banko, D. A. & Hergenrother, P. J. (2005). Iron salts perturb biofilm formation and 
disrupt existing biofilms of Pseudomonas aeruginosa. Chem Biol 12, 789-796. 
 
Neu, H. C. (1992). The crisis in antibiotic resistance. Science 257, 1064-1073. 
 
 37
O'Toole, G. A. & Kolter, R. (1998). Flagellar and twitching motility are necessary for 
Pseudomonas aeruginosa biofilm development. Mol Microbiol 30, 295-304. 
 
Oglesby, A. G., Farrow, J. M., 3rd, Lee, J. H., Tomaras, A. P., Greenberg, E. P., Pesci, E. C. & 
Vasil, M. L. (2008). The influence of iron on Pseudomonas aeruginosa physiology: a regulatory 
link between iron and quorum sensing. J Biol Chem 283, 15558-15567. 
 
Pamp, S. J. & Tolker-Nielsen, T. (2007). Multiple roles of biosurfactants in structural biofilm 
development by Pseudomonas aeruginosa. J Bacteriol 189, 2531-2539. 
 
Pamp, S. J., Gjermansen, M., Johansen, H. K. & Tolker-Nielsen, T. (2008). Tolerance to the 
antimicrobial peptide colistin in Pseudomonas aeruginosa biofilms is linked to metabolically active 
cells, and depends on the pmr and mexAB-oprM genes. Mol Microbiol 68, 223-240. 
 
Parsek, M. R. & Greenberg, E. P. (2005). Sociomicrobiology: the connections between quorum 
sensing and biofilms. Trends Microbiol 13, 27-33. 
 
Parsek, M. R. & Tolker-Nielsen, T. (2008). Pattern formation in Pseudomonas aeruginosa 
biofilms. Curr Opin Microbiol 11, 560-566. 
 
Passador, L., Cook, J. M., Gambello, M. J., Rust, L. & Iglewski, B. H. (1993). Expression of 
Pseudomonas aeruginosa virulence genes requires cell-to-cell communication. Science 260, 1127-
1130. 
 
Pesci, E. C., Milbank, J. B., Pearson, J. P., McKnight, S., Kende, A. S., Greenberg, E. P. & 
Iglewski, B. H. (1999). Quinolone signaling in the cell-to-cell communication system of 
Pseudomonas aeruginosa. Proc Natl Acad Sci U S A 96, 11229-11234. 
 
Poole, K. & McKay, G. A. (2003). Iron acquisition and its control in Pseudomonas aeruginosa: 
many roads lead to Rome. Front Biosci 8, d661-686. 
 
Qin, Z., Zhang, J., Xu, B. & other authors (2006). Structure-based discovery of inhibitors of the 
YycG histidine kinase: new chemical leads to combat Staphylococcus epidermidis infections. BMC 
Microbiol 6, 96. 
 
Qin, Z., Ou, Y., Yang, L., Zhu, Y., Tolker-Nielsen, T., Molin, S. & Qu, D. (2007). Role of 
autolysin-mediated DNA release in biofilm formation of Staphylococcus epidermidis. Microbiology 
153, 2083-2092. 
 
Rice, K. C., Mann, E. E., Endres, J. L., Weiss, E. C., Cassat, J. E., Smeltzer, M. S. & Bayles, K. 
W. (2007). The cidA murein hydrolase regulator contributes to DNA release and biofilm 
development in Staphylococcus aureus. Proc Natl Acad Sci U S A 104, 8113-8118. 
 
Riedel, K., Hentzer, M., Geisenberger, O. & other authors (2001). N-acylhomoserine-lactone-
mediated communication between Pseudomonas aeruginosa and Burkholderia cepacia in mixed 
biofilms. Microbiology 147, 3249-3262. 
 
 38
Ritchie, A. J., Jansson, A., Stallberg, J., Nilsson, P., Lysaght, P. & Cooley, M. A. (2005). The 
Pseudomonas aeruginosa quorum-sensing molecule N-3-(oxododecanoyl)-L-homoserine lactone 
inhibits T-cell differentiation and cytokine production by a mechanism involving an early step in T-
cell activation. Infect Immun 73, 1648-1655. 
 
Royt, P. W., Honeychuck, R. V., Pant, R. R., Rogers, M. L., Asher, L. V., Lloyd, J. R., Carlos, 
W. E., Belkin, H. E. & Patwardhan, S. (2007). Iron- and 4-hydroxy-2-alkylquinoline-containing 
periplasmic inclusion bodies of Pseudomonas aeruginosa: a chemical analysis. Bioorg Chem 35, 
175-188. 
 
Ryder, C., Byrd, M. & Wozniak, D. J. (2007). Role of polysaccharides in Pseudomonas 
aeruginosa biofilm development. Curr Opin Microbiol 10, 644-648. 
 
Schooling, S. R. & Beveridge, T. J. (2006). Membrane vesicles: an overlooked component of the 
matrices of biofilms. J Bacteriol 188, 5945-5957. 
 
Shak, S., Capon, D. J., Hellmiss, R., Marsters, S. A. & Baker, C. L. (1990). Recombinant human 
DNase I reduces the viscosity of cystic fibrosis sputum. Proc Natl Acad Sci U S A 87, 9188-9192. 
 
Shak, S. (1995). Aerosolized recombinant human DNase I for the treatment of cystic fibrosis. Chest 
107, 65S-70S. 
 
Shanks, R. M., Sargent, J. L., Martinez, R. M., Graber, M. L. & O'Toole, G. A. (2006). 
Catheter lock solutions influence staphylococcal biofilm formation on abiotic surfaces. Nephrol 
Dial Transplant 21, 2247-2255. 
 
Singh, P. K., Parsek, M. R., Greenberg, E. P. & Welsh, M. J. (2002). A component of innate 
immunity prevents bacterial biofilm development. Nature 417, 552-555. 
 
Soulere, L., Frezza, M., Queneau, Y. & Doutheau, A. (2007). Exploring the active site of acyl 
homoserine lactones-dependent transcriptional regulators with bacterial quorum sensing modulators 
using molecular mechanics and docking studies. J Mol Graph Model 26, 581-590. 
 
Stapper, A. P., Narasimhan, G., Ohman, D. E., Barakat, J., Hentzer, M., Molin, S., Kharazmi, 
A., Hoiby, N. & Mathee, K. (2004). Alginate production affects Pseudomonas aeruginosa biofilm 
development and architecture, but is not essential for biofilm formation. J Med Microbiol 53, 679-
690. 
 
Sternberg, C. & Tolker-Nielsen, T. (2006). Growing and analyzing biofilms in flow cells. Curr 
Protoc Microbiol Chapter 1, Unit 1B 2. 
 
Stewart, P. S. (2002). Mechanisms of antibiotic resistance in bacterial biofilms. Int J Med 
Microbiol 292, 107-113. 
 
Stewart, P. S. (2003). New ways to stop biofilm infections. Lancet 361, 97. 
 
Stewart, P. S. & Franklin, M. J. (2008). Physiological heterogeneity in biofilms. Nat Rev 
Microbiol 6, 199-210. 
 39
 
Stintzi, A., Evans, K., Meyer, J. M. & Poole, K. (1998). Quorum-sensing and siderophore 
biosynthesis in Pseudomonas aeruginosa: lasR/lasI mutants exhibit reduced pyoverdine biosynthesis. 
FEMS Microbiol Lett 166, 341-345. 
 
Stoodley, P., Sauer, K., Davies, D. G. & Costerton, J. W. (2002). Biofilms as complex 
differentiated communities. Annu Rev Microbiol 56, 187-209. 
 
Tang, H., Kays, M. & Prince, A. (1995). Role of Pseudomonas aeruginosa pili in acute pulmonary 
infection. Infect Immun 63, 1278-1285. 
 
van Schaik, E. J., Giltner, C. L., Audette, G. F., Keizer, D. W., Bautista, D. L., Slupsky, C. M., 
Sykes, B. D. & Irvin, R. T. (2005). DNA binding: a novel function of Pseudomonas aeruginosa 
type IV pili. J Bacteriol 187, 1455-1464. 
 
Vasseur, P., Vallet-Gely, I., Soscia, C., Genin, S. & Filloux, A. (2005). The pel genes of the 
Pseudomonas aeruginosa PAK strain are involved at early and late stages of biofilm formation. 
Microbiology 151, 985-997. 
 
Wagner, V. E., Bushnell, D., Passador, L., Brooks, A. I. & Iglewski, B. H. (2003). Microarray 
analysis of Pseudomonas aeruginosa quorum-sensing regulons: effects of growth phase and 
environment. J Bacteriol 185, 2080-2095. 
 
West, S. A., Griffin, A. S., Gardner, A. & Diggle, S. P. (2006). Social evolution theory for 
microorganisms. Nat Rev Microbiol 4, 597-607. 
 
West, S. A., Diggle, S. P., Buckling, A., Gardner, A. & Griffin, A. S. (2007). The social lives of 
microbes. Annu Rev Ecol Evol Syst 38, 53-57. 
 
Whitchurch, C. B., Tolker-Nielsen, T., Ragas, P. C. & Mattick, J. S. (2002). Extracellular DNA 
required for bacterial biofilm formation. Science 295, 1487. 
 
Williams, P., Camara, M., Hardman, A. & other authors (2000). Quorum sensing and the 
population-dependent control of virulence. Philos Trans R Soc Lond B Biol Sci 355, 667-680. 
 
Woodard, B. & Saleh, M. A. (2008). Three-dimensional quantitative structure activity 
relationships of quorum-sensing and biofilm inhibitors in gram-negative bacteria. J Environ Sci 
Health B 43, 281-287. 
 
Wozniak, D. J., Wyckoff, T. J., Starkey, M., Keyser, R., Azadi, P., O'Toole, G. A. & Parsek, 
M. R. (2003). Alginate is not a significant component of the extracellular polysaccharide matrix of 
PA14 and PAO1 Pseudomonas aeruginosa biofilms. Proc Natl Acad Sci U S A 100, 7907-7912. 
 
 
 
 
 
 
 40
 
Paper I

Effects of iron on DNA release and biofilm
development by Pseudomonas aeruginosa
Liang Yang, Kim B. Barken, Mette E. Skindersoe, Allan B. Christensen,
Michael Givskov and Tim Tolker-Nielsen
Correspondence
Tim Tolker-Nielsen
ttn@biocentrum.dtu.dk
Centre for BioScience and Technology, BioCentrum-DTU, Technical University of Denmark,
DK-2800 Lyngby, Denmark
Received 4 December 2006
Revised 11 January 2007
Accepted 16 January 2007
Extracellular DNA is one of the major matrix components in Pseudomonas aeruginosa biofilms. It
functions as an intercellular connector and plays a role in stabilization of the biofilms. Evidence that
DNA release in P. aeruginosa PAO1 biofilms is controlled by the las-rhl and pqs quorum-sensing
systems has been previously presented. This paper provides evidence that DNA release in P.
aeruginosa PAO1 biofilms is also under iron regulation. Experiments involving cultivation of P.
aeruginosa in microtitre trays suggested that pqs expression, DNA release and biofilm formation
were favoured in media with low iron concentrations (5 mM FeCl3), and decreased with increasing
iron concentrations. Experiments involving cultivation of P. aeruginosa in a flow-chamber system
suggested that a high level of iron (100 mM FeCl3) in the medium suppressed DNA release,
structural biofilm development, and the development of subpopulations with increased tolerance
toward antimicrobial compounds. Experiments with P. aeruginosa strains harbouring fluorescent
reporters suggested that expression of the pqs operon was induced in particular subpopulations of
the biofilm cells under low-iron conditions (1 mM FeCl3), but repressed in the biofilm cells under
high-iron conditions (100 mM FeCl3).
INTRODUCTION
Biofilms are sessile populations of micro-organisms that are
surrounded by the slime they produce, and may be attached
to an inert or living surface. Biofilm formation is described
as a developmental sequence that varies to some extent
between bacterial species but often results in the formation
of mature microbial communities with tower- or mush-
room-shaped microcolonies (Davey & O’Toole, 2000; Sauer
et al., 2002; Klausen et al., 2003a). The bacteria in biofilms in
medical settings often display increased resistance toward
host immune responses and enhanced tolerance toward
antibiotic treatment (Costerton et al., 1999). Knowledge
about the molecular mechanisms that are involved in
biofilm development, and the factors that lead to the
formation of resistant subpopulations, may be useful for
creating strategies to control biofilm formation and
eradicate persistent infections.
One of the most distinctive features of biofilms is the
extracellular polymeric substances that surround the
bacteria and constitute the biofilmmatrix. The composition
of biofilm matrices varies depending upon the bacterial
species and the environmental conditions, but in general
they contain components such as polysaccharides, proteins
and extracellular DNA (Sutherland, 2001;Whitchurch et al.,
2002).
Evidence for a role of extracellular DNA as matrix
component in Pseudomonas aeruginosa biofilms has been
presented both for the P. aeruginosa PAO1 reference strain
and for clinical P. aeruginosa isolates (Whitchurch et al.,
2002; Nemoto et al., 2003). P. aeruginosa PAO1 biofilm
development in the wells of microtitre plates was attenuated
by the presence of DNase I, and biofilm formation by P.
aeruginosa PAO1 in flow-chambers was almost absent when
the flow-chambers were irrigated with medium containing
DNase I (Whitchurch et al., 2002). In addition, young P.
aeruginosa PAO1 biofilms that had been grown in flow-
chambers irrigated with DNase-free medium dispersed
rapidly after addition of DNase I to the flowing medium,
whereas mature P. aeruginosa PAO1 biofilms were not
dispersed by DNase I treatment, suggesting that compo-
nents other than extracellular DNA stabilize mature P.
aeruginosa PAO1 biofilms (Whitchurch et al., 2002).
Matsukawa & Greenberg (2004) investigated the composi-
tion of the extracellular matrix of mature P. aeruginosa
PAO1 biofilms and found that extracellular DNA was by far
the most abundant polymer, although exopolysaccharide
appeared to be the most critical structural matrix
component. In contrast to the finding that extracellular
DNA may not be the primary cell-to-cell interconnecting
compound in mature P. aeruginosa PAO1 biofilms, Nemoto
Abbreviations: AHL, N-acylhomoserine lactone; CLSM, confocal laser
scanning microscope/microscopy; DDAO, 7-hydroxy-9H-(1,3-dichloro-
9,9-dimethylacridin-2-one; PQS, Pseudomonas quinolone signal.
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et al. (2003) found that mature biofilms formed by four
different clinical P. aeruginosa isolates could be dispersed by
DNase treatment, suggesting that extracellular DNA is the
critical matrix component in mature biofilms formed by
these P. aeruginosa strains.
Quorum sensing, a mechanism by which bacteria can
monitor their cell population density through the extra-
cellular accumulation of signalling molecules, has been
shown to play a role in structural development and
stabilization of P. aeruginosa biofilms (Davies et al., 1998).
P. aeruginosa employs the three interconnected quorum-
sensing systems las, rhl and pqs to control expression of a
wide range of virulence factors (Passador et al., 1993; Latifi
et al., 1995, 1996; Pesci et al., 1999). The major signal
molecules involved are 3-oxo-C12-homoserine lactone (3-
oxo-C12-HSL) in the case of the las system, C4-HSL in the
case of the rhl system, and 2-heptyl-3-hydroxy-4-quinolone,
designated the Pseudomonas quinolone signal (PQS), in the
case of the pqs system (Latifi et al., 1995, 1996; Pesci et al.,
1999). Synthesis of PQS depends on several putative
enzymes encoded by the pqsABCDE, pqsL, phnAB and
pqsH genes, as well as on a LysR-type regulator encoded by
the pqsR gene (also known as mvfR) (Cao et al., 2001;
Gallagher et al., 2002; D’Argenio et al., 2002). Evidence has
been presented that the quorum-sensing systems play a role
in the formation of extracellular DNA in P. aeruginosa
biofilms (Allesen-Holm et al., 2006). Quorum-sensing-
regulated DNA release from P. aeruginosa populations
presumably involves lysis of a subpopulation of the cells (or
lysis of DNA-containing vesicles), as experiments with lacZ-
containing P. aeruginosa strains indicated that the formation
of extracellular b-galactosidase correlated with the forma-
tion of large amounts of extracellular DNA (Allesen-Holm
et al., 2006).
P. aeruginosa colonizes the lungs of cystic fibrosis (CF)
patients and is a major cause of lung deterioration, health
decline and death of these patients (Høiby et al., 2001).
Several studies indicate that P. aeruginosa forms biofilms in
the CF lung (e.g. Lam et al., 1980; Baltimore et al., 1989;
Worlitzsch et al., 2002; Høiby et al., 2001), and the biofilm
mode of growth is considered the major reason that these
bacteria can not be eradicated by host defences or antibiotic
treatment (Costerton et al., 1999; Høiby et al., 2001). The
conditions that infecting bacteria encounter in the CF lung
is of great interest, and artificial CF sputummedia have been
developed to enable experiments to be carried out under
relevant and controllable conditions (Sriramulu et al., 2005;
Palmer et al., 2005). P. aeruginosa cells in the CF lung are
believed to be in intense competition for iron with the host
(Haas et al., 1991; Ratledge & Dover, 2000). Low iron
concentrations were shown to promote biofilm formation in
artificial CF sputum medium (Sriramulu et al., 2005). In
addition to low iron levels, the presence of extracellular
DNA was shown to be important for P. aeruginosa biofilm
formation in artificial sputum medium (Sriramulu et al.,
2005).
Knowledge about the factors that affect DNA release from P.
aeruginosa is important for understanding the environ-
mental cues that can lead to biofilm formation and increased
pathogenicity of this organism. In this paper we present
evidence that the level of iron in the medium affects P.
aeruginosa DNA release and biofilm formation. The iron
level was shown to have an effect on the amount of biofilm
formed in the wells of microtitre trays, as well as on
structural biofilm development in flow chambers, and on
the development of subpopulations with increased tolerance
toward antimicrobial compounds. Evidence is presented
that iron affects P. aeruginosa DNA release and biofilm
development by affecting the PQS signalling pathway.
METHODS
Bacteria and growth conditions. P. aeruginosa PAO1 was
obtained from the Genetic Stock Center (strain PAO0001). The lasI
rhlI derivative was constructed by allelic displacement in PAO1 as
described by Hentzer et al. (2003). The pqsA, pqsR and pqsL mutants
were constructed by D’Argenio et al. (2002) via transposon insertion
in PAO1. The gfp-tagged PAO1 strain was constructed by insertion
of a mini-Tn7-eGFP-Gmr cassette as described by Klausen et al.
(2003b). Escherichia coli strains MT102 and MC1000 were used for
standard DNA manipulations. LB medium (Bertani, 1951) was used
to cultivate E. coli strains. Batch cultivation of P. aeruginosa was car-
ried out at 30 uC in AB minimal medium (Clark & Maaløe, 1967)
supplemented with 30 mg glucose l21. P. aeruginosa biofilms were
cultivated at 30 uC in flow-chambers irrigated with FAB medium
(Heydorn et al., 2000) supplemented with 0.3 mM glucose. FeCl3
was added to the media to give the final ferric iron concentrations
described in the text. Selective media were supplemented with ampi-
cillin (Ap; 100 mg l21), gentamicin (Gm; 60 mg l21), kanamycin
(Km; 100 mg l21), streptomycin (Sm; 100 mg l21), or tetracycline
(Tc; 20 mg l21). AB medium supplemented with 0.05 mg propi-
dium iodide ml21 was used in the microtitre trays for quantification
of extracellular DNA. DDAO [7-hydroxy-9H-(1,3-dichloro-9,9-
dimethylacridin-2-one] was used at a concentration of 1 mM to stain
extracellular DNA in flow-chamber-grown biofilms. Propidium
iodide was used at a concentration of 0.01 mg ml21 to stain dead
cells in flow-chamber-grown biofilms. Syto62 was used at a concen-
tration of 1 mM to stain bacteria in flow-chamber-grown biofilms.
Measurements of pvdD expression. A classical b-galactosidase
assay, described by Miller (1972), was used to measure expression of
the pvdD–lacZ fusion in P. aeruginosa PAO1 cells transformed with
the low-copy-number plasmid pPM190 : : pvdD (Rombel et al.,
1995), which carries the pvdD promoter fused to the E. coli lacZ
gene.
Construction of the pqsA : :gfp(ASV) reporter. The promoter-
probe plasmid pAC37, containing a PpqsA : : gfp(ASV) transcriptional
fusion, was constructed using standard techniques for DNA manipu-
lations (Sambrook et al., 1989). A P. aeruginosa DNA region con-
taining the PpqsA promoter was PCR amplified by use of the primers
PA0996F (59-GGAATTCTGATCAATGCCGTCGCCCCCTTGGA-39)
and PA0996R (59-GGGTACCCATGACAGAACGTTCCCTCTT-39).
A P. aeruginosa DNA region containing the PrhlR promoter and the
rhlR gene was PCR amplified by use of the primers PA3477F (59-
CGTGATCAAACGGCTGGTCCGGCTCG-39) and PA3477R (59-
GGAATTCAAAAAGGCCATCCGTCAGGATGGCCTTCTAGATTA-
TCTACTCAGATGAGACCCAGCGCC-39). An E. coli T2 transcrip-
tional terminator and a unique XbaI cloning site were introduced in
the PCR fragment through use of the PA3477R primer set. pJBA100,
consisting of a NotI fragment with the gfp(ASV) gene from pJBA89
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(Andersen et al., 2001) cloned in the shuttle vector pUCP22NotI,
was used as scaffold. pJBA100 was digested with KpnI and EcoRI;
the PCR product containing the PpqsA promoter was digested with
BclI and KpnI; and the PCR product containing the rhlR gene was
digested with BclI and EcoRI. The expression monitor pAC36 was
constructed by ligating the three DNA fragments in one reaction.
Plasmid pAC37 was constructed by deleting the rhlR gene on
pAC36, via digestion with XbaI and BclI, Klenow treatment, and
religation. The pAC37 plasmid was electroporated into P. aeruginosa
PAO1 and the P. aeruginosa lasI rhlI mutant.
Measurement of biofilm and extracellular DNA in microtitre
trays. The microtitre tray biofilm formation assay was performed
essentially as described by O’Toole & Kolter (1998). Overnight cul-
tures were grown in AB medium and diluted to OD600 0.001 with
fresh AB medium. The diluted cultures were transferred to the wells
of polystyrene microtitre trays (150 ml per well) and incubated for
24 h at 30 uC. The medium was removed from the wells and they
were washed twice with 0.9% NaCl, stained with 0.1% crystal violet
and washed twice with 0.9% NaCl; the crystal violet-stained biofilms
were then resuspended in 96% ethanol, and biofilm cell-associated
dye was measured as A590. Measurements of extracellular DNA in P.
aeruginosa microtitre tray cultures was done as described by Allesen-
Holm et al. (2006). Microtitre tray cultures were started by diluting
P. aeruginosa overnight cultures to OD600 0.001 in AB-glucose
medium supplemented with 0.05 mM propidium iodide and FeCl3
(as indicated) in wells of polystyrene microtitre plates (150 ml per
well). The cultures were incubated for 24 h at 37 uC, after which
propidium iodide absorbance was measured at 480 nm and cell den-
sity was measured at 600 nm by the use of a Wallac microplate
reader.
DNase I treatment of biofilms in microtitre trays. Twenty-
four-hour-old microtitre-tray-grown biofilms of PAO1 were washed
twice with 0.9% NaCl and treated with 0.9% NaCl containing
100 mg DNase I ml21 for 3 h, after which the amount of biofilm was
measured as described above.
Cultivation of biofilms in flow-chambers. Biofilms were grown
in flow-chambers with individual channel dimensions of 1646
40 mm. The flow system was assembled and prepared as described
previously (Sternberg & Tolker-Nielsen, 2005). The flow-chambers
were inoculated by injecting 350 ml overnight culture diluted to an
OD600 of 0.001 into each flow channel using a small syringe. After
inoculation, the flow channels were left without flow for 1 h, after
which medium flow was started using a Watson Marlow 205S peri-
staltic pump. The mean flow velocity in the flow-chambers was
0.2 mm s21, corresponding to laminar flow with a Reynolds number
of 0.02.
Microscopy and image acquisition. All microscopy observations
and image acquisitions were done with a Zeiss LSM510 confocal
laser scanning microscope (CLSM) equipped with detectors and
filter sets for monitoring of Gfp, propidium iodide Syto62 and
DDAO fluorescence. Images were obtained using a 636/1.4 objective
or a 406/1.3 objective. Simulated three-dimensional images and sec-
tions were generated using the IMARIS software package (Bitplane
AG).
Assessment of extracellular DNA in flow-chamber-grown
biofilms. DDAO was added to the medium to a final concentration
of 1 mM to fluorescently stain extracellular DNA in flow-chamber-
grown biofilms. DDAO fluorescence in different biofilms was
recorded with fixed settings of the CLSM.
Antimicrobial treatment. Biofilm tolerance to EDTA or ciproflox-
acin was assessed by irrigating 4-day-old flow-chamber-grown P.
aeruginosa biofilms with medium containing 50 mM EDTA or 50 mg
ciprofloxacin ml21 for 24 h, followed by staining of the dead cells
with propidium iodide, and CLSM image acquisition. To quantify
survival rates, the bacteria from flow-chamber biofilms were recov-
ered after EDTA treatment, ciprofloxacin treatment, or no antimi-
crobial treatment, by pumping bead-containing (Sigma glass-beads
212–300 mm) medium rapidly in and out of the flow-chambers
using syringes. The bead-containing bacterial suspensions were
vortex mixed, and the bacteria were plated on LB plates; c.f.u. were
determined and survival rates calculated.
COMSTAT image analysis. CLSM images were analysed by use of
the computer program COMSTAT (Heydorn et al., 2000). A fixed
threshold value and connected volume filtration were used for all
image stacks.
RESULTS
We initially performed experiments to determine the iron
status of P. aeruginosa in our AB-glucose medium supple-
mented with different concentrations of iron. Expression of
the pvdD gene in P. aeruginosa is known to be suppressed by
high levels of iron (Ochsner et al., 2002). We measured b-
galactosidase activity in microtitre tray cultures of P.
aeruginosa harbouring the low-copy-number plasmid
pPM190 : : pvdD, which carries the pvdD promoter fused
to the E. coli lacZ gene (Rombel et al., 1995). The b-
galactosidase activity (Miller units) was 7757, 4944, 2773
and 2206 (three replicates, SD 581, 458, 347 and 58) in
cultures supplemented with 5, 10, 50 and 100 mM FeCl3.
Accordingly, the selected range of iron concentrations in our
medium evidently affected the iron status of the P.
aeruginosa cells.
When P. aeruginosa PAO1 was cultivated in microtitre trays,
a high cell density was reached in wells containing AB-
glucose medium supplemented with 100 or 50 mM iron,
whereas a slightly lower cell density was reached in wells
containing AB-glucose medium supplemented with 10 mM
iron, and a significantly lower cell density was reached in
wells containing AB-glucose medium supplemented with
5 mM iron (Fig. 1A). However, the lowest iron concentra-
tion used did not limit growth dramatically, and the highest
iron concentration used did not inhibit growth.
Iron affects P. aeruginosa DNA release and
biofilm formation in microtitre trays
High concentrations of iron salts were reported to inhibit P.
aeruginosa biofilm formation (Musk et al., 2005). Because
extracellular DNA is a major matrix component of P.
aeruginosa biofilms (Whitchurch et al., 2002; Nemoto et al.,
2003; Matsukawa & Greenberg, 2004; Allesen-Holm et al.,
2006), we found it of interest to investigate whether the
presence of high levels of iron might inhibit the generation
of extracellular DNA from P. aeruginosa. In accordance with
the work of Musk et al. (2005), we found that biofilm
formation by P. aeruginosa PAO1 in microtitre trays
decreased with increasing iron concentrations (Fig. 1B).
In order to quantify the extracellular DNA generated in the
microtitre tray cultures (from planktonic as well as from
biofilm cells), we supplemented the medium with propi-
dium iodide (which fluoresces when it is bound to DNA,
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and does not penetrate live bacteria) and measured the level
of fluorescence in the cultures after 1 day of growth. The
amount of extracellular DNA in P. aeruginosa PAO1
microtitre tray cultures was high in medium supplemented
with 5 mM iron, and decreased with increasing iron
concentrations (Fig. 1C). Treatment of 1-day-old P.
aeruginosa PAO1 biofilms with DNase I led to dispersal of
large amounts of the biofilms (Fig. 1D), showing that
extracellular DNA plays a critical role in biofilm formation
in the experimental setup used.
Iron affects the Pseudomonas quinolone signal
(PQS) pathway
In a previous report, we presented evidence that release of
extracellular DNA from P. aeruginosa populations was
regulated through the pqs quorum-sensing system (Allesen-
Holm et al., 2006). To investigate whether the observed
effect of iron on DNA release from P. aeruginosa
populations occurs through the PQS system, we initially
tested DNA release from different PQS mutants in
microtitre tray cultures supplemented with different con-
centrations of iron. The mutants pqsA and pqsR were found
to release less extracellular DNA than the wild-type in an
iron-independent manner, whereas a pqsL mutant was
found to release more extracellular DNA than the wild-type
via a pathway that was suppressed by high iron concentra-
tions (Fig. 2). These results are in agreement with evidence
reported by D’Argenio et al. (2002) that the pqsA and pqsR
mutants were deficient in PQS production and autolysis,
whereas the pqsLmutant overproduced PQS and was hyper-
autolysing.
To further investigate whether the observed effect of iron on
DNA release and biofilm formation might be caused by an
effect on the PQS pathway, we constructed a plasmid-based
pqsA : : gfp(ASV) transcriptional reporter (as detailed in
Methods). The gfp(ASV) gene encodes an unstable version
of Gfp (Andersen et al., 1998) and the pqsA : : gfp(ASV)
reporter-construct is thus useful for monitoring pqsABCDE
expression. The plasmid with the reporter-construct was
transferred to the P. aeruginosa wild-type as well as to an
isogenic P. aeruginosa lasI rhlI quorum-sensing mutant, and
pqsA : : gfp(ASV) expression was measured in microtitre tray
cultures. The experiments confirmed that the pqsABCDE
operon is under N-acylhomoserine lactone (AHL) quorum-
sensing control, as expression of the pqsA : : gfp(ASV) reporter
consistently was lower in the lasI rhlI quorum-sensingmutant
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Fig. 1. P. aeruginosa PAO1 was grown for 24 h in microtitre tray wells containing AB-glucose medium with different
concentrations of FeCl3, then culture densities, biofilm amounts and extracellular DNA amounts were determined. (A) Final
OD600 of the cultures. (B) Relative amounts of biofilm in the wells determined via a crystal violet staining assay. (C) Relative
amounts of extracellular DNA in the cultures determined via a propidium iodide staining assay. (D) Relative amounts of biofilm
in the wells after 3 h of DNase I treatment. Means and standard deviations of eight replicates are shown.
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than in the wild-type (Fig. 3A). Transcription of the
pqsABCDE operon in the P. aeruginosa wild-type was
found to be high in medium supplemented with 5 mM
iron, and decreased with increasing iron concentrations
(Fig. 3A). In the lasI rhlI quorum-sensing mutant there was
also an inverse relation between pqsA : : gfp(ASV) expression
and the level of iron in the medium (Fig. 3A), suggesting that
the effect of iron on pqsABCDE expression to some extent is
independent of the AHL quorum-sensing system. DNA
release in the microtitre tray cultures was found to correlate
with the expression of the pqsABCDE operon (Fig. 3B). Based
on these results, we suggest that iron affects P. aeruginosa
DNA release and biofilm formation by affecting the PQS
signalling pathway.
In order to address whether the observed effects of ferric
iron supplementation could be due to induction of an
oxidative stress response in the P. aeruginosa cells, we
investigated microtitre tray cultures supplemented with
different concentrations (ranging from 0 to 10 mM) of
H2O2, and found no reduction in pqsA : : gfp(ASV) expres-
sion, DNA release, or biofilm formation (data not shown),
indicating that the observed effects of iron are not due to an
oxidative stress response.
Iron affects P. aeruginosa DNA release and
structural biofilm development in flow-
chambers
In order to examine the effect of iron concentration on DNA
release in P. aeruginosa biofilms, we grew the PAO1 wild-
type in flow-chambers irrigated with normal FAB medium
(containing 1 mM iron) or FAB100 medium (containing
100 mM iron). Because of the continuous supply of medium,
the amount of iron available to the bacteria will be higher in
the flow-chamber setup than in the microtitre tray setup,
and we therefore chose to use FAB, containing 1 mM iron, as
the medium with the lowest iron concentration in the
investigations. After 4 days of growth, the extracellular DNA
in the biofilms was visualized by staining with the
compound DDAO followed by CLSM. In agreement with
our previous study (Allesen-Holm et al., 2006), the biofilms
grown in FAB medium contained large amounts of
extracellular DNA in the part of the biofilm close to the
substratum and in the outer region of the stalk portions of
the mushroom-shaped multicellular structures (Fig. 4A). In
agreement with the quantifications of extracellular DNA and
biofilm formation in the microtitre tray assays (described
above), the biofilms grown in FAB100 medium contained
less extracellular DNA and less biomass than the biofilms
grown in normal FAB medium (Fig. 4B). In addition,
biofilms grown in FAB100 medium appeared less spatially
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Fig. 3. (A) Expression of a plasmid-borne pqsA : : gfp(ASV) fusion in microtitre tray cultures of the PAO1 wild-type (black
bars) and a lasI rhlI mutant (grey bars) grown in AB-glucose medium with different concentrations of FeCl3. (B) Relative
amounts of extracellular DNA, determined via a propidium iodide staining assay, in microtitre tray cultures of the PAO1 wild-
type (black bars) and lasI rhlI mutant (grey bars) grown in AB-glucose medium containing different amounts of FeCl3. Means
and standard deviations of eight replicates are shown.
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organized and did not contain the mushroom-shaped
multicellular structures typical of the biofilms grown in
normal FAB medium (Fig. 4). The difference in biomass
and spatial structure between biofilms grown in normal FAB
medium and FAB100 medium was confirmed by COMSTAT
analysis (Table 1).
Iron affects expression of the pqsABCDE
operon in flow-chamber-grown P. aeruginosa
biofilms
In order to investigate expression of the pqsABCDE operon
in P. aeruginosa biofilms, we grew PAO1 containing the
pqsA : : gfp(ASV) reporter plasmid in flow-chambers irri-
gated with FAB medium or FAB100 medium. In FAB
medium, expression of the pqsA : : gfp(ASV) fusion was
detectable at day 1 (Fig. 5A) and reached the highest
expression level at day 2 where it was localized mainly in the
outer part of the microcolonies (Fig. 5C). After day 2,
expression of the pqsA : : gfp(ASV) fusion decreased, and at
day 4 only a weak green signal could be detected in the stalk
portion of the mushroom-shaped multicellular structures
(Fig. 5E). In FAB100 medium, there was significantly less
expression of the pqsA : : gfp(ASV) fusion, and this expres-
sion appeared less coordinated in time and space (Fig. 5B, D
and F).
Iron affects tolerance to antimicrobial
compounds in flow-chamber-grown P.
aeruginosa biofilms
Since we had found that the level of iron in the mediummay
control whether a structured or an unstructured P.
aeruginosa biofilm is formed, and because tolerance to
antimicrobial compounds in biofilms may be related to the
spatial structure, we found it of interest to investigate
tolerance to the antibiotic ciprofloxacin and to the
antimicrobial compound EDTA in P. aeruginosa biofilms
grown in FAB medium or FAB100 medium. After 4 days of
growth, the biofilms were treated with either ciprofloxacin
or EDTA, after which the dead bacteria in the biofilms were
visualized by staining with propidium iodide. In 4-day-old
P. aeruginosa PAO1 biofilms grown in FAB medium,
ciprofloxacin treatment caused killing of the bacteria located
in the outer part of the cap portion of the mushroom-
shaped structures (Fig. 6C), whereas EDTA treatment
caused killing of the cells located within the mushroom-
shaped structures (Fig. 6E). In 4-day-old P. aeruginosa
PAO1 biofilms grown in FAB100 medium, treatment with
ciprofloxacin or EDTA appeared to kill a large proportion of
the bacteria, and there was no special area for the
ciprofloxacin- or EDTA-mediated killing (Fig. 6D, F).
Propidium iodide staining of biofilms that had not been
treated with antibiotic showed that virtually no dead cells
Fig. 4. Four-day-old biofilms of gfp-tagged
PAO1 grown in FAB medium (A) or
FAB100 medium (B) were stained with
DDAO and images visualizing cells (green)
and extracellular DNA (appearing red or
yellow) were acquired by CLSM. The central
pictures show horizontal optical sections,
and the flanking pictures show vertical opti-
cal sections. Bars, 20 mm.
Table 1. Quantification of biofilm architecture
The results are means of datasets obtained from analysis of eight CLSM images acquired at random positions in each of the biofilms.
Standard deviations are shown in parentheses.
Biofilm medium Total biomass
(mm3 mm”2)
Mean thickness
(mm)
Roughness
coefficient
Surface area
covered (mm2)
Surface/
volume (mm2 mm”3)
Max. thickness
(mm)
FAB (containing
1 mM FeCl3)
40.06 (1.97) 42.82 (2.74) 0.39 (0.08) 8.716105 (2.726105) 0.41 (0.12) 96.63 (3.42)
FAB100 (containing
100 mM FeCl3)
13.08 (4.76) 17.56 (5.41) 0.59 (0.18) 1.216106 (3.306105) 1.81 (0.36) 59.75 (2.12)
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were present in the biofilms before antibiotic treatment, and
that the propidium iodide staining did not visualize
extracellular DNA with the setting of the CLSM that was
used (Fig. 6A, B). (Propidium iodide does not give as high a
signal as DDAO, and with normal settings of the CLSM it
will therefore mainly visualize dead cells where the
concentration of DNA is high compared to in the biofilm
matrix.)
Assessment of survival in the biofilms through recovery of
the bacteria from the flow-chambers, after EDTA treatment,
ciprofloxacin treatment, or no antimicrobial treatment,
followed by plating and c.f.u. counting, confirmed that the
structured P. aeruginosa biofilms grown in FAB medium
displayed higher tolerance to the ciprofloxacin and EDTA
treatment than the unstructured P. aeruginosa biofilms
grown in FAB100 medium. C.f.u. from ciprofloxacin-
treated biofilms divided by c.f.u. from untreated biofilms
was 0.22 (three replicates, SD 0.13) for the biofilms grown in
FAB, and 0.02 (three replicates, SD 0.001) for the biofilms
grown in FAB100. C.f.u. from EDTA-treated biofilms
divided by c.f.u. from untreated biofilms was 0.55 (three
replicates, SD 0.095) for the biofilms grown in FAB and 0.21
(three replicates, SD 0.082) for the biofilms grown in
FAB100.
DISCUSSION
A number of recent reports suggest that iron affects biofilm
formation by P. aeruginosa. Experiments using iron-chelating
lactoferrin suggested that a minimum concentration of free
Fig. 5. Biofilms of PAO1 containing a
pqsA-gfp(ASV) reporter were grown for 1
(A, B), 2 (C, D) and 4 (E, F) days in flow
chambers irrigated with FAB medium (A, C,
E) or FAB100 medium (B, D, F). The cells
were stained with Syto62, and images visua-
lizing cells (red) and pqsA-gfp(ASV) expres-
sion (appearing yellow) were acquired by
CLSM. The central pictures show horizontal
optical sections, and the flanking pictures
show vertical optical sections. Bars, 20 mm.
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iron is necessary for the formation of structured P.
aeruginosa biofilms in a flow-chamber system (Singh et al.,
2002; Banin et al., 2005). On the other hand, high
concentrations of iron were shown to suppress P. aeruginosa
biofilm formation in both microtitre tray and flow-chamber
systems (Musk et al., 2005), and low iron concentrations
were shown to be required for P. aeruginosa biofilm
(microcolony) formation in artificial sputum medium
(Sriramulu et al., 2005). In agreement with these previous
studies, we found in the present study that in our microtitre
tray and flow-chamber setups low iron levels promoted
biofilm formation while high iron levels suppressed biofilm
formation. Experiments involving DNase I treatment of
biofilms in microtitre trays (this study) or flow-chambers
(Allesen-Holm et al., 2006) suggested that extracellular
DNA is an important constituent of the biofilm matrix.
Furthermore, evidence was presented that the formation of
extracellular DNA in P. aeruginosa biofilms is regulated via
the PQS quorum-sensing system (Allesen-Holm et al.,
2006). In this paper, we present evidence that low iron
concentrations promote P. aeruginosa biofilm development
via up-regulation of the pqs genes and the formation of
extracellular DNA, and that high levels of iron suppress P.
aeruginosa biofilm development via down-regulation of the
pqs genes and the formation of extracellular DNA. In
agreement with our present and previous work, a study
Fig. 6. Four-day-old biofilms of gfp-tagged
PAO1 grown in FAB medium (A, C, E) or
FAB100 medium (B, D, F) were either not
treated (A, B), treated with ciprofloxacin (C,
D), or treated with EDTA (E, F), after which
they were stained with propidium iodide and
images were acquired by CLSM. Live cells
appear green and dead cells appear yellow
or red. The central pictures show horizontal
optical sections, and the flanking pictures
show vertical optical sections. Bars, 20 mm.
http://mic.sgmjournals.org 1325
Iron-regulated DNA release in P. aeruginosa
comparing different microarray results identified the PQS
regulator gene pqsR as being among genes that are induced
at low iron levels and also positively controlled by quorum
sensing (Cornelis & Aendekerk, 2004).
Under specific conditions in flow-chamber systems (e.g. the
glucose FAB medium used in the present study), P.
aeruginosa forms heterogeneous biofilms with mushroom-
shaped multicellular structures via a process that involves
formation of microcolonies in the initial phase and
subsequent formation of cap-shaped structures on top of
the microcolonies in the later phase (e.g. Klausen et al.,
2003a). In agreement with the present study, the extra-
cellular DNA in such P. aeruginosa biofilms was shown to be
present in high concentrations close to the substratum and
in the outer part of the microcolonies in the initial phase of
biofilm development, and in the outer region of the stalk
portion of the mushroom-shapedmulticellular structures in
the later phase of biofilm development (Allesen-Holm et al.,
2006). In the present study we observed that when P.
aeruginosa formed biofilms in flow-chambers irrigated with
FAB medium, expression of a pqsA : : gfp(ASV) fusion was
detectable in 1-day-old biofilms and reached the highest
expression level at day 2, where it was localized mainly in the
outer part of the microcolonies. After day 2, expression of
the pqsA : : gfp(ASV) fusion in the biofilms decreased, and at
day 4 only a weak green signal could be detected in the stalk
portion of the mushroom-shaped multicellular structures.
This spatio-temporal expression pattern of pqsABCDE is in
accordance with the location of extracellular DNA in P.
aeruginosa biofilms reported here and by Allesen-Holm et al.
(2006). In the medium containing a high iron concentra-
tion, there was significantly less expression of the
pqsA : : gfp(ASV) fusion, and this expression appeared less
coordinated in time and space. In agreement with the
quantifications of extracellular DNA and biofilm formation
in the microtitre tray assays, and in agreement with the
role of the pqs genes in DNA release (Allesen-Holm et al.,
2006), the biofilms grown at high iron concentration
contained less extracellular DNA and less biomass than the
biofilms grown in normal FAB medium. In addition,
biofilms grown at high iron concentration appeared less
spatially organized and did not develop mushroom-shaped
multicellular structures.
The cap-forming and the stalk-forming subpopulation of
the mushroom-shaped multicellular structures in P.
aeruginosa biofilms in many cases display differential
tolerance to antimicrobial compounds. For example, the
antibiotic tobramycin was shown to kill preferentially
bacteria located in the outer part of the cap portion of the
mushroom-shaped structures, whereas the antibiotic colis-
tin, the detergent SDS and the chelator EDTA were shown to
kill preferentially bacteria in the stalk portion of the
mushroom-shaped structures (Bjarnsholt et al., 2005;
Banin et al., 2006; Haagensen et al., 2007). Since we had
found that the level of iron in the medium may control
whether a structured or an unstructured P. aeruginosa
biofilm is formed, we found it of interest to investigate
tolerance to antimicrobial compounds in P. aeruginosa
biofilms grown in FAB medium or in FAB100 high-iron
medium. Ciprofloxacin treatment and EDTA treatment
caused killing of cells located in the cap portion and stalk
portion, respectively, of the mushroom-shaped structures of
4-day-old P. aeruginosa biofilms grown in FAB medium,
whereas there was no special area for ciprofloxacin- or
EDTA-mediated killing in 4-day-old biofilms grown in
high-iron medium. In addition, the structured P. aeruginosa
biofilms, grown in FAB medium, displayed higher tolerance
to the antimicrobial treatment than the unstructured P.
aeruginosa biofilms, grown in high-iron medium.
The formation of P. aeruginosa extracellular DNA is
evidently regulated by both quorum sensing and the level
of available iron. Other processes that appear to be subject to
regulation by the same cues include elastase production and
Mn-superoxide dismutase (SOD) production, which were
both shown to be quorum-sensing controlled (Hassett et al.,
1999; Winson et al., 1995), and also regulated by iron so that
they were induced under low-iron conditions but repressed
under high-iron conditions (Bjorn et al., 1979; Hassett et al.,
1997; Sokol et al., 1982; Bollinger et al., 2001). The fact that
iron regulation of these processes to some extent is
independent of quorum-sensing regulation makes nutri-
tional override of quorum sensing possible. Other examples
of possible nutritional override of quorum sensing include
pyocyanin production, which is positively controlled by
quorum sensing (Brint & Ohman, 1995), but can also be
induced by phosphate starvation (Hassett et al., 1992). The
possibility of nutritional override of quorum sensing
should be taken into account when possible strategies for
manipulating quorum sensing for controlling bacterial
infections are considered.
Evidence was recently presented that biofilm formation by
Staphylococcus aureus is induced at low iron concentrations
and repressed at high iron concentrations via a mechanism
that does not affect expression of polymeric N-acetylglucos-
amine, which is the major exopolysaccharide implicated in
S. aureus biofilm formation (Johnson et al., 2005). Our
unpublished results suggest that extracellular DNA plays a
role in S. aureus biofilm formation, and that formation of S.
aureus extracellular DNA occurs at high levels in low-iron
medium and at low levels in high-iron medium. It is
possible, therefore, that there is a connection between iron
concentration, extracellular DNA and biofilm formation
also for the Gram-positive organism S. aureus.
The finding that high amounts of iron may inhibit P.
aeruginosa biofilm formation raises the question whether
iron might be used to treat biofilm infections in medical
settings. However, because the lack of free iron in the human
body in most cases is limiting bacterial growth (Weinberg,
1999), treatment of biofilm-based infections with iron
might not be feasible. Nevertheless, the possibility exists that
a combination treatment involving antibiotics and iron
might be useful. The finding that iron can suppress biofilm
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formation may motivate a search for similar compounds
that can suppress biofilm formation but do not stimulate
bacterial growth.
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Abstract 
 
Pseudomonas aeruginosa is an opportunistic pathogen and can cause a wide range of persistent 
human infections, which are to a large extent due to its ability to form biofilms. We have previously 
provided evidence that extracellular DNA is an important constituent of the extracellular matrix in 
P. aeruginosa biofilms, and is released via a process that requires the Pseudomonas Quinolone 
Signal (PQS) system. In the present study, we have constructed a P. aeruginosa transposon 
insertion mutant library and performed a screen for mutants defective in DNA-release. tatA and tatB 
mutants, defective in the twin-arginine translocation pathway, were among the mutants that 
displayed a reduced  level of DNA release. Characterization of P. aeruginosa tatA showed that the 
defect in the tatA gene attenuated PQS secretion, but did not affect the level of PQS synthesis. In 
addition to PQS-mediated DNA-release, the P. aeruginosa tatA mutant was also deficient in 
virulence factor production and biofilm development.  
 
Introduction 
 
Pseudomonas aeruginosa is an opportunistic 
pathogen which can cause a wide range of 
human infections such as pulmonary infections, 
medical-device-related infections, urinary tract 
infections, wound infections and bacteremia 
(Bodey et al., 1983). P. aeruginosa is notorious 
for its tolerance to antimicrobial agents and this 
is to a large extent due to its ability to form 
biofilms (Costerton et al., 1995; Costerton et al., 
1999). Biofilms are agglomerates of 
microorganisms embedded in a self-produced 
polymeric matrix (Costerton et al., 1995). 
Bacterial cells living in biofilms were shown to 
be 1000-times more resistant to antibiotic 
treatment than their planktonic counterparts 
(Costerton et al., 1999). 
 
P. aeruginosa is a model organism for biofilm 
research. Intercellular communication (quorum-
sensing), cell surface appendages, extracellular 
polymeric substances, biosurfactants, and 
motility were reported to be involved in P. 
aeruginosa biofilm development (Davies et al., 
1998; Donlan, 2002; Allesen-Holm et al., 2006; 
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Barken et al., 2008; Klausen et al., 2003a; 
Klausen et al., 2003b; Pamp & Tolker-Nielsen, 
2007; Flemming et al., 2007). P. aeruginosa 
biofilms were reported to contain distinct 
subpopulations which are tolerant to different 
antibiotics (Haagensen et al., 2007; Pamp & 
Tolker-Nielsen, 2007).  
 
Recently, extracellular DNA was recognized as 
one of the major matrix components of bacterial 
biofilms (Allesen-Holm et al., 2006; Qin et al., 
2007; Rice et al., 2007; Whitchurch et al., 
2002). In P. aeruginosa, release of extracellular 
DNA is regulated through the quorum-sensing 
systems (Allesen-Holm et al., 2006; Yang et al., 
2007). Evidence has been provided that 
Pseudomonas Quinolone Signal (PQS)-
mediated cell lysis or membrane vesicle release 
is a major cause of DNA release in P. 
aeruginosa biofilms (Allesen-Holm et al., 
2006). Membrane vesicles containing DNA and 
other virulence factors were shown to be 
released from the outer membrane of P. 
aeruginosa cells dependent on PQS (Mashburn 
et al., 2005), and they were found to be a 
common particulate feature of the matrix of 
Pseudomonas aeruginosa biofilms (Schooling 
& Beveridge, 2006). Recently, PQS was 
reported to act as a pro-oxidant which sensitizes 
the bacteria towards oxidative and other stresses 
(Haussler & Becker, 2008), which may provide 
another explanation for PQS-mediated cell lysis. 
However, to better understand P. aeruginosa 
biofilm development, more studies are needed 
on PQS-mediated DNA release.  
 
In this study, we identified genes which are 
involved in the release of extracellular DNA 
from P. aeruginosa. A P. aeruginosa mutant 
library was constructed by the use of Mariner 
transposon mutagenesis, and a screen for DNA 
release defective mutants was carried out. In 
addition to mutants that were inactivated in 
genes involved in PQS synthesis, tat mutants, 
defective in the twin-arginine translocation 
pathway, were identified to have reduced levels 
of DNA release. Further studies showed that a 
tatA mutation did not affect the level of PQS 
synthesis but blocked PQS secretion, virulence 
factor production and biofilm structure 
development.   
 
  
Materials and Methods 
 
Bacterial strains and growth conditions 
P. aeruginosa PAO1 (Holloway & Morgan, 
1986) was used as the wild-type strain in this 
study. Escherichia coli strains MT102 and 
DH5a were used for standard DNA 
manipulations. Luria–Bertani (LB) medium 
(Bertani, 1951) was used to cultivate E. coli 
strains. P. aeruginosa biofilms were cultivated 
at 30oC in flow-chambers irrigated with FAB 
medium (Heydorn et al., 2000) supplemented 
with 0.3 mM glucose. Selective media were 
supplemented with ampicillin (Ap; 100mg/liter), 
gentamicin (Gm; 60mg/liter), or streptomycin 
(Sm; 100mg/liter). 
 
Mutant library construction and screening 
The P. aeruginosa mutant library was 
constructed by using the Mariner transposon 
vector pBT20 as previously described 
(Kulasekara et al., 2005). Transconjugants 
carrying transposon insertion were picked from 
the selective plates and inoculated into 
microtiter tray wells containing ABTG medium 
supplemented with propidium iodide (PI) 
(Allesen-Holm et al., 2006) by using a Qpix2 
robot (Genetix). The red fluorescence 
originating from propidium bound to DNA was 
measured in a Wallac Victor 2 1420 Multilabel 
Counter (Perkin Elmer), and it was used as a 
measure of the amount of extracellular DNA 
produced by each mutant. Mutants that 
produced reduced levels of extracellular DNA 
were selected and saved for further analysis. 
 
PqsA::gfp(ASV) expression assay 
For measuring pqs operon expression in P. 
aeruginosa, a reporter plasmid harbouring a 
pqsA::gfp(ASV) fusion (Yang et al., 2007) was 
transformed into the P. aeruginosa wild-type 
PAO1 strain and different mutants by 
electroporation, and Gfp fluorescence was 
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measured as previously reported (Yang et al., 
2007).  
 
Sequencing of transponson mutants 
The sequence flanking the Mariner transponson 
in mutants was identified by arbitrary PCR 
essentially as previously described (Friedman & 
Kolter, 2004) but with the following TnM 
specific primers: Rnd1-TnM 5’-GTG AGC 
GGA TAA CAA TTT CAC ACA G, Rnd2-
TNm 5’-ACA GGA AAC AGG ACT CTA 
GAG G. Sequencing was performed by 
Macrogen, Seoul, Korea with the TnM specific 
primer: TnMseq 5’-CAC CCA GCT TTC TTG 
TAC AC. 
 
Construction of the tatA complementation 
plasmid 
A full length tatA fragment was PCR amplified 
by use of the primers tatAF 5’-
GGAATTCCCCTGAACCTACACATTGCCA-
3’ and tatAR 5’-
GGGGTACCCCATTCCGAACATCGATGGC
TA-3’. The PCR product was digested with 
EcoRI and KpnI and then ligated into 
EcoRI/KpnI digested pUCP22Not vector 
(Herrero et al., 1990). The ligation product was 
electroporated into the P. aeruginosa tatA 
mutant. Transformants were selected on LB 
plates containing 200 μg/ml carbenicillin. Lack 
of pyoverdine production and different types of 
motility was observed for the P. aeruginosa 
tatA mutant as previously reported (Ochsner et 
al., 2002), and these defects were found to be 
restored in the complemented strain P. 
aeruginosa tatA/pUCP22::tatA 
 
PQS assay 
The P. aeruginosa PAO1 wild-type, P. 
aeruginosa tatA mutant and P. aeruginosa 
tatA/pUCP22::tatA complemented mutant were 
grown in LB at 37°C with vigorous shaking. 
Samples were obtained at OD600 values 0.3, 0.8 
and 2.0 unless otherwise indicated, and were 
prepared as previously published (Gallagher et 
al., 2002) with modifications. At each time 
point, 300 μl culture was added to 900 μl 
acidified ethyl acetate, and samples were 
vortexed for 2 min and centrifuged for 2 min at 
13.000 g (Gallagher et al., 2002). A portion of 
the ethyl acetate layer (450 μl) was removed to 
a clean tube and allowed to dry down at 37°C. 
Extracts were resuspended in 50 μl of 1:1 
acidified ethyl acetate: acetonitrile by vortexing 
for 10 min at low speed. Thin layer 
chromatography (TLC) was used to quantify 
PQS production by P. aeruginosa strains as 
previously described (Gallagher et al., 2002). 
Aluminum TLC sheets (EMD Chemicals, silica 
gel 60 F254) were activated in a 0.5% KH2PO4 
solution, air dried, and baked at 100°C for 1 h 
prior to use. Samples (2μl) were applied to each 
plate using 1μl glass capillaries, and synthetic 
PQS (25μg) was loaded for comparison. The 
TLC solvent used was 17:2:1 methylene 
chloride:acetonitrile:dioxane. Plates were 
visualized using a handheld long-wave UV light, 
and photographs were taken using a digital 
camera. Fold changes in spot intensity were 
determined with Image J (available at 
http://rsb.info.nih.gov/ij; developed by Wayne 
Rasband, National Institutes of Health, 
Bethesda, MD). 
 
Rhamnolipid assay 
An emulsification activity assay was used to 
measure the production of rhamnolipid from P. 
aeruginosa strains as previously described 
(Cooper & Goldenberg, 1987) with slight 
modification. Simply, 1 ml of (18 hours) over 
night culture supernatant and 1 ml of n-
hexadecane was mixed in an eppendorf tube 
and vortexed at high speed for 1 min. The 
mixture was allowed to stand for 1 hour before 
inspection.  The emulsification activity was 
defined as the height of the emulsion layer 
divided by the total height of the liquid column.  
 
Cultivation of static biofilms, and analysis of 
them by atomic force microscopy (AFM) 
P. aeruginosa overnight cultures were diluted 
100 times in ABTG medium and incubated in 
eppendorf tubes with glass cover slips at 37oC 
for 24 hours without shaking. After incubation 
the biofilms formed at the air-liquid interface on 
the glass cover slips were dipped 3 times into 
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double distilled water, and air-dried at room 
temperature for AFM analysis. The air-dried P. 
aeruginosa biofilms were imaged with a 
DualScope DS 95-50/200 AFM scanner (DME 
- Danish Micro Engineering A/S, 
Copenhagen/Herlev, Denmark). The instrument 
was operated using the tapping mode (Jalili & 
Laxminarayana, 2004). Images were obtained 
using SenseMode™ AC probes (DME) with a 
spring constant of 42 N/m. At least three, and 
up to five high-quality images were captured for 
each bacterial strain. After images were 
collected, the data were analyzed with the SPM 
program (DME) to gain information on biofilm 
topography. AFM images were also analyzed 
with SPIP 4.8.1 (Image Metrology A/S, 
Hørsholm, Denmark) to gain detailed 
information such as 3D image and height 
profile. For each strain, the cell length and cell 
width of 20 different bacteria were measured on 
topographic images acquired with the SPIP 
4.8.1 software.  
 
Cultivation of flow-chamber biofilms  
Biofilms were grown in flow-chambers with 
individual channel dimensions of 1 x 4 x 40 mm. 
The flow system was assembled and prepared 
as described previously (Heydorn et al., 2000). 
The flow-chambers were inoculated by 
injecting 350 µl of overnight culture diluted to 
an OD600 of 0.001 into each flow channel using 
a small syringe. After inoculation, the flow 
channels were left without flow for 1 h, after 
which medium flow was started using a Watson 
Marlow 205S peristaltic pump. The mean flow 
velocity in the flow-chambers was 0.2 mm/s, 
corresponding to laminar flow with a Reynolds 
number of 0.02. After 4-days of cultivation 10 
µM of tobramycin was added to the biofilm 
medium, and after 24-hours of tobramycin 
treatment 10 µM propidum iodide (Invitrogen) 
was added to the flow cells to visualize the dead 
cells. 
 
Microscopy and image processing of flow cell 
biofilms 
All microscopy observations and image 
acquisitions of flow-chamber-grown biofilms 
were done with a Zeiss LSM510 confocal laser 
scanning microscope (CLSM) (Carl Zeiss, Jena, 
Germany) equipped with detectors and filter 
sets for monitoring of green fluorescent protein 
and propidium iodide. Images were obtained 
using a 63x/1.4 objective or a 40 x/1.3 objective. 
Simulated 3-D images and sections were 
generated using the IMARIS software package 
(Bitplane AG, Zürich, Switzerland). 
 
 
Results 
 
Tn Mariner mutagenesis and mutant library 
screening 
In order to identify genes involved in DNA-
release in P. aeruginosa, we generated a 
transposon mutant library by the use of Mariner 
transposon mutagenesis. After screening of 
10.000 mutants, 84 mutants that displayed low 
levels of DNA-release were selected. The 
mutants were subjected to a second screening 
for low levels of DNA-release by inoculation of 
each of them into 8 microtiter tray wells 
followed by quantification of extracellular DNA. 
The mutants that consistently showed reduced 
levels of DNA release were subjected to 
Southern blotting to eliminate double insertion 
mutants. After that, the regions flanking the 
Mariner transposon in 34 DNA-release mutants 
were sequenced and the specific genes 
interrupted by the transposon were identified. 
 
Many of the DNA-release deficient mutants had 
the transposon insertion in PQS synthesis genes 
(e.g. pqsC, pqsH, pqsR) (Fig. 1, and data not 
shown). The DNA-release deficient phenotypes 
of these mutants were in accordance with our 
previous report (Allesen-Holm et al., 2006), and 
were verified with related defined mutants (data 
not shown). In addition, some of the DNA-
release deficient mutants had the Mariner 
transposon insertion in the tatA or tatB gene 
(Fig. 1), which encode part of a membrane 
protein involved in the twin-arginine 
translocation (TAT) pathway (Robinson & 
Bolhuis, 2001).  
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Fig. 1. P. aeruginosa wild-type and mutants were 
grown for 24 h in microtitre tray wells containing 
AB-glucose medium, after which the relative levels 
of extracellular DNA in the cultures were 
determined via a propidium iodide staining assay. 
Averages and standard deviations of eight replicates 
are shown. 
 
Because we previously have obtained evidence 
that DNA-release by P. aeruginosa is connected 
to PQS synthesis (Allesen-Holm et al., 2006), 
we measured expression of the pqs operon in 
the P. aeruginosa tatA mutant and some of the 
pqs mutants by using a reporter plasmid 
carrying a pqsA::gfp(ASV) fusion. Unlike the 
pqs synthesis defective mutants, the tatA mutant 
expressed the pqsA::gfp(ASV) reporter at a level 
similar to the wild-type strain (Fig. 2), 
suggesting that the Tat pathway might have an 
indirect effect on PQS-mediated DNA-release 
in P. aeruginosa.  
 
Fig. 2. P. aeruginosa wild-type and mutants were 
grown for 24 h in microtitre tray wells containing 
AB-glucose medium, after which the relative levels 
of pqsA::gfp(ASV) expression in the cultures were 
determined via a Gfp fluorescence assay. Averages 
and standard deviations of eight replicates are 
shown. 
 
Regulation of PQS secretion by the twin-
arginine translocation pathway 
 
The Tat pathway is a secretion pathway 
originally found in plants and recently 
discovered in bacteria (Robinson & Bolhuis, 
2001). The Tat pathway was shown to be 
essential for export of phospholipases, proteins 
involved in pyoverdine-mediated iron-uptake, 
anaerobic respiration, osmotic stress defense, 
motility, and biofilm formation in P. 
aeruginosa (Ochsner et al., 2002). We therefore 
speculated that PQS might be synthesized in the 
tat mutants but could not be transported out of 
the cells. To test this hypothesis, we quantified 
PQS in the supernatant of P. aeruginosa wild-
type, tatA, and tatA/pUCP22::tatA stationary-
phase cultures by the use of TLC. The tatA 
mutant had reduced levels of PQS in the 
supernatant (Fig. 3A), whereas the 
tatA/pUCP22::tatA complemented strain had 
wild-type levels of PQS in the supernatant (Fig. 
3A). If the cells were lysed prior to removal of 
the supernatant, the tatA mutant and the 
tatA/pUCP22::tatA complemented strain had 
approximately the same level of PQS in the 
supernatant as the wild-type PAO1 strain (Fig. 
3B). 
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Fig. 3. The PQS level in the supernatant of un-lysed 
(A) or lysed (B) P. aeruginosa wild-type, P. 
aeruginosa tatA and P. aeruginosa 
tatA/pUCP22::tatA cultures determined by TLC 
analysis. Averages and standard deviations of three 
replicates are shown. 
 
Regulation of rhamnolipid and pyocanine 
production by the twin-arginine 
translocation pathway 
As PQS mediated quorum sensing system was 
reported to regulate production of virulence 
factors such as rhamnolipid and pyocanine 
(Gallagher et al., 2002; McKnight et al., 2000; 
West et al., 2006), we tested the production of 
rhamnolipid and pyocanine by the P. 
aeruginosa wild-type, P. aeruginosa tatA 
mutant, and P. aeruginosa tatA/pUCP22::tatA 
complemented strain. Unlike the wild-type and 
tatA/pUCP22::tatA complemented strain,  the 
tatA mutant did not produce these two virulence 
factors (Figure 4). 
 
 
 
Fig. 4. Production of biosurfactant and pyocanine by 
P. aeruginosa wild-type (A), P. aeruginosa tatA (B) 
and P. aeruginosa tatA/pUCP22::tatA (C). N-
hexadecane was added to culture supernatant and 
the mixture was vortexed at high speed and was then 
allowed to stand for 1 hour before inspection. 
Biosurfacatant activity is indicated by the extent of 
the top emulsification layer, and the amount of 
pyocanine is indicated by the level of blue color in 
the bottom layer. 
 
Regulation of biofilm structure development 
by the twin-arginine translocation pathway 
We used two different tools, CLSM and AFM, 
to analyse the structural features of biofilms 
formed by the P. aeruginosa wild-type, P. 
aeruginosa tatA mutant, and P. aeruginosa 
tatA/pUCP22::tatA complemented strain under 
different conditions. 
 
CLSM was used to analyse biofilms formed in 
flow-chambers under continuous flow 
conditions. After 4-days cultivation, the P. 
aeruginosa wild-type and P. aeruginosa 
tatA/pUCP22::tatA complemented strain formed 
biofilms with mushroom-shaped structures, 
whereas the P. aeruginosa tatA mutant formed 
thin and flat biofilms (Fig. 5). We challenged 
the biofilms formed by the wild-type, tatA 
mutant and tatA/pUCP22::tatA strain with 
tobramycin, and found that the tatA mutant 
biofilm was more sensitive to tobramycin 
treatment than the wild-type and 
tatA/pUCP22::tatA biofilms (Fig. 5). 
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Fig. 5. CLSM micrographs showing four-day-old biofilms of gfp-tagged P. aeruginosa wild-type (A, D), 
tatA mutant (B, E) and tatA/pUCP22::tatA complemented strain (C, F) before (A, B, C) and after (D, E, F) 
treatment with tobramycin. The medium was supplemented with propidium iodide prior to CLSM, and 
therefore dead cells appear yellow or red while live cells appear green. The central pictures show horizontal 
optical sections, and the flanking pictures show vertical optical sections. Bars, 20 µm.  
 
AFM was used to analyse biofilms formed on 
glass slides in static cultures. Judged from 
AFM topographic, height contrast, and 3D 
images, the wild-type and tatA/pUCP22::tatA 
biofilms showed a higher level of structural 
heterogeneity than the tatA biofilm (Fig. 6). 
The wild-type and tatA/pUCP22::tatA 
biofilms consisted of multiple layers and the 
thickness varied between different areas while 
the tatA biofilm was flat and thin with some 
loosely attached cell aggregates (Fig. 6). The 
cells in the wild-type biofilm and 
tatA/pUCP22::tatA biofilm were rounder and 
smaller in size than the cells in the tatA 
biofilm (Table 1). According to the height  
profiles, the edges around the cells in the 
wild-type and tatA/pUCP22::tatA biofilms 
were not as clear as those around the cells in 
the tatA biofilm (Fig. 6).  
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Fig. 6. AFM analysis of biofilms formed by the P. aeruginosa wild-type (first column), tatA mutant (second 
column) and tatA pUCP22::tatA complemented strain (third column) during static growth for 24 hours. The 
first row shows topography AFM images, the second row shows height contrast images, the third row shows 
3D images, and the fourth row shows topographic line profiles obtained from the AFM images. 
 
 
Discussion 
 
Bacterial biofilm formation is a complicated 
process which needs coordination of different 
mechanisms such as quorum sensing, motilities, 
EPS material production, and iron up take 
(Davey & O'Toole G, 2000; O'Toole et al., 
2000; Klausen et al., 2006; Parsek and Tolker-
Nielsen, 2008). These mechanisms attribute 
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characters like biofilm subpopulation 
differentiation and antibiotic tolerance, which 
are important underlying causes of persistent 
infections (Costerton et al., 1999). It is difficult 
to link genes into a hierarchically ordered 
genetic network that deterministically controls 
biofilm development. However, understanding 
these networks is expected to facilitate the 
development of anti-biofilm strategies. In this 
study, we have screened genes involved in the 
release of extracellular DNA biofilm matrix 
material from P. aeruginosa. We provide 
evidence that the Tat secretion pathway plays a 
role in PQS quorum sensing in P. aeruginosa, 
and control DNA release and the production of 
some virulence factors (e.g. rhamnolipid and 
pyocyanine). Together with an earlier report 
(Ochsner et al., 2002) showing that the tatABC 
operon in P. aeruginosa regulates several 
virulence factors (e.g. phospholipase C and 
pyoverdine) as well as motilities, we have 
uncovered a role of the Tat pathway as a 
regulator in P. aeruginosa biofilm development.   
 
Our group has previously provided evidence 
that the PQS synthesis pathway is necessary for 
DNA release in P. aeruginosa biofilms 
(Allesen-Holm et al., 2006), and this process 
was also shown to be regulated by iron (Yang 
et al., 2007). However, the detailed 
mechanisms concerning PQS mediated DNA 
release and its regulation networks are still 
poorly investigated. In the present study, we 
generated and screened a mutant library to 
identify genes involved in PQS mediated DNA 
release. We found that one group of DNA 
release mutants were inactivated in the tat 
genes which encode components of the twin-
arginine translocase pathway. Measurements of 
the expression level of the pqs operon in the 
wild-type and tatA mutant, and quantification 
of the PQS level in the supernatant of un-lysed 
and lysed cultures of the wild-type and tatA 
mutant, provided evidence that the tatA mutant 
can synthesize PQS but can not secrete it. 
Together these findings suggest that DNA 
release from P. aeruginosa occurs in response 
to extracellular PQS. In accordance, membrane 
vesicles containing DNA and virulence factors 
were shown to be released from the outer 
membrane of P. aeruginosa cells in response to 
extracellular PQS (Mashburn et al., 2005). In 
addition, PQS was reported to act as a pro-
oxidant which sensitizes bacteria towards 
oxidative and other stresses (Haussler & Becker, 
2008), which suggest that extracellular PQS 
may play a role in DNA release via cell lysis.  
 
The Tat pathway is a transport system that 
enables transport of folded proteins across the 
cytoplasmic membrane and it is present in 
many bacterial pathogens (De Buck et al., 2008; 
Robinson & Bolhuis, 2001). A twin-arginine 
motif is the typical characteristics of the signal 
peptide of Tat-dependant proteins and it is 
possible to predict putative Tat substrates by in 
silico analysis (De Buck et al., 2008; Robinson 
& Bolhuis, 2001). Nevertheless, few of the 
predicted Tat substrates were confirmed to be 
actually transported by the Tat pathway (De 
Buck et al., 2008). The exact working 
mechanism of Tat transport is not fully 
unraveled and it is still unclear how the Tat 
pathway is involved directly in virulence. There 
is no substrate identified to explain the 
deficiencies of the P. aeruginosa tatA mutant in 
motility and biofilm formation (De Buck et al., 
2008). However, our study show that the P. 
aeruginosa tatA mutant is unable to perform 
PQS mediated DNA release and produce 
rhamnolipid and pyocanine, and therefore 
provide an explanation for the swarming 
motility and biofilm formation deficiency of P. 
aeruginosa Tat pathway mutants. Together with 
a recent report showing that the Tat pathway is 
involved in the production of an unknown 
secreted signaling molecule in Providencia 
stuartii (Stevenson et al., 2007), our study 
indicates that the Tat pathway might play a 
general role in bacterial cell-to-cell 
communication. However, our unpublished 
investigations suggest that the Tat pathway 
does not play a role in las quorum sensing (data 
not shown), which is in accordance with our 
finding of active expression of the pqs operon 
in the tatA mutant. 
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CLSM analysis of flow-chamber grown 
biofilms showed very clear differences between 
the P. aeruginosa wild-type and tatA biofilms. 
While the wild-type formed characteristic 
mushroom-shaped structures under these 
conditions, the tatA mutant formed flat and thin 
biofilms. In addition, the biofilms formed by 
the tatA mutant was more sensitive to 
tobramycin treatment than wild-type biofilms, 
presumably due to the inability of the tatA 
mutant to form differentiated multicellular 
structures. Formation of flat and thin biofilms 
by the P. aeruginosa tatA mutant is in 
agreement with previous reports showing that 
extracellular DNA, rhamnolipid, and bacterial 
motility all play roles in structural biofilm 
development by P. aeruginosa (Whitchurch et 
al., 2002; Klausen et al., 2003; Allesen-Holm et 
al., 2006; Pamp and Tolker-Nielsen, 2007; 
Barken et al., 2008).    
 
Biofilm development often occurs along with 
the production of a tight network of EPS that 
facilitates dense adherence of cells to each 
other and leads to a differentiated three-
dimensional biofilm architectures (Davey & 
O'Toole G, 2000; Sutherland, 2001). In the 
present study, we have characterized the impact 
of the Tat pathway on biofilm structure 
development at high resolution by the use of 
AFM. Bacterial cells were visible on the AFM 
images as tightly associated cellular unities in 
wild-type biofilm, but as a thin layer in tatA 
mutant biofilm. In addition the AFM analysis 
showed that the edges around the cells in the 
wild-type biofilms were not as clear as those 
around the cells in the tatA biofilm. In 
agreement with our finding that the tatA mutant 
is deficient in DNA release, Auerbach et al. 
(2000) found that EPS production in biofilms 
could lead to difficulties to visualize the edges 
of individual bacterial cells by the use of AFM.  
 
In conclusion, the present study provided 
evidence that the twin-arginine translocation 
pathway in P. aeruginosa is involved in PQS 
release, generation of extracellular DNA, and 
production of rhamnolipid and pyocyanine. In 
accordance with these phenotypes the P. 
aeruginosa tat mutants displayed defects in 
biofilm formation.  
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Summary 
 
The existence of physiologically distinct subpopulations in biofilms plays an important role in their 
tolerance towards environmental insult. The structured nature of biofilms is thought to enable 
buildup and maintenance of physiologically distinct subpopulations in different micro-niches. 
However, using flow-chamber-grown Pseudomonas aeruginosa biofilms as model system, we show 
in the present study that the development of heterogeneous biofilms may occur through mechanisms 
that involve complex subpopulation interactions. One example of this phenomenon is expression of 
the iron-siderophore pyoverdin in one subpopulation being necessary for development of another 
subpopulation which does not itself express the pyoverdin syntheses genes. Another example is 
quorum-sensing-controlled DNA-release in one subpopulation being necessary for development of 
another subpopulation which does not itself express the quorum-sensing genes. Mechanisms 
involved in the development of physiologically distinct subpopulations in biofilms may contribute 
to their innate tolerance towards biocides, protozoa, immune systems, and antibiotics, and therefore 
may be relevant as biofilm control targets.   
 
Introduction 
 
Microorganisms in medical, industrial and 
environmental settings often reside in biofilms 
(Costerton et al., 1995). Because bacteria in 
biofilms in many cases display tolerance to host 
immune systems, antibiotics and biocides they 
are often difficult or impossible to eradicate 
(Costerton et al., 1999). Biofilm formation 
therefore leads to various persistent infections 
in humans and animals, and to a variety of 
complications in industry where solid-water 
interfaces occur. Detailed knowledge about 
biofilm development processes is essential in 
order to create strategies to control biofilm 
formation.   
 
Evidence has been provided that the existence 
of physiologically distinct cells in biofilms is an 
underlying cause of their tolerance towards 
adverse conditions as it often allows one or 
more subpopulations to survive environmental 
insult (e.g. see(Pamp et al., 2008). It is 
generally assumed that physiologically distinct 
subpopulations arise and are maintained in 
biofilms because of the structured nature of the 
biofilms which allow different subpopulations 
to occupy different micro-niches (see(Stewart 
and Franklin, 2008))for a recent review). 
However, we show in the present report that 
development of heterogeneous biofilms may 
occur through mechanisms that involve 
complex subpopulation interactions. Biofilms in 
most medical, industrial and environmental 
settings undergo subpopulation succession and 
turnover, and mechanisms involved in the 
development and maintenance of 
physiologically distinct subpopulations may 
contribute to their innate tolerance towards 
adverse conditions. 
 
The model system used in the present study is 
Pseudomonas aeruginosa biofilms grown in 
flow-chambers irrigated with glucose minimal 
medium. Under these conditions P. aeruginosa 
forms biofilms that contains mushroom-shaped 
multicellular structures. The stalk and cap 
subpopulations in these mushroom-shaped 
multicellular structures are physiologically 
distinct as the cells differ with respect to for 
example antibiotic tolerance properties (e.g. 
Banin et al., 2006; Bjarnsholt et al. 2005; 
Haagensen et al., 2007; Kaneko et al., 2007; 
Pamp et al., 2008; Yang et al., 2007). The 
formation of the mushroom-shaped structures 
evidently occurs in a sequential process 
involving a non-motile subpopulation which 
forms initial microcolonies by growth in certain 
foci of the biofilm, and a migrating 
subpopulation which initially forms a 
monolayer on the substratum, and subsequently 
forms caps by aggregating on top of the initial 
microcolonies (which are then termed stalks) 
(Haagensen et al., 2007; Klausen et al., 2003a). 
A large amount of extracellular DNA is 
produced in P. aeruginosa biofilms via a 
process that depends on the PQS quorum-
sensing system (Allesen-Holm et al., 2006). 
The extracellular DNA functions as a biofilm 
matrix and has a stratified distribution in P. 
aeruginosa biofilms (Allesen-Holm et al., 2006; 
Whitchurch et al., 2002). In young glucose-
grown P. aeruginosa biofilms the extracellular 
DNA was shown to be present in high 
concentrations specifically in the outer layer of 
the microcolonies, whereas in mature P. 
aeruginosa biofilms the extracellular DNA was 
shown to be present in high concentrations 
between the stalk and cap portion of the 
mushroom-shaped structures (Allesen-Holm et 
al., 2006).  
 
Formation of the cap-portion of the mushroom-
shaped structures in P. aeruginosa biofilms 
depends on type IV pili (Klausen et al., 2003a). 
In a biofilm consisting of a mixture of P. 
aeruginosa wild-type and P. aeruginosa pilA 
mutant (deficient in biogenesis of type IV pili) 
the pilA mutants can only form stalks whereas 
the wild-type bacteria can form both stalks and 
caps (Klausen et al., 2003a). The majority of 
the mushroom-shaped structures in a wild-
type/pilA mixed biofilm therefore contain pilA 
mutants in the stalk and wild-type bacteria in 
the cap, and a minority of the mushroom-
shaped structures contain wild-type bacteria in 
both the stalk and the cap (Klausen et al., 
2003a). A model system consisting of cyan 
fluorescent protein-tagged P. aeruginosa pilA 
mutant as the stalk-former, and yellow 
fluorescent protein-tagged P. aeruginosa wild 
type as the cap-former, therefore enables a 
study of the roles of subpopulation interactions 
in structural biofilm development. We focus on 
the two genes, pvdA and pqsA, which have 
previously been shown to be important for the 
development of structured P. aeruginosa 
biofilms (Allesen-Holm et al., 2006, Banin et 
al., 2005; Yang et al., 2007). The pvdA gene 
encodes a synthase necessary for production of 
the pyoverdine siderophore which is involved in 
iron acquisition (Visca et al., 1994). Pyoverdine 
production in P. aeruginosa is derepressed 
under iron limiting conditions, and is in part 
regulated by quorum-sensing (Stintzi et al., 
1998). The pqsA gene is part of an operon 
encoding the PQS quorum-sensing system 
which is under las quorum-sensing regulation 
(Calfee et al., 2001; Gallagher et al., 2002; 
McGrath et al, 2004; Wade et al., 2005). We 
provide evidence that: i) synthesis of the iron-
siderophore pyoverdin occurs in the stalk-
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portion of the mushroom-shaped structures and 
is necessary for development of the cap-forming 
subpopulation which does not express the 
pyoverdin syntheses genes but needs to express 
the fpvA gene encoding part of the ferric-
pyoverdin uptake system; and ii) Pqs-controlled 
DNA-release in the stalk-portion of the 
mushroom-shaped structures is necessary for 
development of the cap-forming subpopulation 
which does not express the pqs genes.  
 
Results 
 
Initially we investigated growth in batch 
cultures of the P. aeruginosa PAO1 wild-type 
and mutants used in the present study. We 
found that planktonic growth of all the mutants 
was similar to planktonic growth of the wild-
type (Fig. S1). Based on these results we 
exclude that the observed differences in biofilm 
structure can be explained due to growth defects 
of the mutants. 
 
Pvd-mediated structure development in P. 
aeruginosa biofilms. 
 
Using a pvdA::gfp fluorescent reporter,(Kaneko 
et al.,(2007) have previously shown that the 
pvdA gene is expressed specifically in the stalk-
portion of the mushroom shaped structures in P. 
aeruginosa wild-type biofilms. Here, we used 
the pvdA::gfp reporter to localize expression of 
the pvdA gene in our pilA/wild-type model 
biofilms. In agreement with the results of 
Kaneko et al. (2007) we found that the 
pvdA::gfp reporter was expressed specifically in 
the stalk-portion of the mushroom-shaped 
structures that contained wild-type bacteria both 
in the stalk and the cap (data not shown). In 
addition, we found that the pvdA::gfp reporter 
was expressed specifically in the pilA stalk-
forming subpopulation in the mushroom-shaped 
structures that contained pilA mutants in the 
stalk and wild-type bacteria in the cap (Fig. 1).  
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Fig. 1. 4-day-old pilA/wild-type biofilms with a pvdA::gfp(L) reporter in the pilA mutant (A, C) or in the 
wild-type (B, D). The pilA mutant was tagged with cfp (blue) and the wild-type was stained with cyto62 
(converted to yellow). A and B visualize the cells, whereas C and D visualize pvdA::gfp(L) fluorescence. The 
central pictures show horizontal CLSM optical sections, and the flanking pictures show vertical CLSM 
optical sections. The bars are 20 μm. 
Subsequently, we investigated the requirement 
for pvdA expression in P. aeruginosa biofilm 
development by determining the morphology of 
biofilms formed by different mutants. The 
controls in the study confirmed in agreement 
with previous studies (Banin et al., 2005; 
Klausen et al., 2003a), that the P. aeruginosa 
wild-type formed biofilms with mushroom-
shaped multicellular structures (Fig. 2A), 
whereas the P. aeruginosa pilA/wild-type 
mixture formed biofilms that contained 
mushroom-shaped structures with wild-type 
bacteria in the cap and pilA mutants in the stalk 
(Fig. 2B), and the P. aeruginosa pvdA mutant 
formed flat biofilms without mushroom-shaped 
structures (Fig. 2C). The biofilm formed by the 
P. aeruginosa pvdA mutant lacks the structural 
heterogeneity of the wild-type biofilm and the 
pilA/wild-type biofilm. Because the 
experiments described above had indicated that 
the pvdA gene is expressed specifically in the 
stalk-portion of the mushroom-shaped 
structures in heterogeneous P. aeruginosa 
biofilms, we wanted to examine whether the 
localised pvdA expression is important for 
structural biofilm development. We therefore 
investigated biofilm formation of a pilA/pvdA 
mixture and a pilApvdA/wild-type mixture. In 
the pilA/pvdA biofilm expression of the pvdA 
gene is blocked by mutation in the cap-formers, 
whereas in the pilApvdA/wild-type biofilm 
expression of the pvdA gene is blocked by 
mutation in the stalk-formers. The pilA/pvdA 
mixture formed biofilms with mushroom-
shaped structures containing the pilA mutant in 
the stalk and the pvdA mutant in the cap (Fig. 
2D), whereas such mushroom-shaped structures 
were not formed in the pilApvdA/wild-type 
biofilm which contained pilApvdA 
microcolonies that were not capped by the wild-
type (Fig 2E). Although we searched 
extensively in numerous pilApvdA/wild-type 
biofilms we did not find mushroom-shaped 
structures formed by the wild-type alone, 
suggesting that formation of such structures is 
inhibited in the pilApvdA/wild-type biofilms. 
Complementation with a plasmid-borne pvdA 
gene restored the ability of the pilApvdA mutant 
to form stalks capped with the wild-type in 
mixed biofilms (Fig. S2). Altogether these 
results indicate that expression of the pvdA gene 
in the stalk is necessary for the cap to be formed. 
 
The cell surface receptor proteins FpvA and 
FpvB are needed for uptake of ferric-
pyoverdine complexes by P. aeruginosa 
(Ghysels et al., 2004; Poole et al., 1993). We 
investigated pilA/fpvA biofilms, pilA/fpvB 
biofilms and pilA/fpvAB biofilms, and found 
that the fpvA mutant (Fig. 2F) and fpvAB mutant 
(Fig. S3A) were unable to form normal caps on 
top of the pilA mutant, whereas the fpvB mutant 
(Fig. S3B) did form normal caps on the pilA 
stalks. Together the experiments indicate that 
the cap-forming subpopulation in P. aeruginosa 
biofilms is dependent on FpvA-mediated uptake 
of ferric-pyoverdine produced by the stalk-
forming subpopulation. In addition, the 
experiments suggest that FpvB does not play a 
role in ferric-pyoverdine uptake in our P. 
aeruginosa biofilms. In agreement with these 
findings, Banin et al. (2005) reported that a P. 
aeruginosa fpvA mutant, unlike the wild-type 
but similar to a pvdA mutant, formed flat 
biofilms in flow-chambers, suggesting that 
FpvB does not contribute significantly to ferric-
pyoverdine uptake in biofilms. 
Fig. 2. 4-day-old wild-type biofilm (A), pilA/wild-type biofilm (B), pvdA biofilm (C), pilA/pvdA biofilm (D), 
pilApvdA/wild-type biofilm (E) and pilA/fpvA biofilm (F). The pilA mutant and pilApvdA mutant were tagged 
with cfp (blue), whereas the wild-type, pvdA mutant and fpvA mutant were tagged with yfp (yellow). The 
central pictures show horizontal CLSM optical sections, and the flanking pictures show vertical CLSM 
optical sections. The bars are 20 μm. 
 
 
 
 
 
Complementation of structure development 
in P. aeruginosa biofilms with Fe-citrate. 
 
The experiments described above suggested that 
the wild-type bacteria do not form caps on top 
of the pilApvdA microcolonies in the 
pilApvdA/wild-type biofilm because of a lack of 
pyoverdine production in the pilApvdA 
microcolonies, whereas the fpvA bacteria do not 
form caps on top of the pilA microcolonies in 
the pilA/fpvA biofilm because they can not take 
up the ferric-pyoverdine produced by the pilA 
bacteria. We wanted to investigate how 
structure development would occur if the 
bacteria could acquire iron via an alternative 
pathway. Because P. aeruginosa can take up 
ferric-citrate independently of the pyoverdine 
system (e.g. see Banin et al., 2005) we used this 
compound as an alternative iron source. As 
shown in Fig. 3, cyan-stalk/yellow-cap 
mushroom-shaped structures were formed in 
pilApvdA/wild-type and pilA/fpvA biofilms 
when they were grown in medium 
supplemented with 5 μM ferric-citrate. These 
experiments support the conclusion that in the 
normal biofilm medium the wild-type does not 
form caps on top of pilApvdA microcolonies 
because they do not produce ferric-pyoverdine, 
whereas the fpvA mutant does not form caps on 
top of the pilA microcolonies because it can not 
take up ferric-pyoverdine. However, the 
experiments also indicate that the suggested 
pyoverdine-mediated metabolic interaction is 
not important per se for structure formation in 
the biofilms. Because we previously have 
provided evidence that extracellular DNA 
produced at distinct locations plays a key role in 
promoting association between the stalk-
forming and cap-forming subpopulations in P. 
aeruginosa biofilms (Allesen-Holm et al., 2006; 
Barken et al., 2008; Yang et al., 2007), we 
subsequently investigated the role of 
extracellular DNA in biofilm structure 
formation.  
 
Fig. 3. 4-day-old pilApvdA/wild-type biofilm (A) and pilA/fpvA biofilm (B) grown in FAB medium 
supplemented with 5 µM Fe-citrate. The pilApvdA and pilA mutants were tagged with cfp (blue) and the 
wild-type and fpvA mutant were tagged with yfp (yellow). The central pictures show horizontal CLSM 
optical sections, and the flanking pictures show vertical CLSM optical sections. The bars are 20 μm. 
Pqs-mediated structure development in P. 
aeruginosa biofilms. 
 
We have previously shown that PQS expression 
is involved in DNA release in P. aeruginosa 
biofilms, and that expression of the 
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pqsA::gfp(ASV) reporter occurs specifically in 
the microcolonies in the early phase of biofilm 
development (Allesen-Holm et al., 2006; Yang 
et al., 2007). Here, we monitored 
pqsA::gfp(ASV) expression in pilA/wild-type 
biofilms with the pqsA::gfp(ASV) reporter either 
in the pilA mutant or in the wild-type. 
Expression of the green fluorescent Gfp(ASV) 
protein was recorded in these biofilms after 2 
days of cultivation since the pqsA::ASV(gfp) 
reporter was found to be expressed at a 
maximum level in 2-day-old biofilms (Yang et 
al., 2007). The 2-day-old microcolonies, 
consisting of a stalk of pilA bacteria covered 
with a small cap of wild-type bacteria, showed 
pqsA::gfp(ASV) expression when the reporter 
was present in the pilA mutant (Fig. 4A and 4C) 
but not when it was present in the wild-type 
(Fig. 4B and 4D), suggesting that the pqsA gene 
is expressed specifically in the stalk-forming 
subpopulation.  
 
Fig. 4. 2-day-old pilA/wild-type biofilms with the pqsA::gfp(ASV) reporter in the pilA mutant (A, C) or in the 
wild-type (B, D). The pilA mutant was tagged with cfp (blue) and the wild-type was stained with cyto62 
(converted to yellow). A and B visualize the cells, whereas C and D visualize pqsA::gfp(ASV) fluorescence. 
The central pictures show horizontal CLSM optical sections, and the flanking pictures show vertical CLSM 
optical sections. The bars are 20 μm. 
Subsequently, we investigated the requirement 
for pqsA expression in P. aeruginosa biofilm 
development. The P. aeruginosa pqsA mutant 
formed flat biofilms without mushroom-shaped 
structures (Fig. 5A), lacking the heterogeneity 
of the wild-type biofilm (Fig. 2A) and the 
pilA/wild-type biofilm (Fig. 2B). To examine a 
role of localised pqs expression in the 
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development of the heterogeneous P. 
aeruginosa biofilms, we investigated biofilm 
formation of a pilA/pqsA mixture and a 
pilApqsA/wild-type mixture. The pilA/pqsA 
mixture formed biofilms with mushroom-
shaped structures containing the pilA mutant in 
the stalk and the pqsA mutant in the cap (Fig. 
5B). The pilApqsA/wild-type mixture formed 
biofilms where the wild-type and pilApqsA cells 
were unassociated, so that the wild-type formed 
mushroom-shaped structures independent of the 
pilApqsA colonies (Fig. 5C). Complementation 
with a plasmid-borne pqsA gene restored the 
ability of the pilApqsA mutant to form stalks 
capped with the wild-type in mixed biofilms 
(Fig. S4). These results indicate that expression 
of the pqsA gene in the stalk is necessary for the 
cap to be formed. 
 
Fig. 5. 4-day-old pqsA biofilm (A), pilA/pqsA biofilm (B), and pilApqsA/wild-type biofilm (C). The pilA 
mutant and pilApqsA mutant were tagged with cfp (blue), whereas the wild-type and pqsA mutant were 
tagged with yfp (yellow). The central pictures show horizontal CLSM optical sections, and the flanking 
pictures show vertical CLSM optical sections. The bars are 20 μm. 
Complementation of structure development 
in P. aeruginosa biofilms with extracellular 
DNA. 
 
Based on our present and previous findings 
(Allesen-Holm et al., 2006; Barken et al., 2008; 
Yang et al., 2007) we suggest that the wild-type 
bacteria do not form caps on top of the 
pilApqsA microcolonies in the pilApqsA/wild-
type biofilm because the pilApqsA 
microcolonies do not produce extracellular 
DNA.  In analogy with the experiments with 
complementation of the pilApvdA/wild-type and 
pilA/fpvA biofilms with ferric-citrate, we 
wanted to investigate if formation of cyan-
stalk/yellow-cap mushroom-shaped structures 
would occur in pilApqsA/wild-type biofilm if it 
was supplemented with P. aeruginosa genomic 
DNA. We supplemented the medium irrigated 
to a pilApqsA/wild-type biofilm with DNA at 
day 2 where pqs-dependent DNA-release is 
known to occur (Allesen-Holm et al., 2006; 
Yang et al., 2007). Staining of DNA-
supplemented biofilms with propidium iodide 
showed that the extracellular DNA associated 
with and covered the microcolonies (data not 
shown). As shown in Fig. 6A, cyan-
stalk/yellow-cap mushroom-shaped structures 
were formed in the DNA-supplemented 
pilApqsA/wild-type biofilm. This result 
supports the conclusion that cyan-stalk/yellow-
cap mushroom-shaped structures are normally 
not formed in the pilApqsA/wild-type biofilms 
due to a lack of extracellular DNA on the 
pilApqsA microcolonies, and it constitutes 
further evidence that extracellular DNA is an 
important factor in structure formation in our P. 
aeruginosa biofilms. Addition of DNA to P. 
aeruginosa wild-type biofilms led to the 
formation of huge mushroom shaped structures 
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much bigger than those found in wild-type 
biofilms without DNA addition (Fig. 6B). On 
the contrary, addition of DNA to P. aeruginosa 
pilA biofilms did not result in changed structure 
compared to pilA biofilms without addition of 
DNA (Fig. 6C), suggesting that extracellular 
DNA-promoted cap-formation requires type IV 
pili on the cap-forming bacteria. 
 
Fig. 6. 4-day-old pilApqsA/wild-type biofilm (A), wild-type biofilm (B), and pilA biofilm (C) 
grown in FAB medium supplemented with P. aeruginosa genomic DNA at day 2. The pilApqsA 
and pilA mutants were tagged with cfp (blue) and the wild-type was tagged with yfp (yellow). The 
upper pictures show horizontal CLSM optical sections, and the lower pictures show vertical CLSM 
optical sections. The bars are 20 μm. 
 
 
Inhibition of structure development in P. 
aeruginosa biofilms. 
 
The finding that pyoverdine and PQS 
production evidently are involved in mushroom 
structure formation in our P. aeruginosa 
biofilms, suggested that it should be possible to 
inhibit structure development by inhibiting 
pyoverdine and PQS production via chemical 
treatment. High concentrations of iron have 
previously been shown to inhibit both 
pyoverdine production (Ochsner et al., 2002) 
and PQS production (Bredenbuch et al., 2006; 
Yang et al., 2007), and it has been reported that 
high iron concentrations could perturb P. 
aeruginosa biofilm formation and structure 
development (Musk et al., 2005; Musk and 
Hergenrother, 2008; Yang et al., 2007). 
Experiments with P. aeruginosa microtiter tray 
cultures showed that addition of 100 μM FeCl3 
repressed expression of the pvdA::gfp and 
pqsA::gfp reporters without inhibiting growth of 
the P. aeruginosa bacteria (Fig. S5). In 
agreement with the suggestion that pyoverdine 
and PQS production are involved in mushroom 
structure formation in our P. aeruginosa 
biofilms, the pilA/wild-type biofilm, pilA/pvdA 
biofilm and pilA/pqsA biofilm all formed un-
associated microcolonies in flow-chambers 
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irrigated with medium containing 100 μM FeCl3 (Fig. 7). 
 
Fig. 7. 4-day-old pilA/wild-type biofilm (A), pilA/pvdA biofilm (B), and pilA/pqsA biofilm grown in 
FAB medium supplemented with 100 μM FeCl3. The pilA mutant was tagged with cfp (blue) and 
the wild-type, pvdA and pqsA mutant were tagged with yfp (yellow). The central pictures show 
horizontal CLSM optical sections, and the flanking pictures show vertical CLSM optical sections. 
The bars are 20 μm. 
Discussion 
 
In the present report we provide evidence that 
subpopulation interactions are involved in the 
development of mushroom-shaped multicellular 
structures in P. aeruginosa biofilms. Our results 
indicate that: i) synthesis of the iron-
siderophore pyoverdin in the stalk-portion of 
the mushroom-shaped structures is necessary 
for development of the cap-forming 
subpopulation which does not express the 
pyoverdin syntheses genes but needs to express 
the fpvA gene encoding part of the ferric-
pyoverdin uptake system; and ii)  quorum-
sensing-controlled DNA-release in the stalk-
portion of the mushroom-shaped structures is 
necessary for development of the cap-forming 
subpopulation which does not express the 
quorum-sensing genes.  
 
Our experiments suggest that the pyoverdine 
mediated interaction is not important for 
structure formation per se, but is a metabolic 
interaction where stalk cells provide Fe-
pyoverdine to cap-forming cells. On the 
contrary, the available evidence suggests that 
the extracellular DNA produced by the stalk 
subpopulation is a critical component in 
structure formation. We suggest that the PQS 
mediated interaction plays a role in locating the 
cap-forming cells on the microcolonies, 
whereas the pyoverdin mediated interaction 
feeds the cap cells with Fe-pyoverdine so that 
they can form the cap. As an alternative to 
promoting growth of the cap-forming cells by 
supplying them with iron, the Fe-pyoverdin 
produced by the stalk cells may be required for 
settling the migrating bacteria on the cap, since 
iron limitation has been shown to induce 
twitching motility (Singh et al., 2002). 
 
The present study, and our previous studies (e.g. 
Allesen-Holm et al., 2006; Yang et al., 2007; 
Barken et al., 2008), have shown that the 
microcolonies formed by stalk cells usually 
have much higher cell density than the 
structures formed by the cap-forming cells (e.g. 
see Fig. 2A). Expression of the Pvd system 
most likely occurs specifically in the stalk 
forming cells due to iron limitation arising in 
these dense cell populations. However, 
presently we can not explain why the cap-
forming cells, that evidently need an iron source 
to form the cap, apparently do not produce 
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pyoverdine themselves. Expression of the 
quorum-sensing controlled Pqs system most 
likely also occurs specifically in the stalk 
subpopulation due to its high cell density. In 
agreement with our findings, de Kievit et al. 
(2001) provided evidence that the Las and Rhl 
quorum-sensing systems were maximally 
expressed in the portion of cells close to the 
substratum in P. aeruginosa biofilms.  
 
The inability of the P. aeruginosa wild-type to 
form mushroom shaped structures on its own in 
the pilApvdA/wild-type biofilm may be because 
the pilApvdA bacteria do not produce pyoverdin 
but take up the Fe-pyoverdin produced by the 
wild-type bacteria. The wild-type bacteria that 
differentiate to become pyoverdin-producing 
stalk cells therefore can not deliver Fe-
pyoverdin to potential cap-formers. In support 
of this suggestion, complementation with a 
plasmid-borne pvdA gene in the pilApvdA 
mutant not only restored the ability of the 
pilApvdA mutant to form stalks capped with the 
wild-type, but also restored the ability of the 
wild-type to form mushroom-shaped structures 
on its own in the pilApvdA(pPvdA)/wild-type 
biofilm (see Fig. S2). The finding that the P. 
aeruginosa wild-type does form mushroom-
shaped structures on its own in the 
pilApqsA/wild-type biofilm may be because the 
extracellular DNA, unlike pyoverdin, does not 
diffuse but stays on the producing 
microcolonies. Even if the extracellular DNA 
can diffuse to some extent in biofilms, the 
piliated wild-type bacteria are expected to bind 
more efficiently to extracellular DNA than the 
non-piliated pilApqsA mutants, because type IV 
pili have been shown to bind with high affinity 
to DNA (Aas et al., 2002; van Schaik et al., 
2005).  
 
The finding that the inability of the 
pilApqsA/wild-type mixture to form blue-
stalk/yellow-cap mushroom shaped structures 
could be complemented by addition of P. 
aeruginosa genomic DNA supports our 
previous findings that the pqs genes play a role 
in the generation of extracellular DNA in P. 
aeruginosa biofilms (Allesen-Holm et al., 2006; 
Yang et al., 2007), and constitutes additional 
evidence that this matrix component is 
important for structure formation in our P. 
aeruginosa biofilms. Addition of DNA to P. 
aeruginosa wild-type biofilms led to the 
formation of huge mushroom shaped structures 
much bigger than those found in wild-type 
biofilms without DNA addition. Because the 
biofilm biomass is determined by the opposing 
effects of bacterial growth and detachment, we 
believe that addition of DNA to the wild-type 
biofilm resulted in decreased detachment of the 
cap-forming piliated bacteria. Addition of DNA 
to P. aeruginosa pilA biofilms did not result in 
changed structure compared to pilA biofilms 
without addition of DNA, suggesting that DNA-
promoted cap-formation requires type IV pili on 
the cap-forming bacteria. 
 
The involvement of biosurfactant production in 
the formation of the mushroom-shaped 
structures in P. aeruginosa biofilms (Davey et 
al., 2003; Pamp and Tolker-Nielsen, 2007) may 
be another example of a role of subpopulation 
interactions in the development of structured 
biofilms. A P. aeruginosa rhlA mutant, which is 
deficient in biosurfactant production, was 
shown to form a flat biofilm under conditions 
similar to those used in the present study 
(Davey et al., 2003; Pamp and Tolker-Nielsen, 
2007). Furthermore, a study which employed 
fluorescent reporter-genes indicated that 
biosurfactant production preferentially takes 
place in the stalk-portion of the mushroom-
shaped structures in P. aeruginosa biofilms 
(Lequette and Greenberg, 2005). It appears, 
therefore, that formation of the heterogeneous P. 
aeruginosa biofilm with mushroom-shaped 
structures is dependent on biosurfactant 
production by the stalk-forming subpopulation. 
 
Studies of flow-chamber-grown P. aeruginosa 
biofilms have provided evidence that the 
antibiotics tobramycin, ciprofloxacin, and 
tetracycline preferentially kill bacteria located 
in the cap-portion of the mushroom-shaped 
structures, whereas the antibiotic colistin, the 
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detergent SDS, and the chelator EDTA 
preferentially kill bacteria located in the stalk-
portion of the mushroom-shaped structures 
(Bjarnsholt et al. 2005; Banin et al., 2006; 
Haagensen et al., 2007; Yang et al., 2007; 
Pamp et al., 2008). P. aeruginosa biofilms that 
were grown in the presence of high levels of 
iron or quorum-sensing inhibitors developed 
more flat biofilms than the untreated control 
biofilms, were much more sensitive to various 
antimicrobials including tobramycin, 
ciprofloxacin, and EDTA, and did not show the 
characteristic spatial distributions of tolerant 
and sensitive bacteria (e.g. Bjarnsholt et al. 
2005, Yang et al., 2007). The existence of 
physiologically distinct subpopulations in 
heterogeneous biofilms therefore appears to 
function as an insurance mechanism against 
environmental insult, and the mechanisms 
involved in their formation and maintenance 
may be relevant as biofilm control targets. 
 
Experimental procedures 
 
Bacteria and growth conditions. 
 
P. aeruginosa PAO1 (Holloway and Morgan, 
1986) was used as the model organism in this 
study. The pilA and pilApqsA mutants were 
constructed by allelic displacement in the PAO1 
wild-type and a pqsA mutant (D’Argenio et al., 
2002) as described (Klausen et al., 2003b). The 
pvdA, pilApvdA, fpvA, fpvB, and fpvAB mutants 
were constructed by allelic displacement as 
described below. Fluorescence-tagged strains 
were constructed by insertion of a mini-Tn7-
eCFP-Gmr or mini-Tn7-eYFP-Smr cassette as 
described (Klausen et al., 2003b, Koch et al., 
2001). Escherichia coli strains MT102, DH5a 
and S17-1 were used for standard DNA 
manipulations. LB medium (Bertani, 1951) was 
used to cultivate E. coli strains. P. aeruginosa 
biofilms were cultivated at 30oC in flow-
chambers irrigated with FAB medium (Heydorn 
et al., 2000) supplemented with 0.3 mM 
glucose. FAB medium contains approximately 
1 μM ferric sulphate, but FAB medium 
supplemented with 5 μM ferric citrate or 100 
μM ferric chloride was used where indicated in 
the text. Selective media were supplemented 
with ampicillin (Ap; 100mg/liter), gentamicin 
(Gm; 60mg/liter), streptomycin (Sm; 
100mg/liter), or tetracycline (Tc; 60mg/liter). 
Cyto62 was used at a concentration of 1 µM to 
stain untagged cells in biofilms where three 
fluorescent colours (Yfp, Gfp, and cyto62) were 
needed.    
 
Construction of P. aeruginosa pvdA, 
pilApvdA, fpvA, fpvB, and fpvAB mutants. 
 
The P. aeruginosa pvdA, pilApvdA, fpvA, fpvB, 
and fpvAB mutants were constructed as follows: 
Knockout fragments containing a gentamicin 
(Gm) resistance cassette were generated by 
PCR overlap extension essentially as described 
by (Choi and Schweizer (2005). Primers PvdA-
UpF-GW, PvdA-UpR-Gm, PvdA-DnF-Gm, 
PvdA-DnR-GW, FpvA-UpF-GW, FpvA-UpR-
Gm, FpvA-DnF-Gm, FpvA-DnR-GW, FpvB-
UpF-GW, FpvB-UpR-Gm, FpvB-DnF-Gm, and 
FpvB-DnR-GW were used to amplify 
chromosomal regions of pvdA, fpvA and fpvB, 
and primer Gm-F and Gm-R were used to 
amplify a gentamicin resistance cassette with 
plasmid pPS856 (Hoang et al., 1998) as 
template. The PCR fragments were fused 
together and amplified with primers GW-attB1 
and GW-attB2 incorporating the attB1 and 
attB2 recombination sites at either end of the 
knockout cassette. Using the Gateway cloning 
system (Invitrogen) the resulting knockout 
fragments were first transferred by the BP 
reaction into pDONR221 generating entry 
plasmids pDONR211pvdA, pDONR211fpvA, 
and pDONR211fpvB, and subsequently 
transferred by the LR reaction into 
pEX18ApGW generating the knockout 
plasmids pEX18AppvdA, pEX18ApfpvA, and 
pEX18ApfpvB. The knockout plasmids were 
transferred into the PAO1 wild-type and pilA 
mutant by two-parental mating using the donor 
strain E. coli S17-1 with selection done on AB-
citrate plates supplemented with gentamicin. 
Resolution of single cross-over events was 
achieved by streaking on 5% sucrose plates via 
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the counter-selectable sacB marker on the 
knockout plasmid. In order to construct the 
fpvAB double mutant, Flp-mediated excision of 
the Gm resistance cassette in the fpvA mutant 
was performed using the pFLP2 plasmid as 
described by Choi and Schweizer (2005). The 
resulting double crossovers in the mutants were 
confirmed by PCR. Sequences of the primers 
will be supplied upon request. 
 
Construction of a pvdA complementation 
plasmid. 
 
A full length pvdA fragment was PCR amplified 
by use of the primers pvdAF and pvdAR. The 
PCR product was digested with EcoRI and KpnI 
and then ligated into EcoRI/KpnI digested 
pME6031 vector (Heeb et al., 2000). The 
ligation product was electroporated into the P. 
aeruginosa pilApvdA strain. Transformants 
were selected on LB plates containing 60 µg/ml 
tetracycline and later confirmed by checking the 
pyoverdine production as described (Meyer et 
al., 1998). Sequences of the primers will be 
supplied upon request.  
 
Construction of a pqsA complementation 
plasmid. 
 
A full length pqsA fragment was PCR amplified 
by use of the primers pqsAF and pqsAR. The 
PCR product was digested with BamHI and 
XbaI and then ligated into BamHI/XbaI digested 
pUCP22Not vector (Herrero et al., 1990). The 
ligation product was electroporated into the P. 
aeruginosa pilApqsA strain. Transformants 
were selected on LB plates containing 60 µg/ml 
gentamicin and later confirmed by checking the 
PQS production as described (Calfee et al., 
2001). Sequences of the primers will be 
supplied upon request.  
 
Cultivation of biofilms in flow-chambers. 
 
Biofilms were grown in flow-chambers with 
individual channel dimensions of 1 x 4 x 40 mm. 
The flow system was assembled and prepared 
as described previously (Sternberg and Tolker-
Nielsen, 2006). The flow-chambers were 
inoculated by injecting 350 µl of overnight 
culture diluted to an OD600 of 0.001 into each 
flow channel using a small syringe. After 
inoculation, the flow channels were left without 
flow for 1 h, after which medium flow was 
started using a Watson Marlow 205S peristaltic 
pump. The mean flow velocity in the flow-
chambers was 0.2 mm/s, corresponding to 
laminar flow with a Reynolds number of 0.02. 
In one experiment the biofilm medium was 
supplemented with 0.25 μg/ml P. aeruginosa 
DNA after 48 hours of biofilm cultivation. 
 
Measurements of pvdA::gfp(L) expression in 
flow-chamber biofilms. 
 
For observing pvdA::gfp(L) expression in flow-
chamber biofilms, we transformed the P. 
aeruginosa wild-type and P. aeruginosa pilA 
mutant with the pvdA::gfp(L) reporter plasmid 
(Kaneko et al., 2007). Expression of 
pvdA::gfp(L) was subsequently recorded via 
CLSM in 4-day-old pilA/wild-type mixed 
biofilms containing the reporter fusion in either 
the wild-type or the pilA mutant. 
 
Measurements of pqsA::ASV(gfp) expression 
in flow-chamber biofilms. 
 
For observing pqsA::gfp(ASV) expression in 
flow-chamber biofilms, we transformed the P. 
aeruginosa wild-type and P. aeruginosa pilA 
mutant with the pqsA::ASV(gfp) reporter 
plasmid (Yang et al., 2007). Expression of 
pqsA::gfp(ASV) was subsequently recorded via 
CLSM in 2-day-old pilA/wild-type two-strain 
biofilms containing the reporter fusion in either 
the wild-type or the pilA mutant.  
 
Measurements of pvdA::gfp(L) and 
pqsA::ASV(gfp) expression in microtiter tray 
cultures. 
 
Cultures in wells of polystyrene microtitre trays 
(150 µl per well) were started by diluting P. 
aeruginosa(pvdA::gfp) or P. 
aeruginosa(pqsA::gfp) overnight cultures to 
 13
OD600 = 0.001 in AB medium supplemented 
with 0.05% glucose and 10 μM FeCl3 or 100 
μM FeCl3. The cultures were incubated for 24 
hours at 37oC, and Gfp-fluorescence and cell 
density were measured regularly by the use of a 
Wallac microplate reader. 
 
Microscopy and image acquisition. 
 
All microscopy observations and image 
acquisitions were done with a Zeiss LSM510 
confocal laser scanning microscope (CLSM) 
(Carl Zeiss, Jena, Germany) equipped with 
detectors and filter sets for monitoring of Gfp, 
Cfp, Yfp, and cyto62 fluorescence. Images were 
obtained using a 63x/1.4 objective or a 40 x/1.3 
objective. Simulated 3-D images and sections 
were generated using the IMARIS software 
package (Bitplane AG, Zürich, Switzerland). 
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Supplementary figures 
 
 
S1. Growth curves of P. aeruginosa strains in shake flasks containing biofilm medium at 37 degree.  
 
 
S2. 4-day-old pilApvdA(pME6031::pvdA)/wild-type biofilms. The pilApvdA(pME6031::pvdA) mutant was 
tagged with cfp (blue) and the wild-type was tagged with Yfp (yellow). The central pictures show horizontal 
CLSM optical sections, and the flanking pictures show vertical CLSM optical sections. The bars are 20 μm. 
 19
 
S3. 4-day-old pilA/fpvAB biofilm (A) and pilA/fpvB (B) biofilm. The pilA mutant was tagged with cfp (blue), 
whereas the fpvAB mutant and fpvB mutant were tagged with yfp (yellow). The central pictures show 
horizontal CLSM optical sections, and the flanking pictures show vertical CLSM optical sections. The bars 
are 20 μm. 
 
S4. 4-day-old pilApqsA(pUCP22::pqsA)/wild-type biofilms. The pilApqsA(pUCP22::pqsA) mutant was 
tagged with cfp (blue) and the wild-type was tagged with Yfp (yellow). The central pictures show horizontal 
CLSM optical sections, and the flanking pictures show vertical CLSM optical sections. The bars are 20 μm. 
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 S5. Expression of pvdA::gfp and pqsA::gfp (ASV) fusion reporters in minimal glucose medium containing 10 
µM iron and 100 µM iron. Final OD 600 was also reordered as an indication of growth.   
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Attenuation of Pseudomonas aeruginosa virulence by the use of small-molecule quorum-sensing inhibitors
(referred to as the antipathogenic drug principle) is likely to play a role in future treatment strategies for
chronic infections. In this study, structure-based virtual screening was used in a search for putative quorum-
sensing inhibitors from a database comprising approved drugs and natural compounds. The database was
built from compounds which showed structural similarities to previously reported quorum-sensing inhibitors,
the ligand of the P. aeruginosa quorum-sensing receptor LasR, and a quorum-sensing receptor agonist. Six
top-ranking compounds, all recognized drugs, were identified and tested for quorum-sensing-inhibitory activ-
ity. Three compounds, salicylic acid, nifuroxazide, and chlorzoxazone, showed significant inhibition of quorum-
sensing-regulated gene expression and related phenotypes in a dose-dependent manner. These results suggest
that the identified compounds have the potential to be used as antipathogenic drugs. Furthermore, the results
indicate that structure-based virtual screening is an efficient tool in the search for novel compounds to combat
bacterial infections.
One of the major problems in the treatment of infectious
diseases is the occurrence of antibiotic resistance, which is
prevalent among many bacterial species, in particular, strains
of the opportunistic pathogen Pseudomonas aeruginosa (39).
This bacterium is a common gram-negative species found in
nosocomial infections such as urinary tract infections, respira-
tory system infections, dermatitis, chronic wounds, soft-tissue
infections, and a variety of systemic infections, particularly in
patients with severe burns and in cancer and AIDS patients
who are immunocompromised (43, 66). Furthermore, people
who are suffering from the genetic disease cystic fibrosis are
highly susceptible to chronic lung infection with this organism
(16).
The resistance of P. aeruginosa to multiple antibiotics is the
result of a variety of specific mechanisms that includes an
inherent -lactamase and a broad-spectrum efflux pump sys-
tem. Furthermore, impermeability of the membrane, adaptive
mutations, and horizontal transfer of resistance genes also
contribute to its resistance (38). Besides these specific resis-
tance mechanisms, the ability of P. aeruginosa to grow as struc-
tured communities of cells enclosed in a self-produced poly-
meric matrix, known as a biofilm (11), significantly adds to its
tolerance to antimicrobial agents (12). Current antibiotics are
susceptible to resistance development, as there will inevitably
be selection pressure for bacteria able to grow in the presence
of these growth-inhibiting compounds (39). Therefore, new
approaches to combat microbes without selecting for resis-
tance would hold great promise for the treatment of infectious
diseases. An approach that does not target bacterial growth is
the use of antipathogenic drugs that work by decreasing bac-
terial virulence and rendering bacteria incapable of establish-
ing infection. An area where the use of antipathogenic drugs
has received much attention is virulence attenuation by block-
ing bacterial intercellular communication, i.e., quorum sensing
(QS) (recently reviewed in reference 52). In gram-negative
bacteria, most QS systems are members of the LuxR-LuxI
homologous system that use acyl homoserine lactone (AHL)
signal molecules. These systems function by means of a LuxR
homolog, the transcriptional activator, and a LuxI homolog,
the AHL synthase. LuxI produces the required AHL molecule,
which diffuses out into the local environment, and upon reach-
ing the required concentration, the signal molecule binds to
and activates LuxR, which in turn activates the transcription of
the target genes (20, 59, 68). In P. aeruginosa, QS is mediated
through the LuxRI-type systems LasRI and RhlRI, which
sense 3-oxo-C12-homoserine lactone (HSL) and C4-HSL, re-
spectively, and via the Pqs system, which senses Pqs (2-heptyl-
3-hydroxy-4-quinolone). The systems are hierarchically ar-
ranged, with LasR regulating the Rhl and Pqs systems (35, 60).
AHL-mediated QS coordinates the production of virulence
factors and plays a role in biofilm formation (4, 15, 45). Fur-
thermore, QS-controlled activities, as well as QS signals, evi-
dently also affect the activities of host immune systems (34, 37,
53, 64). By using various QS inhibition assays and high-
throughput screening, small antagonistic molecules displaying
some structural similarities to AHL signals have been identi-
fied as QS inhibitors (QSIs) and shown to greatly reduce the
virulence of P. aeruginosa both in vitro and in vivo (29, 42, 50).
Recently, computer-aided drug design, especially structure-
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based virtual screening (SB-VS), has emerged as a new tool in
pharmaceutical chemistry (40, 54). The increasing availability
of structural data and the affordability of high-performance
computing platforms have broadened the applicability of this
method (54). SB-VS has been adopted as an effective paradigm
for lead discovery that fits in well alongside high-throughput
screening programs. Screening has been successfully used to
find inhibitors of various enzymes and proteins, including hu-
man carbonic anhydrase II, human protein tyrosine phos-
phatase 1B, and the omnipresent bacterial enzyme DNA gy-
rase, which in the latter case resulted in novel classes of
inhibitors with potential for use as antibiotics (6, 17, 27). In
addition to the discovery of novel antibiotics by virtual screen-
ing, the approach also holds great promise for the discovery of
antipathogenic drugs and especially for the discovery of new
QSIs. The structures of TraR from Agrobacterium tumefaciens
and the ligand binding domain of LasR from P. aeruginosa
bound to their natural ligands have become available recently
and can be exploited in SB-VS (7, 67, 71). The availability of
the LasR structure is particularly important, as it can be used
to complement the traditional QSI discovery strategies previ-
ously mentioned.
In the present study, 147 recognized drugs and natural com-
pounds were selected from the SuperNatural and SuperDrug
databases (18, 26) on the basis of their two-dimensional (2D)
structural similarity to the P. aeruginosa LasR natural ligand,
the identified QSIs furanone C30 and patulin, or the QS ago-
nist TP-1. The automated docking program Molegro Virtual
Docker (MVD) was used to screen these selected compounds
for QSI candidates. Six top-ranking drugs were acquired and
tested for biological activity. Three compounds, salicylic acid,
nifuroxazide, and chlorzoxazone, showed significant, dose-de-
pendent inhibition of QS-regulated gene expression and re-
lated phenotypes.
MATERIALS AND METHODS
Bacterial strains, plasmids, and growth media. P. aeruginosa PAO1 (33), an
isogenic P. aeruginosa lasR mutant (29), and an isogenic P. aeruginosa lasI rhlI
mutant (29) were used in this study. PAO1 with a mini-Tn5 insert containing a
translational fusion of the LasR-regulated lasB promoter and a gene coding for
an unstable version of green fluorescent protein (GFP), gfp(ASV), and an extra
copy of lasR under the influence of the lac promoter (constitutively expressed in
P. aeruginosa) (28) was used for the LasR inhibition assay. For the RhlR inhi-
bition assays, the plasmid pMHRA was introduced by electroporation into P.
aeruginosa PAO1 and P. aeruginosa lasR. pMHRA contains an RlhR-regulated
rhlA::gfp(ASV) translational fusion inserted into the vector pMH391 (28). The P.
aeruginosa PAO1 strain and the lasR mutant used for the Pqs inhibition assay
carried plasmid pAC37 containing a transcriptional fusion of the Pqs-regulated
pqsA promoter and gfp(ASV) (70). Measurement of virulence factor production
was carried out with the wild-type PAO1 strain and a QS-deficient PAO1 lasI rhlI
mutant strain (29). GFP-tagged variants of these two strains were used for flow
cell biofilm experiments. Tagging of the strains was done with mini-Tn7–en-
hanced GFP as previously described (36). Serratia liquefaciens MG1 (wild type)
and an swrI (swarming-deficient) mutant (19) were used to assess the effect of the
QSIs on the swarming motility of the bacterium.
For the QS inhibition and LasR specificity assays, ABT minimal medium (BT
plus 10% A10) supplemented with 0.5% glucose (wt/vol) and 0.5% Casamino
Acids (wt/vol) (28) was used to grow the cells. This medium supplemented with
0.6% Bacto agar (BD, NJ) was used in the S. liquefaciens swarming assay.
Modified Luria-Bertani (3) medium containing 4 g NaCl liter1 was used as a
basic medium to grow cells overnight (ON) prior to carrying out the swarming
assay and the virulence factor assays and prior to inoculating the flow cell biofilm
system. Virulence factor assays were carried out with cultures grown in modified
BM2 medium (24) containing 0.5 mM Mg2, 0.01 mM FeCl3, 0.06 M glucose,
and 0.2% (wt/vol) Casamino Acids. Flow cell biofilms were cultivated in FAB
minimal medium (30) supplemented with 0.3 mM glucose. Selective media were
supplemented with ampicillin (100 mg liter1), carbenicillin (500 mg liter1),
gentamicin (60 mg liter1), or streptomycin (100 mg liter1) where appropriate.
Protein structure file and drug/natural ligand database. The X-ray crystallo-
graphic structure of the P. aeruginosa LasR ligand binding domain bound to its
natural ligand n-3-oxododecanoyl-L-homoserine lactone (OdDHL; Protein Data
Bank [PDB] identification [ID]: 2UV0) (7) was used in the SB-VS of small
molecules. Recognized drugs and natural compounds were selected from the
SuperDrug and SuperNatural databases (18, 26) on the basis of their 2D struc-
tural similarity to the P. aeruginosa LasR ligand OdDHL (45), the identified QSIs
furanone C30 and patulin (29, 51), or the LasR agonist TP-1 (42). The structures
of the similarity templates are displayed in Fig. 1A. The 2D structures of the
selected compounds were downloaded from Chembank (http://chembank.broad
.harvard.edu/) (56) or drawn manually in MarvinSketch ver. 4.1.10 (ChemAxon
Ltd., Hungary) and then saved as 2D coordinate structure-data file (SDF) files.
The SDF files were merged into a single SDF file database by OpenBabel ver.
2.1.1 (OpenEye Scientific Software) and then converted to a three-dimensional
(3D) structure database in CORINA ver. 3.4 (Molecular Networks GmbH,
Germany).
Molecular docking. The automated docking software MVD ver. 2007.2.2.0
(65) (Molegro Aps., Denmark) was used in the SB-VS to dock the compounds
from the created database. The LasR structure file contained four monomers of
the ligand binding domain each in a complex with one OdDHL ligand, but only
the E monomer in a complex with the ligand named OHN 1169 [E] was chosen
for importation into the MVD workspace. Water was excluded from the work-
space, and standard preparation of the molecules was used in the importation of
the database.
Docking of the database was carried out in the following way. Initially, a
template based on the present ligand was created to award poses of the docked
compounds that showed similarity to the molecule. The template consisted of
four individual criteria: steric, hydrogen donor, hydrogen acceptor, and ring.
Subsequently, the actual docking procedure was set up by choosing template
docking, the Ligand Evaluator scoring function, and the default search algorithm
MolDock Optimizer. The binding site restraining the search space was sphere
shaped and centered on the OdDHL ligand with a radius of 15 Å. Docking of
each compound was repeated five times to ensure conformation to the lowest-
energy state due to the iterative nature of the process. Five poses of each
molecule in a complex with the protein were returned, one for each run, and
these were finally ranked according to their rerank scores. For the specific
settings for the docking process, see Fig. S1 and Table S1 in the supplemental
material. In addition to the database of selected compounds, the docking process
was supplemented with the LasR natural ligand structure for reference together
with the structures of known LasR agonists and antagonists for comparison (Fig.
1A and Table 1). Scenes of molecules in complex with the LasR ligand binding
domain were generated with PyMOL ver. 1.00 (DeLano Scientific LLC, San
Carlos, CA; http://www.pymol.org) by importing the 3D poses of the docked
molecules from MVD together with the structure of the LasR ligand binding
domain (PDB ID: 2uV0).
QSI candidates selected for assessment of QS-inhibitory activity. The drugs
selected on the basis of the docking results were tested for the ability to inhibit
LasR-controlled lasB::gfp gene expression from P. aeruginosa. Salicylic acid,
nifuroxazide, and chlorzoxazone were purchased from Sigma-Aldrich in their
pure form, while indoramine (Wydora; Riemser Arzneimittel AG), tiaprofenic
acid (Surgamyl; Patheon Ltd., United Kingdom), and donepezil (Aricept; Pfizer
SA) were acquired as pills. Stock solutions or suspensions of the compounds
were made by dissolving or suspending the compounds and pills in 96% ethanol.
The pill solutions were filtered to remove the binding material, and sufficient
content and purity of the active compounds were verified by high-performance
liquid chromatography (HPLC)-mass spectrometry (MS).
QS inhibition assays. The LasR inhibition assay was carried out by growing
the P. aeruginosa lasB::gfp strain in a 96-well microtiter tray (black polystyrene;
Nunc) together with serial twofold dilutions of the putative inhibitors as previ-
ously described with modifications (50). Briefly, growth medium and inhibitor
stock solution were initially added to the first column of wells to give a final
inhibitor concentration of 1,600 g/ml in a volume of 300 l. A volume of 150 l
of medium was added to each of the rest of the wells. Next, serial twofold
dilutions of the inhibitors were made by transferring 150 l of medium between
the wells in a sequential manner. The final two columns of wells were kept
without added inhibitor as a reference. Finally, 150 l of cell culture with an
optical density at 450 nm (OD450) of 0.2 was added to the wells to give a final
OD450 of 0.1 and inhibitor concentrations ranging from 800 g/ml to 1.5625
g/ml in a volume of 300 l. The added culture was prepared from an ON
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culture grown at 30°C by appropriate dilution with growth medium based on the
measurement of OD450. The OD of the ON culture was measured with a Thermo
Scientific GENESYS 10 UV spectrophotometer. The microtiter tray was incu-
bated at 34°C in a Wallac 1420 VICTOR2 plate reader (Perkin-Elmer, MA), and
the instrument was set to measure GFP(ASV) expression by means of the
protein’s fluorescence at 535 nm upon excitation at 485 nm and the growth in the
wells as the OD450 every 15 min for at least 14 h. The Rhl and Pqs inhibition
assays were carried out in essentially the same way as the LasR inhibition assay.
However, instead of using serial twofold dilutions, salicylic acid, nifuroxazide,
and chlorzoxazone were added to final concentrations of 200 g/ml, 200 g/ml,
and 100 g/ml, respectively.
LasR specificity assay. The LasR specificity assay was carried out in the same
way as the Rhl and Pqs inhibition assays. P. aeruginosa lasR harboring reporter
plasmid pMHRA or pAC37 was grown ON with the required antibiotics to
maintain the plasmids, while the assay was carried out without added antibiotics
to avoid secondary effects from the possible interaction between the antibiotics
and the added inhibitors.
Measurement of virulence factors. P. aeruginosa PAO1 and the QS-deficient
lasI rhlI strain were inoculated in modified BM2 medium to an OD600 of 0.01
from ON cultures of the two strains. Inhibitors were added from stock solutions
to a final concentration of 200 g/ml for salicylic acid and nifuroxazide and to a
final concentration of 100 g/ml for chlorzoxazone. After 18 h of growth at 37°C,
the OD600 of the cultures was measured and the assays were carried out. The OD
was measured with a Thermo Scientific GENESYS 10 UV spectrophotometer.
Regular BM2 medium was used as a blank sample. Estimation of exogenous
proteolytic activity was carried out as described by Hentzer et al. (28), with some
modifications. Briefly, 150 l of culture supernatant, centrifuged at 15,000  g
and 4°C for 15 min, was mixed with 250 l of an azocasein solution (2% [wt/vol]
in 2 mM CaCl2 and 40 mM Tris-HCl [pH 7.8]; Sigma-Aldrich) and allowed to
react for 45 min at 37°C. Undigested substrate was precipitated with 1.2 ml of
trichloroacetic acid (10% [wt/vol]) for 15 min at room temperature and subse-
quently centrifuged at 15,000  g for 10 min. Nine hundred microliters of the
supernatant was transferred to new Eppendorf tubes and mixed with 750 l of 1
M NaOH. Proteolytic activity was measured as the OD440 against a blank sample
FIG. 1. 2D structures of the compounds tested in this study. (A) Structures of the known LasR binding compounds used in the 2D similarity
search against the SuperNatural and SuperDrug databases (OdDHL, TP-1, furanone C30, and patulin) and included in the SB-VS for reference
(OdDHL) and comparison (all). (B) Structures of the six compounds tested for the ability to inhibit LasR in P. aeruginosa.
TABLE 1. Names and types of LasR binding compounds used as
references and for comparison in the SB-VS
Compound Type Reference
3-Oxo-C12-HSL Natural ligand 45
3-Oxo-C12-(2-aminophenol) Inhibitor 62
4-Nitropyridine-N-oxide Inhibitor 50
Furanone C30 Inhibitor 29
Patulin Inhibitor 51
Penicillic acid Inhibitor 51
TP-1 Activator 42
TP-5 Inhibitor 42
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run in parallel with the other samples and divided by the OD600 of the culture to
estimate the relative protease production. Pyoverdine production was measured
according to a spectrophotometric method previously described by Ho¨fte et al.
(32), with modifications. Briefly, the concentration of pyoverdine in the culture
supernatant was measured directly at 400 nm. Because the compound nifuroxa-
zide also absorbed light at 400 nm, a sample containing medium and nifuroxazide
was used as a control for measurement of the nifuroxazide-treated replicates.
Relative pyoverdine production was estimated as the OD400 divided by the
OD600 of the cultures. Rhamnolipid production was estimated by two modified
biosurfactant production assays: a drop collapse assay (5) and an emulsification
activity assay (10). For the drop collapse assay, 2-l spots of mineral oil were
added to the lid of a 96-well microtiter plate (Nunc). The lid was equilibrated for
1 h at room temperature, after which 5-l drops of culture supernatant were
added to the surface of the oil spots. The shape of the drops was inspected after
1 min. For the emulsification activity assay, 2 ml of n-hexadecane was added to
2 ml of culture supernatant. The mixture was vortexed at high speed for 2 min
and allowed to stand for 6 h before inspection. Emulsification activity was
defined as the height of the emulsion layer divided by the total height and
expressed as a percentage.
Cultivation of biofilms in flow chambers. Biofilms were grown for 4 days in
flow chambers with individual channel dimensions of 1 by 4 by 40 mm. The flow
system was assembled and prepared as described previously (63). Inoculation of
the system was carried out by injecting 300 l of an ON culture diluted to an
OD600 of 0.001 into each flow channel with a small syringe. After inoculation, the
flow chambers were left upside down without flow for 1 h to allow bacterial
attachment to the glass cover, after which medium flow was started with a
Watson Marlow 205S peristaltic pump. The flow chambers were irrigated with
medium with or without QSIs (salicylic acid at 20 g ml1, nifuroxazide at 20 g
ml1, and chlorzoxazone at 10 g ml1). The concentrations of the QSIs were
reduced by a factor of 10 compared to those in the batch assays due to the
continuous flowthrough of medium. The mean flow velocity in the flow chambers
was 0.2 mm s1, corresponding to laminar flow with a Reynolds number of 0.02.
The biofilms were grown at 30°C.
Microscopy and image acquisition. All microscopy observations and image
acquisitions were done with a Zeiss LSM510 confocal laser scanning microscope
(CLSM) equipped with detectors and filter sets for monitoring of GFP. Images
were obtained with a 40/1.3 objective. Simulated 3D images and sections were
generated with the Imaris software package (Bitplane AG).
COMSTAT image analysis. CLSM images were analyzed by use of the com-
puter program COMSTAT (30). Thresholds for the different image stacks were
determined automatically, and connected volume filtration was used in the
analysis.
S. liquefaciens swarming assay. Swarming plates consisted of ABT minimal
medium supplemented with glucose, Casamino Acids, and 0.6% Bacto agar.
QSIs were mixed into the medium immediately before casting at concentrations
of 200 g/ml for salicylic acid and nifuroxazide and 100 g/ml for chlorzoxazone.
The plates were left for drying without lids in a fume hood for 1 h at room
temperature. Five-microliter drops of 10-times-diluted ON cultures of S. lique-
faciens MG1 and an swrI mutant were placed on the appropriate plates and
incubated for 18 h at room temperature before pictures of each plate were taken.
The areas of the swarming zones were calculated by use of the free ImageJ
software. Measurements were done in triplicate. The viability of S. liquefaciens in
the presence of the QSI compounds was assessed by monitoring growth at 30°C
in a 96-well microtiter tray via OD600 measurement. The concentrations of the
QSI compounds were equal to those used in the swarming assay.
RESULTS
Virtual screening for LasR QSI candidates. The initial 2D
similarity search for drugs/natural compounds similar to the P.
aeruginosa LasR natural ligand 3-oxo-C12-HSL, the proven
QSIs furanone C30 and patulin, and the tri-phenyl LasR
agonist TP-1 (Fig. 1A) in the publicly available (http:
//bioinformatics.charite.de/content/index.php) SuperNatural
and SuperDrug databases (18, 26) resulted in 149 similar com-
pounds. A 3D structural database of the compounds was sub-
sequently docked against the ligand binding domain of LasR
(PDB ID: 2UV0) in the docking program MVD. Furthermore,
the screening included docking of the natural ligand itself and
structures of known LasR antagonists and agonists (Fig. 1A
and Table 1) for comparison. Six top-ranking drug/natural
ligands (Fig. 1B) displaying docking scores better than that of
the recognized QSI 4-nitropyridine-N-oxide (4-NPO), which
was set as the cutoff for selection, were acquired to test their
LasR-inhibitory potential. The docking scores of the six ac-
quired compounds, together with those of the OdDHL refer-
ence and the known LasR binding compounds, are displayed in
Table 2.
Determination of LasR inhibition. In order to determine the
QS-inhibitory potential of the six acquired drugs, they were
initially screened by means of a LasR inhibition assay based on
a lasB::gfp(ASV) translational fusion in P. aeruginosa PAO1.
lasB codes for the virulence factor elastase and has been shown
to be under the transcriptional control of LasR (22). As shown
in Fig. 2, three of the six compounds, salicylic acid, nifuroxa-
zide, and chlorzoxazone, showed significant reductions in the
number of relative fluorescence units (RFU) over time in a
dose-dependent manner. This suggests that the compounds
possess inhibitory activity against LasR and function as QSIs.
Furthermore, the compounds did not inhibit growth at the
concentrations used. These results are in accordance with the
finding that QS deficiency in P. aeruginosa exerts no effect on
the growth of the bacterium (25).
Inhibition of the Rhl and Pqs QS systems. The activity of the
three compounds salicylic acid, nifuroxazide, and chlorzoxa-
zone against LasR-controlled lasB::gfp expression prompted us
to investigate their inhibitory effects on the other major parts
of the P. aeruginosa QS circuit, the Rhl and Pqs systems, which
are both under LasR regulation (35, 60). Inhibition of the
systems was investigated by assays similar to the LasR assay,
with Rhl system inhibition being assessed by an rhlA::gfp(ASV)
translational fusion and the Pqs inhibition being assessed by a
pqsA::gfp(ASV) transcriptional fusion as described in Materials
and Methods. rhlA is the first gene of the rhlAB operon that
TABLE 2. Rerank scores, similarity scores, and molecular weights
of the acquired compounds, the reference ligand, and the
known LasR binding compounds included for comparisona
Compound Mol wt Similarityscore Rerank score
Acquired compounds
Indoramine 340.4 491.29 121.281
Nifuroxazide 274.2 447.124 86.3983
Tiaprofenic acid 258.3 396.031 71.4197
Donepezil 370.4 499.284 70.7016
Chlorzoxazone 169.6 344.493 69.6008
Salicylic acid 138.1 336.595 66.156
Reference, 3-oxo-C12-HSL 297.4 129.739
Known LasR binders
3-Oxo-C12-(2-
aminophenol)
305.4 470.817 93.8255
Patulin 154.1 354.068 70.1662
4-NPO 140.1 305.698 63.1366
Furanone C30 257.9 265.816 47.9107
Penicillic acid 170.2 315.516 75.4073
TP-1 568.6 497.462 220.864
TP-5 385.2 398.532 431.434
a The compounds were ranked on the basis of their rerank scores. The scores
of the individual compounds are the best of five scores derived from independent
docking rounds.
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codes for a rhamnosyltransferase essential for the production
of rhamnolipid, the major product controlled by the Rhl QS
system (44), and pqsA is the first gene of the pqsABCDE
operon that is required for production of the Pqs signal (21).
The two assays should thus give a relevant indication of the
levels of Rhl and Pqs QS system inhibition by the three iden-
tified active compounds. The compounds were tested at con-
centrations of 200 g/ml for salicylic acid and nifuroxazide and
100 g/ml for chlorzoxazone. These concentrations displayed
the largest degree of LasR inhibition without inhibiting growth
(Fig. 2). As Fig. 3A shows, treatment of the two reporter
strains with the three compounds resulted in a reduction of
RFU levels in all cases. The reductions were statistically sig-
nificant at the   0.01 level (single-factor analysis of variance
[ANOVA]). This added further evidence to the finding that the
three identified compounds induce conditions of reduced QS
activity in P. aeruginosa.
The results, however, were inconclusive regarding the spec-
ificity of the compounds. It could not be inferred if inhibition
of the Rhl and Pqs systems occurred solely as a result of LasR
inhibition or if the two systems were also directly inhibited by
the compounds. To investigate this further, the GFP reporter
plasmids for the two systems were introduced into a P. aerugi-
nosa lasR mutant. The fluorescence levels from these reporter
strains should only relate to the activity of the Rhl and Pqs
systems abolishing fluorescence occurring as a result of system
FIG. 2. Dose-response curves of the three drugs salicylic acid (A), nifuroxazide (B), and chlorzoxazone (C) when incubated together with PAO1
lasB::gfp(ASV). The three compounds reduce the RFU level (GFP fluorescence units divided by OD450) at various concentrations (right), indicating
inhibition of LasR, while displaying no effect on growth (left). Growth is displayed as the increase in OD450 compared to the initial level. Salicylic
acid and nifuroxazide were tested at concentrations of 400 (f), 200 (), 50 (F), 12.5 (), 3.125 (Œ), and 0 (E) g/ml, while chlorzoxazone was
tested at 200 (f), 100 (‚), 20 (F), 6.25 (), 1.5625 (Œ), and 0 (E) g/ml. Results are representative of three independent experiments.
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activation by LasR. As shown in Fig. 3B, expression of the
rhlA::gfp(ASV) and pqsA::gfp(ASV) reporters was significantly
lower in the P. aeruginosa lasR mutant than in the wild type, in
accordance with LasR acting as a positive regulator of both the
Rhl and Pqs systems. Interestingly, the experiment also showed
that the three compounds reduced the expression of the rhlA::
gfp(ASV) and pqsA::gfp(ASV) reporters in the lasR mutant
compared to that in the untreated lasR mutant, indicating that
the compounds, to some degree, exert an effect on the Rhl and
Pqs systems independently of the effects seen from LasR inhi-
bition.
Influence of QSIs on virulence factor production. We sub-
sequently tested the effects of our identified QSIs on the pro-
duction of three QS-controlled virulence factors: exogenous
proteases, pyoverdine, and rhamnolipid. The production of
exogenous proteases was assessed indirectly by measuring the
ability of culture supernatant to degrade the colored protein
substrate azocasein. Pyoverdine production was estimated
directly through spectrophotometric measurements of the
pyoverdine concentrations in culture supernatants. Rhamno-
lipid production was estimated indirectly by an emulsification
activity assay and a drop collapse assay that estimates the
presence of biosurfactants.
As shown in Fig. 4A, the three compounds significantly in-
hibited the production of exogenous proteases (  0.01; sin-
gle-factor ANOVA). However, it was evident that the reduc-
tion in protease production observed for the three inhibitors
was less than that observed in the QS-deficient lasI rhlI mutant
strain, suggesting that some QS activity remains in P. aerugi-
nosa when it is treated with the inhibitors at the concentrations
used. Treatment of P. aeruginosa with the three identified QSIs
resulted in a reduction in the supernatant levels of pyoverdine
(Fig. 4B), suggesting that the three compounds reduce the
production of the siderophore. The results were statistically
significant at the   0.01 level in a single-factor ANOVA.
Interestingly, inhibition of pyoverdine production occurred to
a greater extent than the inhibition of protease production and
the chlorzoxazone treatment resulted in pyoverdine levels
comparable to that of the P. aeruginosa lasI rhlI mutant. This
indicates that chlorzoxazone, at the concentration tested, is
able to reduce pyoverdine production to a level resembling the
level observed in QS deficiency. Finally, evidence was obtained
that rhamnolipid production was inhibited by the three
identified QSIs. An emulsification activity assay resulted in
activities that were significantly reduced in cultures treated
with the three compounds (  0.01; single-factor ANOVA)
compared to the activity in untreated wild-type cultures (Fig.
4C). As for the pyoverdine results, the emulsification results
indicate that chlorzoxazone has the ability to reduce rhamno-
FIG. 3. Expression of rhlA::gfp(ASV) (A) and pqsA::gfp(ASV)
(B) in wild-type and lasR mutant P. aeruginosa PAO1 treated with the
three identified LasR inhibitors. Results are average RFU values taken
from a single time point measurement corresponding to maximal in-
duction of the reporters in the late log phase of growth. Inhibitors were
added at concentrations of 200 g/ml for salicylic acid and nifuroxa-
zide and 100 g/ml for chlorzoxazone. Averages and SDs of eight
replicates are shown.
FIG. 4. Inhibition of exogenous protease production (A), pyover-
dine production (B), and rhamnolipid production (C) in P. aeruginosa
treated with the three identified LasR inhibitors. 1, untreated; 2, lasI
rhlI mutant (QS deficient); 3, salicylic acid treated; 4, nifuroxazide
treated; 5, chlorzoxazone treated. Results were taken after 18 h of
growth at 37°C. Averages and SDs of five replicates are shown. Relat.,
relative; activ., activity; prod., production.
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lipid production to a level resembling that seen in a QS-defi-
cient P. aeruginosa lasI rhlI mutant. The results were corrobo-
rated by a qualitative estimation of rhamnolipid production
based on a drop collapse biosurfactant assay (5), which indi-
cated that treatment with the three inhibitors affected the
production of rhamnolipid by P. aeruginosa as follows: wild
type, 100% production; lasI rhlI, 0%; salicylic acid treatment,
50%; nifuroxazide treatment, 25%; chlorzoxazone treatment,
0% (see Fig. S2 in the supplemental material).
Effects of the QSIs on flow chamber biofilm development.
QS has been reported to play an important role in P. aerugi-
nosa biofilm development and biofilm-related tolerance to an-
tibiotics (4, 15, 45). Evidence has previously been presented
that biofilms grown under conditions that repress QS are sub-
ject to sloughing (28), which may, at least in part, be caused by
a lack of extracellular DNA matrix material (1). This prompted
us to test the influence of the identified QSIs on P. aeruginosa
biofilm formation. Biofilms were grown on glucose minimal
medium in flow chambers in the presence or absence of non-
growth-inhibitory concentrations of the QSI compounds, and
as shown in Fig. 5, the characteristic mushroom-shaped struc-
tures normally observed in such P. aeruginosa biofilms (36)
were not present in the inhibitor-treated biofilms. Instead, the
inhibitor-treated biofilms resembled the QS-deficient P. aerugi-
nosa lasI rhlI biofilm both in structure (flat and relatively
unstructured) and in thickness. The finding that the inhibitor-
treated biofilms were flatter and less structured than the wild-
type biofilm was supported by objective image analysis.
COMSTAT analysis was used for estimation of the total bio-
mass present in biofilms formed by untreated, QSI treated, and
QS-deficient cells. As shown in Fig. 6, inhibitor-treated bio-
films contained less biomass than untreated biofilms, indicating
impairment of the ability of P. aeruginosa to develop or main-
tain biofilms when treated with the selected QSIs. In support of
these results, the QSI-treated biofilms had a total biomass
comparable to that of biofilms formed by the QS-deficient lasI
rhlI mutant strain.
Assessment of the inhibitory activity of the QSI compounds
in another microbial species. The results of the Rhl inhibition
assay and the LasR specificity assays indicated that the QSIs, in
addition to the effect seen through inhibition of LasR, to some
degree directly inhibit the activity of RhlR. It was therefore of
interest to investigate whether the three compounds could
FIG. 5. CLSM pictures of 4-day-old P. aeruginosa biofilms. A, untreated; B, lasI rhlI mutant (QS deficient); C, salicylic acid treated; D,
nifuroxazide treated; E, chlorzoxazone treated. The strains were GFP tagged for visualization. The main pictures are top-down 3D projections,
while the flanking pictures are vertical sections. Bars, 20 m.
FIG. 6. Results of COMSTAT analysis for total biomass calcula-
tion of the individual biofilms. 1, untreated; 2, lasI rhlI mutant (QS
deficient); 3, salicylic acid treated; 4, nifuroxazide treated; 5, chlor-
zoxazone treated. Averages and SDs from analysis of 12 images taken
at random positions in three different biofilms are shown.
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inhibit AHL-based QS in other organisms. S. liquefaciens uses
QS by means of C4-HSL and C6-HSL in the coordination of
cellular functions such as swarming motility (19). In order to
assess the activity of the QSIs on S. liquefaciens QS, we inves-
tigated the effects of the three compounds on S. liquefaciens
swarming motility. A reduction of the swarming zone was ob-
served when the bacteria were grown on agar with salicylic acid
(0.347 cm2; n  3, standard deviation [SD]  0.03) or chlor-
zoxazone (0.150 cm2; n  3, SD  0.007), compared to that of
bacteria grown on plates with no QSI (11.1 cm2; n  3, SD 
0.9). The sizes of the zones were similar to that of the zone
observed for an swrI mutant (0.143 cm2; n 3, SD 0.01) that
is defective in swarming motility due to a lack of AHL synthesis
(19). Nifuroxazide inhibited swarming at an intermediate, but
significant, level (5.41 cm2; n  3, SD  0.5). Growth experi-
ments confirmed that the QSIs do not affect the growth of S.
liquefaciens at the concentrations used in the swarmer assays
(data not shown). The results thus suggest that the three QSIs
also have the potential of inhibiting QS in organisms using
short-to-medium-chain AHLs.
Investigation of the structural features required for LasR-
inhibitory activity. It was of interest to investigate the pro-
posed binding of salicylic acid, nifuroxazide, and chlorzoxa-
zone to the LasR ligand binding domain as determined by the
docking program MVD compared to the binding modes pro-
posed by the program for known QSIs and the natural ligand
itself. Finding a certain pattern in the proposed interactions
between the active compounds and the binding site would be of
interest in the identification of other QSIs, as well as for op-
timization of the already discovered ones. As shown in Fig. 7A
to C, the three discovered QSIs were proposed to align with a
ring structure in place of the homoserine lactone moiety of the
natural ligand, a feature also proposed to occur for the LasR
antagonists 4-NPO and furanone C30 (Fig. 7D and E). This,
however, was the only pattern present since specific interac-
tions between the compounds and LasR revealed no similarity
and was therefore inadequate to improve the screening used in
the present study.
DISCUSSION
The increase in antibiotic resistance seen in P. aeruginosa
clinical isolates (8, 9) and their ability to form persistent infec-
tions through the formation of biofilms (13, 11) have drawn
attention to the improvement of current treatment strategies.
A great effort has been made to develop antipathogenic drugs
and strategies (29, 57, 61), especially by means of reducing
bacterial virulence through intercellular communication (QS).
Blocking of QS in P. aeruginosa by the use of QSIs has been
shown to be a promising strategy for the treatment of infec-
tions (29, 49), and a series of QSIs has been identified by
different groups through traditional methods (29, 42, 50, 62).
The traditional methods, however, have limitations that can be
complemented by novel computer-aided drug design (40, 54).
Use of X-ray crystallography-derived 3D structures for
structure-aided drug design is a common activity in drug dis-
covery today (14). In this process, the structures of macromo-
lecular targets, often proteins or protein complexes complexed
with their natural ligands or identified inhibitors, are solved
and the structural information is used to design inhibitors or
screen molecules for putative inhibitory activity. In the present
study, we have used structure-based virtual screening to iden-
tify novel P. aeruginosa QSIs. The database used consisted of
recognized drugs/natural ligands, i.e., compounds that have a
significant potential for the clinical treatment of P. aeruginosa
infections.
Our screening identified three compounds, salicylic acid,
nifuroxazide, and chlorzoxazone, that displayed QS-inhibitory
activity at concentrations that did not affect bacterial growth
(Fig. 2 and 3).
The results indicated a direct inhibition of LasR by the
compounds, and they were also shown to inhibit the two re-
maining QS systems in P. aeruginosa, Rhl and Pqs. As LasR
controls these two systems (35, 60), the observed inhibition
could be an effect resulting from LasR inhibition, as opposed
to direct inhibition of the two systems. To elaborate on the
specificity of the compounds, Rhl and Pqs inhibition was in-
vestigated in a P. aeruginosa lasR mutant. The results indicated
that the two systems were affected by the compounds to some
degree in the absence of LasR, which suggests that the three
identified QSIs directly affect the Rhl and Pqs systems as well.
Salicylic acid appears to be a fairly potent inhibiter of Pqs-
dependent signaling (Fig. 3), suggesting that this compound
might act as a Pqs signal antagonist. Further work could use-
fully include microarray experiments to gain more insight into
the mode of action of the three identified QSIs.
In addition, treatment of P. aeruginosa with the compounds
resulted in a decrease in the production of QS-controlled vir-
ulence factors (Fig. 4). Interestingly, treatment with chlorzoxa-
zone was found to result in virulence factor inhibition resem-
bling that of a lasI rhlI mutant. This result suggests that
chlorzoxazone has the potential to function as an effective
antipathogenic drug which can be used in the treatment of P.
aeruginosa infections. Treatment with salicylic acid and nifu-
roxazide resulted in virulence factor inhibition that occurred to
a lesser extent than that seen in the QS-deficient lasI rhlI
mutant strain, indicating that QS regulation is not completely
switched off by these two identified inhibitors at the concen-
trations tested. The facts that chlorzoxazone was less inhibitory
of lasB expression than salicylic acid and nifuroxazide (Fig. 2)
but displayed more potent virulence factor inhibition (Fig. 4)
support the findings that the identified QSIs affect the Rhl and
Pqs systems, in addition to the Las system. Compared to other
identified inhibitors, such as furanone C30, patulin, and peni-
cillic acid, the inhibitors discovered here are not as potent (29,
51), but the fact that the compounds are already approved
drugs for human use is a significant benefit in the further
application and development of antipathogenic drugs. Our
previously identified potent inhibitors are experimental drugs
and have been important for proof of concept (29, 51), but they
are not pharmaceutically relevant due to toxicity and
instability.
The three compounds salicylic acid, nifuroxazide, and chlor-
zoxazone were also found to alter biofilm formation by wild-
type P. aeruginosa PAO1. Treated biofilms were thinner and
less structured than untreated ones and resembled the biofilms
formed by the QS-deficient mutant (Fig. 5). An analysis of the
total biomass present in the biofilms showed that the inhibitor-
treated biofilms and the QS-deficient biofilm contained
roughly half the biomass of the wild-type biofilm (Fig. 6).
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FIG. 7. Scenes displaying the conformations (magenta) of the identified LasR inhibitors and known LasR inhibitors as proposed by MVD after
docking of the compounds. A, salicylic acid; B, nifuroxazide; C, chlorzoxazone; D, 4-NPO, the known LasR inhibitor used as cutoff in the docking;
E, furanone C30, a potent LasR and QSI; F, OdDHL, the natural LasR ligand, as it is present in the LasR crystal structure with its hydrogen bonds
(black lines) to the protein (green residues). In scenes A to E, hydrogen bonds proposed by MVD to occur upon binding are shown as black dotted
lines together with the interaction residues (green). The conformation of OdDHL (white) has been included in scenes A to E for comparison, and
the backbone of the LasR ligand binding domain is shown in blue-white with -helical residues 65 to 72 omitted for clarity.
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These results agree with a study by Davies et al. (15), who
presented evidence that QS is involved in the maturation of P.
aeruginosa biofilms. Furthermore, alteration of P. aeruginosa
biofilms through the action of QSIs has been shown to result in
a decrease in the tolerance of antibiotics and an increase in the
effectiveness of phagocytosis by polymorphonuclear leukocytes
(4, 13, 29). These observations emphasize the importance of
the ability to alter biofilm formation by blocking QS, as shown
by the inhibitors discovered in this study. Interestingly, the
prolonged continuous exposure of P. aeruginosa to salicylic
acid and nifuroxazide occurring in the flow chambers at de-
creased concentrations, compared to the virulence factor as-
says, apparently improved the potency of the compounds. This
indicates that the activity of the compounds, and QSIs in gen-
eral, against virulence factor production should also be as-
sessed in comparable treatment schemes to fully estimate the
potency of the compounds in question.
The finding that the three QSIs, to some degree, exerted
inhibitory effects on the Rhl QS system independently of LasR
prompted an investigation of QS inhibition in other bacterial
species that use AHLs similar in length to the Rhl system
autoinducer C4-HSL. The compounds were found to reduce
swarming motility of S. liquefaciens, which uses C4- and C6-
HSL for QS-regulated swarming (19). This result thus indi-
cates that the three compounds have the potential of inhibiting
QS in other bacterial species, which can have implications for
the treatment of mixed-species infections with, e.g., P. aerugi-
nosa and Burkholderia cenocepacia.
Salicylic acid is a small organic acid that is produced by
plants and functions in the induction of defense responses
against pathogenic attack (58). It is the major metabolite of
aspirin and is responsible for the antiinflammatory properties
of the drug in humans (31). In agreement with our findings,
previous studies have implicated salicylic acid in the reduction
of P. aeruginosa virulence (2, 48). Besides reducing the pro-
duction of virulence factors and biofilms, the compound was
shown to reduce the infectious potential of the bacterium
against the plant Arabidopsis thaliana and the nematode Cae-
norhabditis elegans (48). Our results confirm these previous
findings and directly establish salicylic acid as a QSI in P.
aeruginosa.
Nifuroxazide is a synthetic antimicrobial agent used in the
treatment of enteric infections (41). The antimicrobial effects
of the compound should, at first glance, prevent it from being
a useful antipathogenic drug. The results presented here (Fig.
2) showed, however, that the compound, at the concentrations
used, did not affect bacterial growth. This discrepancy between
the normal use of the compound and the observed effect is not
unique to nifuroxazide. Recent studies showed that ceftaz-
idime, tobramycin, and macrolide antibiotics, used at subin-
hibitory concentrations, displayed strong QS-inhibitory effects
(23, 60, 69). Thus, nifuroxazide should still be a candidate in
the development of antipathogenic drugs despite its antimicro-
bial activity at high concentrations.
The third drug found to be QS inhibitory, chlorzoxazone, is
a centrally acting muscle relaxant when administered to hu-
mans (46). In addition to its medical effects, the compound has
also been found to be hepatotoxic in some patients (47). The
high QSI activity of the compound at the concentrations
tested, however, makes the compound an interesting an-
tipathogenic drug candidate, and therefore the exact hepato-
toxic effects at the amounts required should be assessed before
the compound is excluded from further development. Due to
its small size, the compound may also be used as a lead com-
pound from which other nontoxic QSIs for use as antipatho-
genic drugs can be synthesized.
Our discovery of three new QSIs prompted us to investigate
the proposed binding of the three compounds to the LasR
ligand binding domain in order to improve the screening pro-
cedure. Knowing specific interactions required for inhibition is
of great value in the search for new inhibitors. A pattern in the
interactions between the molecule and its binding site indicat-
ing inhibitory activity was, however, not present (Fig. 7). The
identified feature of having a ring structure in place of the
homoserine lactone moiety of the natural ligand is inadequate
for screening improvement. This lack of features indicating
inhibitory activity should also be seen in light of the mode of
binding between LasR and its natural ligand. The structure of
LasR complexed to OdDHL reveals that the ligand is deeply
buried in a cavity inside the protein (7). Combined with results
displaying irreversible binding of the ligand to LasR (55), this
indicates that competitive binding of QSIs occurs with the
protein in a more open conformation. Therefore, the available
structure of the LasR ligand binding domain with bound
OdDHL may not be representative of the structure to which
the inhibitors bind, which is why structural features and inter-
actions required for inhibition may be impossible, or at least
difficult, to determine. The combination of SB-VS and a pre-
liminary similarity search for molecules similar to already
known LasR binding compounds presented here has, however,
proven to be successful in the discovery of new QSIs.
Despite its insufficiencies for using the structure of LasR as
a powerful tool in the future discovery of QSIs, the screening
strategy used here has proven successful, with a hit rate of 50%
(three active compounds out of six tested). Unlike the three
indentified QSIs, the three compounds that did not show QSI
activity were all from pills. Although HPLC-MS confirmed that
the extraction procedure was adequate, we cannot exclude the
possibility that some of the filler used in the pills binds the
active compound under the conditions of the experiment and
thereby limits its accessibility to the bacteria. (Oral delivery of
the pills to humans has the benefit of extremes of pH to disrupt
such binding.) The relatively small amount of compounds in-
cluded for the SB-VS renders the possibility of false negatives,
i.e., compounds with undiscovered activity that were discarded
on the basis of the virtual screening process. Despite the desire
to detect as many active compounds as possible, the occur-
rence of false negatives lies in the very nature of virtual screen-
ing. The methods used in the process are far from perfect,
resulting in the possible exclusion of active compounds. In the
screening strategy used here, the potent inhibitor furanone
C30 would have been discarded on the basis of the cutoff
values used. To avoid or reduce this phenomenon, an in-
creased number of compounds should be tested in future
searches.
In conclusion, we have used SB-VS for the identification of
three P. aeruginosa QSIs. One of them, salicylic acid, was
discovered previously to be an inhibitor of P. aeruginosa viru-
lence, including virulence regulated by QS, which has been
further established in this study. In addition, we have identified
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the two new QSIs nifuroxazide and chlorzoxazone. These two
compounds display a higher level of inhibition than salicylic
acid, with chlorzoxazone treatment resembling conditions of
QS deficiency, which is of particular interest in the further
development of effective antipathogenic drugs active against P.
aeruginosa.
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